1	where	_	Where	_	WRB	0	_	_	_	_	_	where.adv	Locative_relation	O
2	is	_	Is	_	VBZ	0	_	_	_	_	_	_	_	O
3	buprenorphine	_	UNK	_	NNP	0	_	_	_	_	_	_	_	O
4	dispensed	_	UNK	_	VBN	0	_	_	_	_	_	_	_	O
5	to	_	to	_	TO	0	_	_	_	_	_	_	_	O
6	treat	_	UNK	_	NNP	0	_	_	_	_	_	_	_	O
7	opioid	_	UNK	_	NNP	0	_	_	_	_	_	_	_	O
8	use	_	UNK	_	NNP	0	_	_	_	_	_	_	_	O
9	disorders	_	UNK	_	NNP	0	_	_	_	_	_	_	_	O
10	?	_	?	_	.	0	_	_	_	_	_	_	_	O

1	where	_	Where	_	WRB	0	_	_	_	_	_	_	_	O
2	is	_	Is	_	VBZ	0	_	_	_	_	_	_	_	O
3	buprenorphine	_	UNK	_	NNP	0	_	_	_	_	_	_	_	O
4	dispensed	_	UNK	_	VBN	0	_	_	_	_	_	_	_	O
5	to	_	to	_	TO	0	_	_	_	_	_	to.prep	Goal	O
6	treat	_	UNK	_	NNP	0	_	_	_	_	_	_	_	O
7	opioid	_	UNK	_	NNP	0	_	_	_	_	_	_	_	O
8	use	_	UNK	_	NNP	0	_	_	_	_	_	_	_	O
9	disorders	_	UNK	_	NNP	0	_	_	_	_	_	_	_	O
10	?	_	?	_	.	0	_	_	_	_	_	_	_	O

1	context	_	UNK	_	NN	2	_	_	_	_	_	_	_	O
2	:	_	:	_	:	2	_	_	_	_	_	_	_	O
3	opioid	_	UNK	_	NNP	2	_	_	_	_	_	_	_	O
4	use	_	use	_	NN	2	_	_	_	_	_	use.n	Ingest_substance	O
5	disorders	_	UNK	_	NNS	2	_	_	_	_	_	_	_	O
6	are	_	be	_	VBP	2	_	_	_	_	_	_	_	O
7	a	_	a	_	DT	2	_	_	_	_	_	_	_	O
8	significant	_	significant	_	JJ	2	_	_	_	_	_	_	_	O
9	public	_	public	_	JJ	2	_	_	_	_	_	_	_	O
10	health	_	health	_	NN	2	_	_	_	_	_	_	_	O
11	problem	_	problem	_	NN	2	_	_	_	_	_	_	_	O
12	.	_	.	_	.	2	_	_	_	_	_	_	_	O

1	context	_	UNK	_	NN	2	_	_	_	_	_	_	_	O
2	:	_	:	_	:	2	_	_	_	_	_	_	_	O
3	opioid	_	UNK	_	NNP	2	_	_	_	_	_	_	_	O
4	use	_	use	_	NN	2	_	_	_	_	_	_	_	O
5	disorders	_	UNK	_	NNS	2	_	_	_	_	_	_	_	O
6	are	_	be	_	VBP	2	_	_	_	_	_	_	_	O
7	a	_	a	_	DT	2	_	_	_	_	_	_	_	O
8	significant	_	significant	_	JJ	2	_	_	_	_	_	_	_	O
9	public	_	public	_	JJ	2	_	_	_	_	_	public.a	Secrecy_status	O
10	health	_	health	_	NN	2	_	_	_	_	_	_	_	O
11	problem	_	problem	_	NN	2	_	_	_	_	_	_	_	O
12	.	_	.	_	.	2	_	_	_	_	_	_	_	O

1	context	_	UNK	_	NN	2	_	_	_	_	_	_	_	O
2	:	_	:	_	:	2	_	_	_	_	_	_	_	O
3	opioid	_	UNK	_	NNP	2	_	_	_	_	_	_	_	O
4	use	_	use	_	NN	2	_	_	_	_	_	_	_	O
5	disorders	_	UNK	_	NNS	2	_	_	_	_	_	_	_	O
6	are	_	be	_	VBP	2	_	_	_	_	_	_	_	O
7	a	_	a	_	DT	2	_	_	_	_	_	_	_	O
8	significant	_	significant	_	JJ	2	_	_	_	_	_	_	_	O
9	public	_	public	_	JJ	2	_	_	_	_	_	_	_	O
10	health	_	health	_	NN	2	_	_	_	_	_	health.n	Medical_conditions	O
11	problem	_	problem	_	NN	2	_	_	_	_	_	_	_	O
12	.	_	.	_	.	2	_	_	_	_	_	_	_	O

1	context	_	UNK	_	NN	2	_	_	_	_	_	_	_	O
2	:	_	:	_	:	2	_	_	_	_	_	_	_	O
3	opioid	_	UNK	_	NNP	2	_	_	_	_	_	_	_	O
4	use	_	use	_	NN	2	_	_	_	_	_	_	_	O
5	disorders	_	UNK	_	NNS	2	_	_	_	_	_	_	_	O
6	are	_	be	_	VBP	2	_	_	_	_	_	_	_	O
7	a	_	a	_	DT	2	_	_	_	_	_	_	_	O
8	significant	_	significant	_	JJ	2	_	_	_	_	_	_	_	O
9	public	_	public	_	JJ	2	_	_	_	_	_	_	_	O
10	health	_	health	_	NN	2	_	_	_	_	_	_	_	O
11	problem	_	problem	_	NN	2	_	_	_	_	_	problem.n	Predicament	O
12	.	_	.	_	.	2	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	3	_	_	_	_	_	_	_	O
2	2002	_	2002	_	CD	3	_	_	_	_	_	_	_	O
3	,	_	,	_	,	3	_	_	_	_	_	_	_	O
4	the	_	the	_	DT	3	_	_	_	_	_	_	_	O
5	fda	_	FDA	_	NNP	3	_	_	_	_	_	_	_	O
6	approved	_	approve	_	VBD	3	_	_	_	_	_	approve.v	Deny_or_grant_permission	O
7	buprenorphine	_	UNK	_	RP	3	_	_	_	_	_	_	_	O
8	as	_	a	_	IN	3	_	_	_	_	_	_	_	O
9	an	_	an	_	DT	3	_	_	_	_	_	_	_	O
10	opioid	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
11	use	_	use	_	NN	3	_	_	_	_	_	_	_	O
12	disorder	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
13	treatment	_	treatment	_	NN	3	_	_	_	_	_	_	_	O
14	when	_	when	_	WRB	3	_	_	_	_	_	_	_	O
15	prescribed	_	UNK	_	VBN	3	_	_	_	_	_	_	_	O
16	by	_	by	_	IN	3	_	_	_	_	_	_	_	O
17	unk	_	UNK	_	JJ	3	_	_	_	_	_	_	_	O
18	physicians	_	UNK	_	NNS	3	_	_	_	_	_	_	_	O
19	who	_	who	_	WP	3	_	_	_	_	_	_	_	O
20	were	_	be	_	VBD	3	_	_	_	_	_	_	_	O
21	limited	_	limit	_	VBN	3	_	_	_	_	_	_	_	O
22	to	_	to	_	TO	3	_	_	_	_	_	_	_	O
23	treating	_	treat	_	VBG	3	_	_	_	_	_	_	_	O
24	30	_	30	_	CD	3	_	_	_	_	_	_	_	O
25	patients	_	patient	_	NNS	3	_	_	_	_	_	_	_	O
26	at	_	at	_	IN	3	_	_	_	_	_	_	_	O
27	a	_	a	_	DT	3	_	_	_	_	_	_	_	O
28	time	_	time	_	NN	3	_	_	_	_	_	_	_	O
29	.	_	.	_	.	3	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	3	_	_	_	_	_	_	_	O
2	2002	_	2002	_	CD	3	_	_	_	_	_	_	_	O
3	,	_	,	_	,	3	_	_	_	_	_	_	_	O
4	the	_	the	_	DT	3	_	_	_	_	_	_	_	O
5	fda	_	FDA	_	NNP	3	_	_	_	_	_	_	_	O
6	approved	_	approve	_	VBD	3	_	_	_	_	_	_	_	O
7	buprenorphine	_	UNK	_	RP	3	_	_	_	_	_	_	_	O
8	as	_	a	_	IN	3	_	_	_	_	_	_	_	O
9	an	_	an	_	DT	3	_	_	_	_	_	_	_	O
10	opioid	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
11	use	_	use	_	NN	3	_	_	_	_	_	use.n	Ingest_substance	O
12	disorder	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
13	treatment	_	treatment	_	NN	3	_	_	_	_	_	_	_	O
14	when	_	when	_	WRB	3	_	_	_	_	_	_	_	O
15	prescribed	_	UNK	_	VBN	3	_	_	_	_	_	_	_	O
16	by	_	by	_	IN	3	_	_	_	_	_	_	_	O
17	unk	_	UNK	_	JJ	3	_	_	_	_	_	_	_	O
18	physicians	_	UNK	_	NNS	3	_	_	_	_	_	_	_	O
19	who	_	who	_	WP	3	_	_	_	_	_	_	_	O
20	were	_	be	_	VBD	3	_	_	_	_	_	_	_	O
21	limited	_	limit	_	VBN	3	_	_	_	_	_	_	_	O
22	to	_	to	_	TO	3	_	_	_	_	_	_	_	O
23	treating	_	treat	_	VBG	3	_	_	_	_	_	_	_	O
24	30	_	30	_	CD	3	_	_	_	_	_	_	_	O
25	patients	_	patient	_	NNS	3	_	_	_	_	_	_	_	O
26	at	_	at	_	IN	3	_	_	_	_	_	_	_	O
27	a	_	a	_	DT	3	_	_	_	_	_	_	_	O
28	time	_	time	_	NN	3	_	_	_	_	_	_	_	O
29	.	_	.	_	.	3	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	3	_	_	_	_	_	_	_	O
2	2002	_	2002	_	CD	3	_	_	_	_	_	_	_	O
3	,	_	,	_	,	3	_	_	_	_	_	_	_	O
4	the	_	the	_	DT	3	_	_	_	_	_	_	_	O
5	fda	_	FDA	_	NNP	3	_	_	_	_	_	_	_	O
6	approved	_	approve	_	VBD	3	_	_	_	_	_	_	_	O
7	buprenorphine	_	UNK	_	RP	3	_	_	_	_	_	_	_	O
8	as	_	a	_	IN	3	_	_	_	_	_	_	_	O
9	an	_	an	_	DT	3	_	_	_	_	_	_	_	O
10	opioid	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
11	use	_	use	_	NN	3	_	_	_	_	_	_	_	O
12	disorder	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
13	treatment	_	treatment	_	NN	3	_	_	_	_	_	_	_	O
14	when	_	when	_	WRB	3	_	_	_	_	_	when.adv	Temporal_collocation	O
15	prescribed	_	UNK	_	VBN	3	_	_	_	_	_	_	_	O
16	by	_	by	_	IN	3	_	_	_	_	_	_	_	O
17	unk	_	UNK	_	JJ	3	_	_	_	_	_	_	_	O
18	physicians	_	UNK	_	NNS	3	_	_	_	_	_	_	_	O
19	who	_	who	_	WP	3	_	_	_	_	_	_	_	O
20	were	_	be	_	VBD	3	_	_	_	_	_	_	_	O
21	limited	_	limit	_	VBN	3	_	_	_	_	_	_	_	O
22	to	_	to	_	TO	3	_	_	_	_	_	_	_	O
23	treating	_	treat	_	VBG	3	_	_	_	_	_	_	_	O
24	30	_	30	_	CD	3	_	_	_	_	_	_	_	O
25	patients	_	patient	_	NNS	3	_	_	_	_	_	_	_	O
26	at	_	at	_	IN	3	_	_	_	_	_	_	_	O
27	a	_	a	_	DT	3	_	_	_	_	_	_	_	O
28	time	_	time	_	NN	3	_	_	_	_	_	_	_	O
29	.	_	.	_	.	3	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	3	_	_	_	_	_	_	_	O
2	2002	_	2002	_	CD	3	_	_	_	_	_	_	_	O
3	,	_	,	_	,	3	_	_	_	_	_	_	_	O
4	the	_	the	_	DT	3	_	_	_	_	_	_	_	O
5	fda	_	FDA	_	NNP	3	_	_	_	_	_	_	_	O
6	approved	_	approve	_	VBD	3	_	_	_	_	_	_	_	O
7	buprenorphine	_	UNK	_	RP	3	_	_	_	_	_	_	_	O
8	as	_	a	_	IN	3	_	_	_	_	_	_	_	O
9	an	_	an	_	DT	3	_	_	_	_	_	_	_	O
10	opioid	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
11	use	_	use	_	NN	3	_	_	_	_	_	_	_	O
12	disorder	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
13	treatment	_	treatment	_	NN	3	_	_	_	_	_	_	_	O
14	when	_	when	_	WRB	3	_	_	_	_	_	_	_	O
15	prescribed	_	UNK	_	VBN	3	_	_	_	_	_	_	_	O
16	by	_	by	_	IN	3	_	_	_	_	_	_	_	O
17	unk	_	UNK	_	JJ	3	_	_	_	_	_	_	_	O
18	physicians	_	UNK	_	NNS	3	_	_	_	_	_	_	_	O
19	who	_	who	_	WP	3	_	_	_	_	_	who.UNK	People	O
20	were	_	be	_	VBD	3	_	_	_	_	_	_	_	O
21	limited	_	limit	_	VBN	3	_	_	_	_	_	_	_	O
22	to	_	to	_	TO	3	_	_	_	_	_	_	_	O
23	treating	_	treat	_	VBG	3	_	_	_	_	_	_	_	O
24	30	_	30	_	CD	3	_	_	_	_	_	_	_	O
25	patients	_	patient	_	NNS	3	_	_	_	_	_	_	_	O
26	at	_	at	_	IN	3	_	_	_	_	_	_	_	O
27	a	_	a	_	DT	3	_	_	_	_	_	_	_	O
28	time	_	time	_	NN	3	_	_	_	_	_	_	_	O
29	.	_	.	_	.	3	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	3	_	_	_	_	_	_	_	O
2	2002	_	2002	_	CD	3	_	_	_	_	_	_	_	O
3	,	_	,	_	,	3	_	_	_	_	_	_	_	O
4	the	_	the	_	DT	3	_	_	_	_	_	_	_	O
5	fda	_	FDA	_	NNP	3	_	_	_	_	_	_	_	O
6	approved	_	approve	_	VBD	3	_	_	_	_	_	_	_	O
7	buprenorphine	_	UNK	_	RP	3	_	_	_	_	_	_	_	O
8	as	_	a	_	IN	3	_	_	_	_	_	_	_	O
9	an	_	an	_	DT	3	_	_	_	_	_	_	_	O
10	opioid	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
11	use	_	use	_	NN	3	_	_	_	_	_	_	_	O
12	disorder	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
13	treatment	_	treatment	_	NN	3	_	_	_	_	_	_	_	O
14	when	_	when	_	WRB	3	_	_	_	_	_	_	_	O
15	prescribed	_	UNK	_	VBN	3	_	_	_	_	_	_	_	O
16	by	_	by	_	IN	3	_	_	_	_	_	_	_	O
17	unk	_	UNK	_	JJ	3	_	_	_	_	_	_	_	O
18	physicians	_	UNK	_	NNS	3	_	_	_	_	_	_	_	O
19	who	_	who	_	WP	3	_	_	_	_	_	_	_	O
20	were	_	be	_	VBD	3	_	_	_	_	_	_	_	O
21	limited	_	limit	_	VBN	3	_	_	_	_	_	_	_	O
22	to	_	to	_	TO	3	_	_	_	_	_	to.prep	Goal	O
23	treating	_	treat	_	VBG	3	_	_	_	_	_	_	_	O
24	30	_	30	_	CD	3	_	_	_	_	_	_	_	O
25	patients	_	patient	_	NNS	3	_	_	_	_	_	_	_	O
26	at	_	at	_	IN	3	_	_	_	_	_	_	_	O
27	a	_	a	_	DT	3	_	_	_	_	_	_	_	O
28	time	_	time	_	NN	3	_	_	_	_	_	_	_	O
29	.	_	.	_	.	3	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	3	_	_	_	_	_	_	_	O
2	2002	_	2002	_	CD	3	_	_	_	_	_	_	_	O
3	,	_	,	_	,	3	_	_	_	_	_	_	_	O
4	the	_	the	_	DT	3	_	_	_	_	_	_	_	O
5	fda	_	FDA	_	NNP	3	_	_	_	_	_	_	_	O
6	approved	_	approve	_	VBD	3	_	_	_	_	_	_	_	O
7	buprenorphine	_	UNK	_	RP	3	_	_	_	_	_	_	_	O
8	as	_	a	_	IN	3	_	_	_	_	_	_	_	O
9	an	_	an	_	DT	3	_	_	_	_	_	_	_	O
10	opioid	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
11	use	_	use	_	NN	3	_	_	_	_	_	_	_	O
12	disorder	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
13	treatment	_	treatment	_	NN	3	_	_	_	_	_	_	_	O
14	when	_	when	_	WRB	3	_	_	_	_	_	_	_	O
15	prescribed	_	UNK	_	VBN	3	_	_	_	_	_	_	_	O
16	by	_	by	_	IN	3	_	_	_	_	_	_	_	O
17	unk	_	UNK	_	JJ	3	_	_	_	_	_	_	_	O
18	physicians	_	UNK	_	NNS	3	_	_	_	_	_	_	_	O
19	who	_	who	_	WP	3	_	_	_	_	_	_	_	O
20	were	_	be	_	VBD	3	_	_	_	_	_	_	_	O
21	limited	_	limit	_	VBN	3	_	_	_	_	_	_	_	O
22	to	_	to	_	TO	3	_	_	_	_	_	_	_	O
23	treating	_	treat	_	VBG	3	_	_	_	_	_	treat.v	Processing_materials	O
24	30	_	30	_	CD	3	_	_	_	_	_	_	_	O
25	patients	_	patient	_	NNS	3	_	_	_	_	_	_	_	O
26	at	_	at	_	IN	3	_	_	_	_	_	_	_	O
27	a	_	a	_	DT	3	_	_	_	_	_	_	_	O
28	time	_	time	_	NN	3	_	_	_	_	_	_	_	O
29	.	_	.	_	.	3	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	3	_	_	_	_	_	_	_	O
2	2002	_	2002	_	CD	3	_	_	_	_	_	_	_	O
3	,	_	,	_	,	3	_	_	_	_	_	_	_	O
4	the	_	the	_	DT	3	_	_	_	_	_	_	_	O
5	fda	_	FDA	_	NNP	3	_	_	_	_	_	_	_	O
6	approved	_	approve	_	VBD	3	_	_	_	_	_	_	_	O
7	buprenorphine	_	UNK	_	RP	3	_	_	_	_	_	_	_	O
8	as	_	a	_	IN	3	_	_	_	_	_	_	_	O
9	an	_	an	_	DT	3	_	_	_	_	_	_	_	O
10	opioid	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
11	use	_	use	_	NN	3	_	_	_	_	_	_	_	O
12	disorder	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
13	treatment	_	treatment	_	NN	3	_	_	_	_	_	_	_	O
14	when	_	when	_	WRB	3	_	_	_	_	_	_	_	O
15	prescribed	_	UNK	_	VBN	3	_	_	_	_	_	_	_	O
16	by	_	by	_	IN	3	_	_	_	_	_	_	_	O
17	unk	_	UNK	_	JJ	3	_	_	_	_	_	_	_	O
18	physicians	_	UNK	_	NNS	3	_	_	_	_	_	_	_	O
19	who	_	who	_	WP	3	_	_	_	_	_	_	_	O
20	were	_	be	_	VBD	3	_	_	_	_	_	_	_	O
21	limited	_	limit	_	VBN	3	_	_	_	_	_	_	_	O
22	to	_	to	_	TO	3	_	_	_	_	_	_	_	O
23	treating	_	treat	_	VBG	3	_	_	_	_	_	_	_	O
24	30	_	30	_	CD	3	_	_	_	_	_	_	_	O
25	patients	_	patient	_	NNS	3	_	_	_	_	_	_	_	O
26	at	_	at	_	IN	3	_	_	_	_	_	_	_	O
27	a	_	a	_	DT	3	_	_	_	_	_	_	_	O
28	time	_	time	_	NN	3	_	_	_	_	_	time.n	Measure_duration	O
29	.	_	.	_	.	3	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	4	_	_	_	_	_	_	_	O
2	2006	_	2006	_	CD	4	_	_	_	_	_	_	_	O
3	,	_	,	_	,	4	_	_	_	_	_	_	_	O
4	federal	_	federal	_	JJ	4	_	_	_	_	_	federal.a	Political_locales	O
5	legislation	_	UNK	_	NN	4	_	_	_	_	_	_	_	O
6	raised	_	raise	_	VBD	4	_	_	_	_	_	_	_	O
7	this	_	this	_	DT	4	_	_	_	_	_	_	_	O
8	number	_	number	_	NN	4	_	_	_	_	_	_	_	O
9	to	_	to	_	TO	4	_	_	_	_	_	_	_	O
10	100	_	100	_	CD	4	_	_	_	_	_	_	_	O
11	patients	_	patient	_	NNS	4	_	_	_	_	_	_	_	O
12	.	_	.	_	.	4	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	4	_	_	_	_	_	_	_	O
2	2006	_	2006	_	CD	4	_	_	_	_	_	_	_	O
3	,	_	,	_	,	4	_	_	_	_	_	_	_	O
4	federal	_	federal	_	JJ	4	_	_	_	_	_	_	_	O
5	legislation	_	UNK	_	NN	4	_	_	_	_	_	_	_	O
6	raised	_	raise	_	VBD	4	_	_	_	_	_	_	_	O
7	this	_	this	_	DT	4	_	_	_	_	_	_	_	O
8	number	_	number	_	NN	4	_	_	_	_	_	number.n	Be_subset_of	O
9	to	_	to	_	TO	4	_	_	_	_	_	_	_	O
10	100	_	100	_	CD	4	_	_	_	_	_	_	_	O
11	patients	_	patient	_	NNS	4	_	_	_	_	_	_	_	O
12	.	_	.	_	.	4	_	_	_	_	_	_	_	O

1	in	_	In	_	IN	4	_	_	_	_	_	_	_	O
2	2006	_	2006	_	CD	4	_	_	_	_	_	_	_	O
3	,	_	,	_	,	4	_	_	_	_	_	_	_	O
4	federal	_	federal	_	JJ	4	_	_	_	_	_	_	_	O
5	legislation	_	UNK	_	NN	4	_	_	_	_	_	_	_	O
6	raised	_	raise	_	VBD	4	_	_	_	_	_	_	_	O
7	this	_	this	_	DT	4	_	_	_	_	_	_	_	O
8	number	_	number	_	NN	4	_	_	_	_	_	_	_	O
9	to	_	to	_	TO	4	_	_	_	_	_	to.prep	Goal	O
10	100	_	100	_	CD	4	_	_	_	_	_	_	_	O
11	patients	_	patient	_	NNS	4	_	_	_	_	_	_	_	O
12	.	_	.	_	.	4	_	_	_	_	_	_	_	O

1	although	_	Although	_	IN	5	_	_	_	_	_	although.scon	Concessive	O
2	federal	_	federal	_	JJ	5	_	_	_	_	_	_	_	O
3	legislators	_	legislator	_	NNS	5	_	_	_	_	_	_	_	O
4	are	_	be	_	VBP	5	_	_	_	_	_	_	_	O
5	considering	_	consider	_	VBG	5	_	_	_	_	_	_	_	O
6	increasing	_	increase	_	VBG	5	_	_	_	_	_	_	_	O
7	these	_	these	_	DT	5	_	_	_	_	_	_	_	O
8	limits	_	limit	_	NNS	5	_	_	_	_	_	_	_	O
9	further	_	further	_	RBR	5	_	_	_	_	_	_	_	O
10	and	_	and	_	CC	5	_	_	_	_	_	_	_	O
11	expanding	_	expand	_	VBG	5	_	_	_	_	_	_	_	O
12	prescribing	_	UNK	_	VBG	5	_	_	_	_	_	_	_	O
13	privileges	_	privilege	_	NNS	5	_	_	_	_	_	_	_	O
14	to	_	to	_	TO	5	_	_	_	_	_	_	_	O
15	unk	_	UNK	_	NNS	5	_	_	_	_	_	_	_	O
16	,	_	,	_	,	5	_	_	_	_	_	_	_	O
17	little	_	little	_	JJ	5	_	_	_	_	_	_	_	O
18	information	_	information	_	NN	5	_	_	_	_	_	_	_	O
19	is	_	be	_	VBZ	5	_	_	_	_	_	_	_	O
20	available	_	available	_	JJ	5	_	_	_	_	_	_	_	O
21	regarding	_	regard	_	VBG	5	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	5	_	_	_	_	_	_	_	O
23	impact	_	impact	_	NN	5	_	_	_	_	_	_	_	O
24	of	_	of	_	IN	5	_	_	_	_	_	_	_	O
25	such	_	such	_	JJ	5	_	_	_	_	_	_	_	O
26	changes	_	change	_	NNS	5	_	_	_	_	_	_	_	O
27	on	_	on	_	IN	5	_	_	_	_	_	_	_	O
28	buprenorphine	_	UNK	_	NN	5	_	_	_	_	_	_	_	O
29	use	_	use	_	NN	5	_	_	_	_	_	_	_	O
30	.	_	.	_	.	5	_	_	_	_	_	_	_	O

1	although	_	Although	_	IN	5	_	_	_	_	_	_	_	O
2	federal	_	federal	_	JJ	5	_	_	_	_	_	federal.a	Political_locales	O
3	legislators	_	legislator	_	NNS	5	_	_	_	_	_	_	_	O
4	are	_	be	_	VBP	5	_	_	_	_	_	_	_	O
5	considering	_	consider	_	VBG	5	_	_	_	_	_	_	_	O
6	increasing	_	increase	_	VBG	5	_	_	_	_	_	_	_	O
7	these	_	these	_	DT	5	_	_	_	_	_	_	_	O
8	limits	_	limit	_	NNS	5	_	_	_	_	_	_	_	O
9	further	_	further	_	RBR	5	_	_	_	_	_	_	_	O
10	and	_	and	_	CC	5	_	_	_	_	_	_	_	O
11	expanding	_	expand	_	VBG	5	_	_	_	_	_	_	_	O
12	prescribing	_	UNK	_	VBG	5	_	_	_	_	_	_	_	O
13	privileges	_	privilege	_	NNS	5	_	_	_	_	_	_	_	O
14	to	_	to	_	TO	5	_	_	_	_	_	_	_	O
15	unk	_	UNK	_	NNS	5	_	_	_	_	_	_	_	O
16	,	_	,	_	,	5	_	_	_	_	_	_	_	O
17	little	_	little	_	JJ	5	_	_	_	_	_	_	_	O
18	information	_	information	_	NN	5	_	_	_	_	_	_	_	O
19	is	_	be	_	VBZ	5	_	_	_	_	_	_	_	O
20	available	_	available	_	JJ	5	_	_	_	_	_	_	_	O
21	regarding	_	regard	_	VBG	5	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	5	_	_	_	_	_	_	_	O
23	impact	_	impact	_	NN	5	_	_	_	_	_	_	_	O
24	of	_	of	_	IN	5	_	_	_	_	_	_	_	O
25	such	_	such	_	JJ	5	_	_	_	_	_	_	_	O
26	changes	_	change	_	NNS	5	_	_	_	_	_	_	_	O
27	on	_	on	_	IN	5	_	_	_	_	_	_	_	O
28	buprenorphine	_	UNK	_	NN	5	_	_	_	_	_	_	_	O
29	use	_	use	_	NN	5	_	_	_	_	_	_	_	O
30	.	_	.	_	.	5	_	_	_	_	_	_	_	O

1	although	_	Although	_	IN	5	_	_	_	_	_	_	_	O
2	federal	_	federal	_	JJ	5	_	_	_	_	_	_	_	O
3	legislators	_	legislator	_	NNS	5	_	_	_	_	_	_	_	O
4	are	_	be	_	VBP	5	_	_	_	_	_	_	_	O
5	considering	_	consider	_	VBG	5	_	_	_	_	_	_	_	O
6	increasing	_	increase	_	VBG	5	_	_	_	_	_	increase.v	Change_position_on_a_scale	O
7	these	_	these	_	DT	5	_	_	_	_	_	_	_	O
8	limits	_	limit	_	NNS	5	_	_	_	_	_	_	_	O
9	further	_	further	_	RBR	5	_	_	_	_	_	_	_	O
10	and	_	and	_	CC	5	_	_	_	_	_	_	_	O
11	expanding	_	expand	_	VBG	5	_	_	_	_	_	_	_	O
12	prescribing	_	UNK	_	VBG	5	_	_	_	_	_	_	_	O
13	privileges	_	privilege	_	NNS	5	_	_	_	_	_	_	_	O
14	to	_	to	_	TO	5	_	_	_	_	_	_	_	O
15	unk	_	UNK	_	NNS	5	_	_	_	_	_	_	_	O
16	,	_	,	_	,	5	_	_	_	_	_	_	_	O
17	little	_	little	_	JJ	5	_	_	_	_	_	_	_	O
18	information	_	information	_	NN	5	_	_	_	_	_	_	_	O
19	is	_	be	_	VBZ	5	_	_	_	_	_	_	_	O
20	available	_	available	_	JJ	5	_	_	_	_	_	_	_	O
21	regarding	_	regard	_	VBG	5	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	5	_	_	_	_	_	_	_	O
23	impact	_	impact	_	NN	5	_	_	_	_	_	_	_	O
24	of	_	of	_	IN	5	_	_	_	_	_	_	_	O
25	such	_	such	_	JJ	5	_	_	_	_	_	_	_	O
26	changes	_	change	_	NNS	5	_	_	_	_	_	_	_	O
27	on	_	on	_	IN	5	_	_	_	_	_	_	_	O
28	buprenorphine	_	UNK	_	NN	5	_	_	_	_	_	_	_	O
29	use	_	use	_	NN	5	_	_	_	_	_	_	_	O
30	.	_	.	_	.	5	_	_	_	_	_	_	_	O

1	although	_	Although	_	IN	5	_	_	_	_	_	_	_	O
2	federal	_	federal	_	JJ	5	_	_	_	_	_	_	_	O
3	legislators	_	legislator	_	NNS	5	_	_	_	_	_	_	_	O
4	are	_	be	_	VBP	5	_	_	_	_	_	_	_	O
5	considering	_	consider	_	VBG	5	_	_	_	_	_	_	_	O
6	increasing	_	increase	_	VBG	5	_	_	_	_	_	_	_	O
7	these	_	these	_	DT	5	_	_	_	_	_	_	_	O
8	limits	_	limit	_	NNS	5	_	_	_	_	_	limit.n	Limitation	O
9	further	_	further	_	RBR	5	_	_	_	_	_	_	_	O
10	and	_	and	_	CC	5	_	_	_	_	_	_	_	O
11	expanding	_	expand	_	VBG	5	_	_	_	_	_	_	_	O
12	prescribing	_	UNK	_	VBG	5	_	_	_	_	_	_	_	O
13	privileges	_	privilege	_	NNS	5	_	_	_	_	_	_	_	O
14	to	_	to	_	TO	5	_	_	_	_	_	_	_	O
15	unk	_	UNK	_	NNS	5	_	_	_	_	_	_	_	O
16	,	_	,	_	,	5	_	_	_	_	_	_	_	O
17	little	_	little	_	JJ	5	_	_	_	_	_	_	_	O
18	information	_	information	_	NN	5	_	_	_	_	_	_	_	O
19	is	_	be	_	VBZ	5	_	_	_	_	_	_	_	O
20	available	_	available	_	JJ	5	_	_	_	_	_	_	_	O
21	regarding	_	regard	_	VBG	5	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	5	_	_	_	_	_	_	_	O
23	impact	_	impact	_	NN	5	_	_	_	_	_	_	_	O
24	of	_	of	_	IN	5	_	_	_	_	_	_	_	O
25	such	_	such	_	JJ	5	_	_	_	_	_	_	_	O
26	changes	_	change	_	NNS	5	_	_	_	_	_	_	_	O
27	on	_	on	_	IN	5	_	_	_	_	_	_	_	O
28	buprenorphine	_	UNK	_	NN	5	_	_	_	_	_	_	_	O
29	use	_	use	_	NN	5	_	_	_	_	_	_	_	O
30	.	_	.	_	.	5	_	_	_	_	_	_	_	O

1	although	_	Although	_	IN	5	_	_	_	_	_	_	_	O
2	federal	_	federal	_	JJ	5	_	_	_	_	_	_	_	O
3	legislators	_	legislator	_	NNS	5	_	_	_	_	_	_	_	O
4	are	_	be	_	VBP	5	_	_	_	_	_	_	_	O
5	considering	_	consider	_	VBG	5	_	_	_	_	_	_	_	O
6	increasing	_	increase	_	VBG	5	_	_	_	_	_	_	_	O
7	these	_	these	_	DT	5	_	_	_	_	_	_	_	O
8	limits	_	limit	_	NNS	5	_	_	_	_	_	_	_	O
9	further	_	further	_	RBR	5	_	_	_	_	_	further.a	Increment	O
10	and	_	and	_	CC	5	_	_	_	_	_	_	_	O
11	expanding	_	expand	_	VBG	5	_	_	_	_	_	_	_	O
12	prescribing	_	UNK	_	VBG	5	_	_	_	_	_	_	_	O
13	privileges	_	privilege	_	NNS	5	_	_	_	_	_	_	_	O
14	to	_	to	_	TO	5	_	_	_	_	_	_	_	O
15	unk	_	UNK	_	NNS	5	_	_	_	_	_	_	_	O
16	,	_	,	_	,	5	_	_	_	_	_	_	_	O
17	little	_	little	_	JJ	5	_	_	_	_	_	_	_	O
18	information	_	information	_	NN	5	_	_	_	_	_	_	_	O
19	is	_	be	_	VBZ	5	_	_	_	_	_	_	_	O
20	available	_	available	_	JJ	5	_	_	_	_	_	_	_	O
21	regarding	_	regard	_	VBG	5	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	5	_	_	_	_	_	_	_	O
23	impact	_	impact	_	NN	5	_	_	_	_	_	_	_	O
24	of	_	of	_	IN	5	_	_	_	_	_	_	_	O
25	such	_	such	_	JJ	5	_	_	_	_	_	_	_	O
26	changes	_	change	_	NNS	5	_	_	_	_	_	_	_	O
27	on	_	on	_	IN	5	_	_	_	_	_	_	_	O
28	buprenorphine	_	UNK	_	NN	5	_	_	_	_	_	_	_	O
29	use	_	use	_	NN	5	_	_	_	_	_	_	_	O
30	.	_	.	_	.	5	_	_	_	_	_	_	_	O

1	although	_	Although	_	IN	5	_	_	_	_	_	_	_	O
2	federal	_	federal	_	JJ	5	_	_	_	_	_	_	_	O
3	legislators	_	legislator	_	NNS	5	_	_	_	_	_	_	_	O
4	are	_	be	_	VBP	5	_	_	_	_	_	_	_	O
5	considering	_	consider	_	VBG	5	_	_	_	_	_	_	_	O
6	increasing	_	increase	_	VBG	5	_	_	_	_	_	_	_	O
7	these	_	these	_	DT	5	_	_	_	_	_	_	_	O
8	limits	_	limit	_	NNS	5	_	_	_	_	_	_	_	O
9	further	_	further	_	RBR	5	_	_	_	_	_	_	_	O
10	and	_	and	_	CC	5	_	_	_	_	_	_	_	O
11	expanding	_	expand	_	VBG	5	_	_	_	_	_	expand.v	Cause_expansion	O
12	prescribing	_	UNK	_	VBG	5	_	_	_	_	_	_	_	O
13	privileges	_	privilege	_	NNS	5	_	_	_	_	_	_	_	O
14	to	_	to	_	TO	5	_	_	_	_	_	_	_	O
15	unk	_	UNK	_	NNS	5	_	_	_	_	_	_	_	O
16	,	_	,	_	,	5	_	_	_	_	_	_	_	O
17	little	_	little	_	JJ	5	_	_	_	_	_	_	_	O
18	information	_	information	_	NN	5	_	_	_	_	_	_	_	O
19	is	_	be	_	VBZ	5	_	_	_	_	_	_	_	O
20	available	_	available	_	JJ	5	_	_	_	_	_	_	_	O
21	regarding	_	regard	_	VBG	5	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	5	_	_	_	_	_	_	_	O
23	impact	_	impact	_	NN	5	_	_	_	_	_	_	_	O
24	of	_	of	_	IN	5	_	_	_	_	_	_	_	O
25	such	_	such	_	JJ	5	_	_	_	_	_	_	_	O
26	changes	_	change	_	NNS	5	_	_	_	_	_	_	_	O
27	on	_	on	_	IN	5	_	_	_	_	_	_	_	O
28	buprenorphine	_	UNK	_	NN	5	_	_	_	_	_	_	_	O
29	use	_	use	_	NN	5	_	_	_	_	_	_	_	O
30	.	_	.	_	.	5	_	_	_	_	_	_	_	O

1	although	_	Although	_	IN	5	_	_	_	_	_	_	_	O
2	federal	_	federal	_	JJ	5	_	_	_	_	_	_	_	O
3	legislators	_	legislator	_	NNS	5	_	_	_	_	_	_	_	O
4	are	_	be	_	VBP	5	_	_	_	_	_	_	_	O
5	considering	_	consider	_	VBG	5	_	_	_	_	_	_	_	O
6	increasing	_	increase	_	VBG	5	_	_	_	_	_	_	_	O
7	these	_	these	_	DT	5	_	_	_	_	_	_	_	O
8	limits	_	limit	_	NNS	5	_	_	_	_	_	_	_	O
9	further	_	further	_	RBR	5	_	_	_	_	_	_	_	O
10	and	_	and	_	CC	5	_	_	_	_	_	_	_	O
11	expanding	_	expand	_	VBG	5	_	_	_	_	_	_	_	O
12	prescribing	_	UNK	_	VBG	5	_	_	_	_	_	_	_	O
13	privileges	_	privilege	_	NNS	5	_	_	_	_	_	_	_	O
14	to	_	to	_	TO	5	_	_	_	_	_	to.prep	Goal	O
15	unk	_	UNK	_	NNS	5	_	_	_	_	_	_	_	O
16	,	_	,	_	,	5	_	_	_	_	_	_	_	O
17	little	_	little	_	JJ	5	_	_	_	_	_	_	_	O
18	information	_	information	_	NN	5	_	_	_	_	_	_	_	O
19	is	_	be	_	VBZ	5	_	_	_	_	_	_	_	O
20	available	_	available	_	JJ	5	_	_	_	_	_	_	_	O
21	regarding	_	regard	_	VBG	5	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	5	_	_	_	_	_	_	_	O
23	impact	_	impact	_	NN	5	_	_	_	_	_	_	_	O
24	of	_	of	_	IN	5	_	_	_	_	_	_	_	O
25	such	_	such	_	JJ	5	_	_	_	_	_	_	_	O
26	changes	_	change	_	NNS	5	_	_	_	_	_	_	_	O
27	on	_	on	_	IN	5	_	_	_	_	_	_	_	O
28	buprenorphine	_	UNK	_	NN	5	_	_	_	_	_	_	_	O
29	use	_	use	_	NN	5	_	_	_	_	_	_	_	O
30	.	_	.	_	.	5	_	_	_	_	_	_	_	O

1	although	_	Although	_	IN	5	_	_	_	_	_	_	_	O
2	federal	_	federal	_	JJ	5	_	_	_	_	_	_	_	O
3	legislators	_	legislator	_	NNS	5	_	_	_	_	_	_	_	O
4	are	_	be	_	VBP	5	_	_	_	_	_	_	_	O
5	considering	_	consider	_	VBG	5	_	_	_	_	_	_	_	O
6	increasing	_	increase	_	VBG	5	_	_	_	_	_	_	_	O
7	these	_	these	_	DT	5	_	_	_	_	_	_	_	O
8	limits	_	limit	_	NNS	5	_	_	_	_	_	_	_	O
9	further	_	further	_	RBR	5	_	_	_	_	_	_	_	O
10	and	_	and	_	CC	5	_	_	_	_	_	_	_	O
11	expanding	_	expand	_	VBG	5	_	_	_	_	_	_	_	O
12	prescribing	_	UNK	_	VBG	5	_	_	_	_	_	_	_	O
13	privileges	_	privilege	_	NNS	5	_	_	_	_	_	_	_	O
14	to	_	to	_	TO	5	_	_	_	_	_	_	_	O
15	unk	_	UNK	_	NNS	5	_	_	_	_	_	_	_	O
16	,	_	,	_	,	5	_	_	_	_	_	_	_	O
17	little	_	little	_	JJ	5	_	_	_	_	_	little.a	Size	O
18	information	_	information	_	NN	5	_	_	_	_	_	_	_	O
19	is	_	be	_	VBZ	5	_	_	_	_	_	_	_	O
20	available	_	available	_	JJ	5	_	_	_	_	_	_	_	O
21	regarding	_	regard	_	VBG	5	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	5	_	_	_	_	_	_	_	O
23	impact	_	impact	_	NN	5	_	_	_	_	_	_	_	O
24	of	_	of	_	IN	5	_	_	_	_	_	_	_	O
25	such	_	such	_	JJ	5	_	_	_	_	_	_	_	O
26	changes	_	change	_	NNS	5	_	_	_	_	_	_	_	O
27	on	_	on	_	IN	5	_	_	_	_	_	_	_	O
28	buprenorphine	_	UNK	_	NN	5	_	_	_	_	_	_	_	O
29	use	_	use	_	NN	5	_	_	_	_	_	_	_	O
30	.	_	.	_	.	5	_	_	_	_	_	_	_	O

1	although	_	Although	_	IN	5	_	_	_	_	_	_	_	O
2	federal	_	federal	_	JJ	5	_	_	_	_	_	_	_	O
3	legislators	_	legislator	_	NNS	5	_	_	_	_	_	_	_	O
4	are	_	be	_	VBP	5	_	_	_	_	_	_	_	O
5	considering	_	consider	_	VBG	5	_	_	_	_	_	_	_	O
6	increasing	_	increase	_	VBG	5	_	_	_	_	_	_	_	O
7	these	_	these	_	DT	5	_	_	_	_	_	_	_	O
8	limits	_	limit	_	NNS	5	_	_	_	_	_	_	_	O
9	further	_	further	_	RBR	5	_	_	_	_	_	_	_	O
10	and	_	and	_	CC	5	_	_	_	_	_	_	_	O
11	expanding	_	expand	_	VBG	5	_	_	_	_	_	_	_	O
12	prescribing	_	UNK	_	VBG	5	_	_	_	_	_	_	_	O
13	privileges	_	privilege	_	NNS	5	_	_	_	_	_	_	_	O
14	to	_	to	_	TO	5	_	_	_	_	_	_	_	O
15	unk	_	UNK	_	NNS	5	_	_	_	_	_	_	_	O
16	,	_	,	_	,	5	_	_	_	_	_	_	_	O
17	little	_	little	_	JJ	5	_	_	_	_	_	_	_	O
18	information	_	information	_	NN	5	_	_	_	_	_	information.n	Information	O
19	is	_	be	_	VBZ	5	_	_	_	_	_	_	_	O
20	available	_	available	_	JJ	5	_	_	_	_	_	_	_	O
21	regarding	_	regard	_	VBG	5	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	5	_	_	_	_	_	_	_	O
23	impact	_	impact	_	NN	5	_	_	_	_	_	_	_	O
24	of	_	of	_	IN	5	_	_	_	_	_	_	_	O
25	such	_	such	_	JJ	5	_	_	_	_	_	_	_	O
26	changes	_	change	_	NNS	5	_	_	_	_	_	_	_	O
27	on	_	on	_	IN	5	_	_	_	_	_	_	_	O
28	buprenorphine	_	UNK	_	NN	5	_	_	_	_	_	_	_	O
29	use	_	use	_	NN	5	_	_	_	_	_	_	_	O
30	.	_	.	_	.	5	_	_	_	_	_	_	_	O

1	although	_	Although	_	IN	5	_	_	_	_	_	_	_	O
2	federal	_	federal	_	JJ	5	_	_	_	_	_	_	_	O
3	legislators	_	legislator	_	NNS	5	_	_	_	_	_	_	_	O
4	are	_	be	_	VBP	5	_	_	_	_	_	_	_	O
5	considering	_	consider	_	VBG	5	_	_	_	_	_	_	_	O
6	increasing	_	increase	_	VBG	5	_	_	_	_	_	_	_	O
7	these	_	these	_	DT	5	_	_	_	_	_	_	_	O
8	limits	_	limit	_	NNS	5	_	_	_	_	_	_	_	O
9	further	_	further	_	RBR	5	_	_	_	_	_	_	_	O
10	and	_	and	_	CC	5	_	_	_	_	_	_	_	O
11	expanding	_	expand	_	VBG	5	_	_	_	_	_	_	_	O
12	prescribing	_	UNK	_	VBG	5	_	_	_	_	_	_	_	O
13	privileges	_	privilege	_	NNS	5	_	_	_	_	_	_	_	O
14	to	_	to	_	TO	5	_	_	_	_	_	_	_	O
15	unk	_	UNK	_	NNS	5	_	_	_	_	_	_	_	O
16	,	_	,	_	,	5	_	_	_	_	_	_	_	O
17	little	_	little	_	JJ	5	_	_	_	_	_	_	_	O
18	information	_	information	_	NN	5	_	_	_	_	_	_	_	O
19	is	_	be	_	VBZ	5	_	_	_	_	_	_	_	O
20	available	_	available	_	JJ	5	_	_	_	_	_	_	_	O
21	regarding	_	regard	_	VBG	5	_	_	_	_	_	regard.v	Topic	O
22	the	_	the	_	DT	5	_	_	_	_	_	_	_	O
23	impact	_	impact	_	NN	5	_	_	_	_	_	_	_	O
24	of	_	of	_	IN	5	_	_	_	_	_	_	_	O
25	such	_	such	_	JJ	5	_	_	_	_	_	_	_	O
26	changes	_	change	_	NNS	5	_	_	_	_	_	_	_	O
27	on	_	on	_	IN	5	_	_	_	_	_	_	_	O
28	buprenorphine	_	UNK	_	NN	5	_	_	_	_	_	_	_	O
29	use	_	use	_	NN	5	_	_	_	_	_	_	_	O
30	.	_	.	_	.	5	_	_	_	_	_	_	_	O

1	although	_	Although	_	IN	5	_	_	_	_	_	_	_	O
2	federal	_	federal	_	JJ	5	_	_	_	_	_	_	_	O
3	legislators	_	legislator	_	NNS	5	_	_	_	_	_	_	_	O
4	are	_	be	_	VBP	5	_	_	_	_	_	_	_	O
5	considering	_	consider	_	VBG	5	_	_	_	_	_	_	_	O
6	increasing	_	increase	_	VBG	5	_	_	_	_	_	_	_	O
7	these	_	these	_	DT	5	_	_	_	_	_	_	_	O
8	limits	_	limit	_	NNS	5	_	_	_	_	_	_	_	O
9	further	_	further	_	RBR	5	_	_	_	_	_	_	_	O
10	and	_	and	_	CC	5	_	_	_	_	_	_	_	O
11	expanding	_	expand	_	VBG	5	_	_	_	_	_	_	_	O
12	prescribing	_	UNK	_	VBG	5	_	_	_	_	_	_	_	O
13	privileges	_	privilege	_	NNS	5	_	_	_	_	_	_	_	O
14	to	_	to	_	TO	5	_	_	_	_	_	_	_	O
15	unk	_	UNK	_	NNS	5	_	_	_	_	_	_	_	O
16	,	_	,	_	,	5	_	_	_	_	_	_	_	O
17	little	_	little	_	JJ	5	_	_	_	_	_	_	_	O
18	information	_	information	_	NN	5	_	_	_	_	_	_	_	O
19	is	_	be	_	VBZ	5	_	_	_	_	_	_	_	O
20	available	_	available	_	JJ	5	_	_	_	_	_	_	_	O
21	regarding	_	regard	_	VBG	5	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	5	_	_	_	_	_	_	_	O
23	impact	_	impact	_	NN	5	_	_	_	_	_	impact.n	Objective_influence	O
24	of	_	of	_	IN	5	_	_	_	_	_	_	_	O
25	such	_	such	_	JJ	5	_	_	_	_	_	_	_	O
26	changes	_	change	_	NNS	5	_	_	_	_	_	_	_	O
27	on	_	on	_	IN	5	_	_	_	_	_	_	_	O
28	buprenorphine	_	UNK	_	NN	5	_	_	_	_	_	_	_	O
29	use	_	use	_	NN	5	_	_	_	_	_	_	_	O
30	.	_	.	_	.	5	_	_	_	_	_	_	_	O

1	although	_	Although	_	IN	5	_	_	_	_	_	_	_	O
2	federal	_	federal	_	JJ	5	_	_	_	_	_	_	_	O
3	legislators	_	legislator	_	NNS	5	_	_	_	_	_	_	_	O
4	are	_	be	_	VBP	5	_	_	_	_	_	_	_	O
5	considering	_	consider	_	VBG	5	_	_	_	_	_	_	_	O
6	increasing	_	increase	_	VBG	5	_	_	_	_	_	_	_	O
7	these	_	these	_	DT	5	_	_	_	_	_	_	_	O
8	limits	_	limit	_	NNS	5	_	_	_	_	_	_	_	O
9	further	_	further	_	RBR	5	_	_	_	_	_	_	_	O
10	and	_	and	_	CC	5	_	_	_	_	_	_	_	O
11	expanding	_	expand	_	VBG	5	_	_	_	_	_	_	_	O
12	prescribing	_	UNK	_	VBG	5	_	_	_	_	_	_	_	O
13	privileges	_	privilege	_	NNS	5	_	_	_	_	_	_	_	O
14	to	_	to	_	TO	5	_	_	_	_	_	_	_	O
15	unk	_	UNK	_	NNS	5	_	_	_	_	_	_	_	O
16	,	_	,	_	,	5	_	_	_	_	_	_	_	O
17	little	_	little	_	JJ	5	_	_	_	_	_	_	_	O
18	information	_	information	_	NN	5	_	_	_	_	_	_	_	O
19	is	_	be	_	VBZ	5	_	_	_	_	_	_	_	O
20	available	_	available	_	JJ	5	_	_	_	_	_	_	_	O
21	regarding	_	regard	_	VBG	5	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	5	_	_	_	_	_	_	_	O
23	impact	_	impact	_	NN	5	_	_	_	_	_	_	_	O
24	of	_	of	_	IN	5	_	_	_	_	_	of.prep	Age	O
25	such	_	such	_	JJ	5	_	_	_	_	_	_	_	O
26	changes	_	change	_	NNS	5	_	_	_	_	_	_	_	O
27	on	_	on	_	IN	5	_	_	_	_	_	_	_	O
28	buprenorphine	_	UNK	_	NN	5	_	_	_	_	_	_	_	O
29	use	_	use	_	NN	5	_	_	_	_	_	_	_	O
30	.	_	.	_	.	5	_	_	_	_	_	_	_	O

1	although	_	Although	_	IN	5	_	_	_	_	_	_	_	O
2	federal	_	federal	_	JJ	5	_	_	_	_	_	_	_	O
3	legislators	_	legislator	_	NNS	5	_	_	_	_	_	_	_	O
4	are	_	be	_	VBP	5	_	_	_	_	_	_	_	O
5	considering	_	consider	_	VBG	5	_	_	_	_	_	_	_	O
6	increasing	_	increase	_	VBG	5	_	_	_	_	_	_	_	O
7	these	_	these	_	DT	5	_	_	_	_	_	_	_	O
8	limits	_	limit	_	NNS	5	_	_	_	_	_	_	_	O
9	further	_	further	_	RBR	5	_	_	_	_	_	_	_	O
10	and	_	and	_	CC	5	_	_	_	_	_	_	_	O
11	expanding	_	expand	_	VBG	5	_	_	_	_	_	_	_	O
12	prescribing	_	UNK	_	VBG	5	_	_	_	_	_	_	_	O
13	privileges	_	privilege	_	NNS	5	_	_	_	_	_	_	_	O
14	to	_	to	_	TO	5	_	_	_	_	_	_	_	O
15	unk	_	UNK	_	NNS	5	_	_	_	_	_	_	_	O
16	,	_	,	_	,	5	_	_	_	_	_	_	_	O
17	little	_	little	_	JJ	5	_	_	_	_	_	_	_	O
18	information	_	information	_	NN	5	_	_	_	_	_	_	_	O
19	is	_	be	_	VBZ	5	_	_	_	_	_	_	_	O
20	available	_	available	_	JJ	5	_	_	_	_	_	_	_	O
21	regarding	_	regard	_	VBG	5	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	5	_	_	_	_	_	_	_	O
23	impact	_	impact	_	NN	5	_	_	_	_	_	_	_	O
24	of	_	of	_	IN	5	_	_	_	_	_	_	_	O
25	such	_	such	_	JJ	5	_	_	_	_	_	_	_	O
26	changes	_	change	_	NNS	5	_	_	_	_	_	_	_	O
27	on	_	on	_	IN	5	_	_	_	_	_	_	_	O
28	buprenorphine	_	UNK	_	NN	5	_	_	_	_	_	_	_	O
29	use	_	use	_	NN	5	_	_	_	_	_	use.n	Ingest_substance	O
30	.	_	.	_	.	5	_	_	_	_	_	_	_	O

1	we	_	We	_	PRP	6	_	_	_	_	_	_	_	O
2	therefore	_	therefore	_	RB	6	_	_	_	_	_	_	_	O
3	examined	_	examine	_	VBD	6	_	_	_	_	_	examine.v	Inspecting	O
4	the	_	the	_	DT	6	_	_	_	_	_	_	_	O
5	impact	_	impact	_	NN	6	_	_	_	_	_	_	_	O
6	of	_	of	_	IN	6	_	_	_	_	_	_	_	O
7	the	_	the	_	DT	6	_	_	_	_	_	_	_	O
8	2006	_	2006	_	CD	6	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
10	as	_	a	_	RB	6	_	_	_	_	_	_	_	O
11	well	_	well	_	RB	6	_	_	_	_	_	_	_	O
12	as	_	a	_	IN	6	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	6	_	_	_	_	_	_	_	O
14	association	_	association	_	NN	6	_	_	_	_	_	_	_	O
15	between	_	between	_	IN	6	_	_	_	_	_	_	_	O
16	urban	_	UNK	_	JJ	6	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	6	_	_	_	_	_	_	_	O
18	rural	_	rural	_	JJ	6	_	_	_	_	_	_	_	O
19	unk	_	UNK	_	JJ	6	_	_	_	_	_	_	_	O
20	physicians	_	UNK	_	NNS	6	_	_	_	_	_	_	_	O
21	,	_	,	_	,	6	_	_	_	_	_	_	_	O
22	opioid	_	UNK	_	JJ	6	_	_	_	_	_	_	_	O
23	treatment	_	treatment	_	NN	6	_	_	_	_	_	_	_	O
24	programs	_	program	_	NNS	6	_	_	_	_	_	_	_	O
25	,	_	,	_	,	6	_	_	_	_	_	_	_	O
26	and	_	and	_	CC	6	_	_	_	_	_	_	_	O
27	substance	_	substance	_	NN	6	_	_	_	_	_	_	_	O
28	abuse	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
29	treatment	_	treatment	_	NN	6	_	_	_	_	_	_	_	O
30	unk	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
31	on	_	on	_	IN	6	_	_	_	_	_	_	_	O
32	buprenorphine	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
33	distributed	_	distribute	_	VBN	6	_	_	_	_	_	_	_	O
34	per	_	per	_	IN	6	_	_	_	_	_	_	_	O
35	capita	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
36	over	_	over	_	IN	6	_	_	_	_	_	_	_	O
37	the	_	the	_	DT	6	_	_	_	_	_	_	_	O
38	past	_	past	_	JJ	6	_	_	_	_	_	_	_	O
39	decade	_	decade	_	NN	6	_	_	_	_	_	_	_	O
40	.	_	.	_	.	6	_	_	_	_	_	_	_	O

1	we	_	We	_	PRP	6	_	_	_	_	_	_	_	O
2	therefore	_	therefore	_	RB	6	_	_	_	_	_	_	_	O
3	examined	_	examine	_	VBD	6	_	_	_	_	_	_	_	O
4	the	_	the	_	DT	6	_	_	_	_	_	_	_	O
5	impact	_	impact	_	NN	6	_	_	_	_	_	impact.n	Objective_influence	O
6	of	_	of	_	IN	6	_	_	_	_	_	_	_	O
7	the	_	the	_	DT	6	_	_	_	_	_	_	_	O
8	2006	_	2006	_	CD	6	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
10	as	_	a	_	RB	6	_	_	_	_	_	_	_	O
11	well	_	well	_	RB	6	_	_	_	_	_	_	_	O
12	as	_	a	_	IN	6	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	6	_	_	_	_	_	_	_	O
14	association	_	association	_	NN	6	_	_	_	_	_	_	_	O
15	between	_	between	_	IN	6	_	_	_	_	_	_	_	O
16	urban	_	UNK	_	JJ	6	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	6	_	_	_	_	_	_	_	O
18	rural	_	rural	_	JJ	6	_	_	_	_	_	_	_	O
19	unk	_	UNK	_	JJ	6	_	_	_	_	_	_	_	O
20	physicians	_	UNK	_	NNS	6	_	_	_	_	_	_	_	O
21	,	_	,	_	,	6	_	_	_	_	_	_	_	O
22	opioid	_	UNK	_	JJ	6	_	_	_	_	_	_	_	O
23	treatment	_	treatment	_	NN	6	_	_	_	_	_	_	_	O
24	programs	_	program	_	NNS	6	_	_	_	_	_	_	_	O
25	,	_	,	_	,	6	_	_	_	_	_	_	_	O
26	and	_	and	_	CC	6	_	_	_	_	_	_	_	O
27	substance	_	substance	_	NN	6	_	_	_	_	_	_	_	O
28	abuse	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
29	treatment	_	treatment	_	NN	6	_	_	_	_	_	_	_	O
30	unk	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
31	on	_	on	_	IN	6	_	_	_	_	_	_	_	O
32	buprenorphine	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
33	distributed	_	distribute	_	VBN	6	_	_	_	_	_	_	_	O
34	per	_	per	_	IN	6	_	_	_	_	_	_	_	O
35	capita	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
36	over	_	over	_	IN	6	_	_	_	_	_	_	_	O
37	the	_	the	_	DT	6	_	_	_	_	_	_	_	O
38	past	_	past	_	JJ	6	_	_	_	_	_	_	_	O
39	decade	_	decade	_	NN	6	_	_	_	_	_	_	_	O
40	.	_	.	_	.	6	_	_	_	_	_	_	_	O

1	we	_	We	_	PRP	6	_	_	_	_	_	_	_	O
2	therefore	_	therefore	_	RB	6	_	_	_	_	_	_	_	O
3	examined	_	examine	_	VBD	6	_	_	_	_	_	_	_	O
4	the	_	the	_	DT	6	_	_	_	_	_	_	_	O
5	impact	_	impact	_	NN	6	_	_	_	_	_	_	_	O
6	of	_	of	_	IN	6	_	_	_	_	_	of.prep	Age	O
7	the	_	the	_	DT	6	_	_	_	_	_	_	_	O
8	2006	_	2006	_	CD	6	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
10	as	_	a	_	RB	6	_	_	_	_	_	_	_	O
11	well	_	well	_	RB	6	_	_	_	_	_	_	_	O
12	as	_	a	_	IN	6	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	6	_	_	_	_	_	_	_	O
14	association	_	association	_	NN	6	_	_	_	_	_	_	_	O
15	between	_	between	_	IN	6	_	_	_	_	_	_	_	O
16	urban	_	UNK	_	JJ	6	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	6	_	_	_	_	_	_	_	O
18	rural	_	rural	_	JJ	6	_	_	_	_	_	_	_	O
19	unk	_	UNK	_	JJ	6	_	_	_	_	_	_	_	O
20	physicians	_	UNK	_	NNS	6	_	_	_	_	_	_	_	O
21	,	_	,	_	,	6	_	_	_	_	_	_	_	O
22	opioid	_	UNK	_	JJ	6	_	_	_	_	_	_	_	O
23	treatment	_	treatment	_	NN	6	_	_	_	_	_	_	_	O
24	programs	_	program	_	NNS	6	_	_	_	_	_	_	_	O
25	,	_	,	_	,	6	_	_	_	_	_	_	_	O
26	and	_	and	_	CC	6	_	_	_	_	_	_	_	O
27	substance	_	substance	_	NN	6	_	_	_	_	_	_	_	O
28	abuse	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
29	treatment	_	treatment	_	NN	6	_	_	_	_	_	_	_	O
30	unk	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
31	on	_	on	_	IN	6	_	_	_	_	_	_	_	O
32	buprenorphine	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
33	distributed	_	distribute	_	VBN	6	_	_	_	_	_	_	_	O
34	per	_	per	_	IN	6	_	_	_	_	_	_	_	O
35	capita	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
36	over	_	over	_	IN	6	_	_	_	_	_	_	_	O
37	the	_	the	_	DT	6	_	_	_	_	_	_	_	O
38	past	_	past	_	JJ	6	_	_	_	_	_	_	_	O
39	decade	_	decade	_	NN	6	_	_	_	_	_	_	_	O
40	.	_	.	_	.	6	_	_	_	_	_	_	_	O

1	we	_	We	_	PRP	6	_	_	_	_	_	_	_	O
2	therefore	_	therefore	_	RB	6	_	_	_	_	_	_	_	O
3	examined	_	examine	_	VBD	6	_	_	_	_	_	_	_	O
4	the	_	the	_	DT	6	_	_	_	_	_	_	_	O
5	impact	_	impact	_	NN	6	_	_	_	_	_	_	_	O
6	of	_	of	_	IN	6	_	_	_	_	_	_	_	O
7	the	_	the	_	DT	6	_	_	_	_	_	_	_	O
8	2006	_	2006	_	CD	6	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
10	as	_	a	_	RB	6	_	_	_	_	_	_	_	O
11	well	_	well	_	RB	6	_	_	_	_	_	_	_	O
12	as	_	a	_	IN	6	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	6	_	_	_	_	_	_	_	O
14	association	_	association	_	NN	6	_	_	_	_	_	association.n	Organization	O
15	between	_	between	_	IN	6	_	_	_	_	_	_	_	O
16	urban	_	UNK	_	JJ	6	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	6	_	_	_	_	_	_	_	O
18	rural	_	rural	_	JJ	6	_	_	_	_	_	_	_	O
19	unk	_	UNK	_	JJ	6	_	_	_	_	_	_	_	O
20	physicians	_	UNK	_	NNS	6	_	_	_	_	_	_	_	O
21	,	_	,	_	,	6	_	_	_	_	_	_	_	O
22	opioid	_	UNK	_	JJ	6	_	_	_	_	_	_	_	O
23	treatment	_	treatment	_	NN	6	_	_	_	_	_	_	_	O
24	programs	_	program	_	NNS	6	_	_	_	_	_	_	_	O
25	,	_	,	_	,	6	_	_	_	_	_	_	_	O
26	and	_	and	_	CC	6	_	_	_	_	_	_	_	O
27	substance	_	substance	_	NN	6	_	_	_	_	_	_	_	O
28	abuse	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
29	treatment	_	treatment	_	NN	6	_	_	_	_	_	_	_	O
30	unk	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
31	on	_	on	_	IN	6	_	_	_	_	_	_	_	O
32	buprenorphine	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
33	distributed	_	distribute	_	VBN	6	_	_	_	_	_	_	_	O
34	per	_	per	_	IN	6	_	_	_	_	_	_	_	O
35	capita	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
36	over	_	over	_	IN	6	_	_	_	_	_	_	_	O
37	the	_	the	_	DT	6	_	_	_	_	_	_	_	O
38	past	_	past	_	JJ	6	_	_	_	_	_	_	_	O
39	decade	_	decade	_	NN	6	_	_	_	_	_	_	_	O
40	.	_	.	_	.	6	_	_	_	_	_	_	_	O

1	we	_	We	_	PRP	6	_	_	_	_	_	_	_	O
2	therefore	_	therefore	_	RB	6	_	_	_	_	_	_	_	O
3	examined	_	examine	_	VBD	6	_	_	_	_	_	_	_	O
4	the	_	the	_	DT	6	_	_	_	_	_	_	_	O
5	impact	_	impact	_	NN	6	_	_	_	_	_	_	_	O
6	of	_	of	_	IN	6	_	_	_	_	_	_	_	O
7	the	_	the	_	DT	6	_	_	_	_	_	_	_	O
8	2006	_	2006	_	CD	6	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
10	as	_	a	_	RB	6	_	_	_	_	_	_	_	O
11	well	_	well	_	RB	6	_	_	_	_	_	_	_	O
12	as	_	a	_	IN	6	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	6	_	_	_	_	_	_	_	O
14	association	_	association	_	NN	6	_	_	_	_	_	_	_	O
15	between	_	between	_	IN	6	_	_	_	_	_	_	_	O
16	urban	_	UNK	_	JJ	6	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	6	_	_	_	_	_	_	_	O
18	rural	_	rural	_	JJ	6	_	_	_	_	_	rural.a	Locale_by_use	O
19	unk	_	UNK	_	JJ	6	_	_	_	_	_	_	_	O
20	physicians	_	UNK	_	NNS	6	_	_	_	_	_	_	_	O
21	,	_	,	_	,	6	_	_	_	_	_	_	_	O
22	opioid	_	UNK	_	JJ	6	_	_	_	_	_	_	_	O
23	treatment	_	treatment	_	NN	6	_	_	_	_	_	_	_	O
24	programs	_	program	_	NNS	6	_	_	_	_	_	_	_	O
25	,	_	,	_	,	6	_	_	_	_	_	_	_	O
26	and	_	and	_	CC	6	_	_	_	_	_	_	_	O
27	substance	_	substance	_	NN	6	_	_	_	_	_	_	_	O
28	abuse	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
29	treatment	_	treatment	_	NN	6	_	_	_	_	_	_	_	O
30	unk	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
31	on	_	on	_	IN	6	_	_	_	_	_	_	_	O
32	buprenorphine	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
33	distributed	_	distribute	_	VBN	6	_	_	_	_	_	_	_	O
34	per	_	per	_	IN	6	_	_	_	_	_	_	_	O
35	capita	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
36	over	_	over	_	IN	6	_	_	_	_	_	_	_	O
37	the	_	the	_	DT	6	_	_	_	_	_	_	_	O
38	past	_	past	_	JJ	6	_	_	_	_	_	_	_	O
39	decade	_	decade	_	NN	6	_	_	_	_	_	_	_	O
40	.	_	.	_	.	6	_	_	_	_	_	_	_	O

1	we	_	We	_	PRP	6	_	_	_	_	_	_	_	O
2	therefore	_	therefore	_	RB	6	_	_	_	_	_	_	_	O
3	examined	_	examine	_	VBD	6	_	_	_	_	_	_	_	O
4	the	_	the	_	DT	6	_	_	_	_	_	_	_	O
5	impact	_	impact	_	NN	6	_	_	_	_	_	_	_	O
6	of	_	of	_	IN	6	_	_	_	_	_	_	_	O
7	the	_	the	_	DT	6	_	_	_	_	_	_	_	O
8	2006	_	2006	_	CD	6	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
10	as	_	a	_	RB	6	_	_	_	_	_	_	_	O
11	well	_	well	_	RB	6	_	_	_	_	_	_	_	O
12	as	_	a	_	IN	6	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	6	_	_	_	_	_	_	_	O
14	association	_	association	_	NN	6	_	_	_	_	_	_	_	O
15	between	_	between	_	IN	6	_	_	_	_	_	_	_	O
16	urban	_	UNK	_	JJ	6	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	6	_	_	_	_	_	_	_	O
18	rural	_	rural	_	JJ	6	_	_	_	_	_	_	_	O
19	unk	_	UNK	_	JJ	6	_	_	_	_	_	_	_	O
20	physicians	_	UNK	_	NNS	6	_	_	_	_	_	_	_	O
21	,	_	,	_	,	6	_	_	_	_	_	_	_	O
22	opioid	_	UNK	_	JJ	6	_	_	_	_	_	_	_	O
23	treatment	_	treatment	_	NN	6	_	_	_	_	_	_	_	O
24	programs	_	program	_	NNS	6	_	_	_	_	_	program.n	Project	O
25	,	_	,	_	,	6	_	_	_	_	_	_	_	O
26	and	_	and	_	CC	6	_	_	_	_	_	_	_	O
27	substance	_	substance	_	NN	6	_	_	_	_	_	_	_	O
28	abuse	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
29	treatment	_	treatment	_	NN	6	_	_	_	_	_	_	_	O
30	unk	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
31	on	_	on	_	IN	6	_	_	_	_	_	_	_	O
32	buprenorphine	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
33	distributed	_	distribute	_	VBN	6	_	_	_	_	_	_	_	O
34	per	_	per	_	IN	6	_	_	_	_	_	_	_	O
35	capita	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
36	over	_	over	_	IN	6	_	_	_	_	_	_	_	O
37	the	_	the	_	DT	6	_	_	_	_	_	_	_	O
38	past	_	past	_	JJ	6	_	_	_	_	_	_	_	O
39	decade	_	decade	_	NN	6	_	_	_	_	_	_	_	O
40	.	_	.	_	.	6	_	_	_	_	_	_	_	O

1	we	_	We	_	PRP	6	_	_	_	_	_	_	_	O
2	therefore	_	therefore	_	RB	6	_	_	_	_	_	_	_	O
3	examined	_	examine	_	VBD	6	_	_	_	_	_	_	_	O
4	the	_	the	_	DT	6	_	_	_	_	_	_	_	O
5	impact	_	impact	_	NN	6	_	_	_	_	_	_	_	O
6	of	_	of	_	IN	6	_	_	_	_	_	_	_	O
7	the	_	the	_	DT	6	_	_	_	_	_	_	_	O
8	2006	_	2006	_	CD	6	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
10	as	_	a	_	RB	6	_	_	_	_	_	_	_	O
11	well	_	well	_	RB	6	_	_	_	_	_	_	_	O
12	as	_	a	_	IN	6	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	6	_	_	_	_	_	_	_	O
14	association	_	association	_	NN	6	_	_	_	_	_	_	_	O
15	between	_	between	_	IN	6	_	_	_	_	_	_	_	O
16	urban	_	UNK	_	JJ	6	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	6	_	_	_	_	_	_	_	O
18	rural	_	rural	_	JJ	6	_	_	_	_	_	_	_	O
19	unk	_	UNK	_	JJ	6	_	_	_	_	_	_	_	O
20	physicians	_	UNK	_	NNS	6	_	_	_	_	_	_	_	O
21	,	_	,	_	,	6	_	_	_	_	_	_	_	O
22	opioid	_	UNK	_	JJ	6	_	_	_	_	_	_	_	O
23	treatment	_	treatment	_	NN	6	_	_	_	_	_	_	_	O
24	programs	_	program	_	NNS	6	_	_	_	_	_	_	_	O
25	,	_	,	_	,	6	_	_	_	_	_	_	_	O
26	and	_	and	_	CC	6	_	_	_	_	_	_	_	O
27	substance	_	substance	_	NN	6	_	_	_	_	_	_	_	O
28	abuse	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
29	treatment	_	treatment	_	NN	6	_	_	_	_	_	_	_	O
30	unk	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
31	on	_	on	_	IN	6	_	_	_	_	_	_	_	O
32	buprenorphine	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
33	distributed	_	distribute	_	VBN	6	_	_	_	_	_	distribute.v	Dispersal	O
34	per	_	per	_	IN	6	_	_	_	_	_	_	_	O
35	capita	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
36	over	_	over	_	IN	6	_	_	_	_	_	_	_	O
37	the	_	the	_	DT	6	_	_	_	_	_	_	_	O
38	past	_	past	_	JJ	6	_	_	_	_	_	_	_	O
39	decade	_	decade	_	NN	6	_	_	_	_	_	_	_	O
40	.	_	.	_	.	6	_	_	_	_	_	_	_	O

1	we	_	We	_	PRP	6	_	_	_	_	_	_	_	O
2	therefore	_	therefore	_	RB	6	_	_	_	_	_	_	_	O
3	examined	_	examine	_	VBD	6	_	_	_	_	_	_	_	O
4	the	_	the	_	DT	6	_	_	_	_	_	_	_	O
5	impact	_	impact	_	NN	6	_	_	_	_	_	_	_	O
6	of	_	of	_	IN	6	_	_	_	_	_	_	_	O
7	the	_	the	_	DT	6	_	_	_	_	_	_	_	O
8	2006	_	2006	_	CD	6	_	_	_	_	_	_	_	O
9	unk	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
10	as	_	a	_	RB	6	_	_	_	_	_	_	_	O
11	well	_	well	_	RB	6	_	_	_	_	_	_	_	O
12	as	_	a	_	IN	6	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	6	_	_	_	_	_	_	_	O
14	association	_	association	_	NN	6	_	_	_	_	_	_	_	O
15	between	_	between	_	IN	6	_	_	_	_	_	_	_	O
16	urban	_	UNK	_	JJ	6	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	6	_	_	_	_	_	_	_	O
18	rural	_	rural	_	JJ	6	_	_	_	_	_	_	_	O
19	unk	_	UNK	_	JJ	6	_	_	_	_	_	_	_	O
20	physicians	_	UNK	_	NNS	6	_	_	_	_	_	_	_	O
21	,	_	,	_	,	6	_	_	_	_	_	_	_	O
22	opioid	_	UNK	_	JJ	6	_	_	_	_	_	_	_	O
23	treatment	_	treatment	_	NN	6	_	_	_	_	_	_	_	O
24	programs	_	program	_	NNS	6	_	_	_	_	_	_	_	O
25	,	_	,	_	,	6	_	_	_	_	_	_	_	O
26	and	_	and	_	CC	6	_	_	_	_	_	_	_	O
27	substance	_	substance	_	NN	6	_	_	_	_	_	_	_	O
28	abuse	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
29	treatment	_	treatment	_	NN	6	_	_	_	_	_	_	_	O
30	unk	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
31	on	_	on	_	IN	6	_	_	_	_	_	_	_	O
32	buprenorphine	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
33	distributed	_	distribute	_	VBN	6	_	_	_	_	_	_	_	O
34	per	_	per	_	IN	6	_	_	_	_	_	_	_	O
35	capita	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
36	over	_	over	_	IN	6	_	_	_	_	_	_	_	O
37	the	_	the	_	DT	6	_	_	_	_	_	_	_	O
38	past	_	past	_	JJ	6	_	_	_	_	_	_	_	O
39	decade	_	decade	_	NN	6	_	_	_	_	_	decade.n	Calendric_unit	O
40	.	_	.	_	.	6	_	_	_	_	_	_	_	O

1	methods	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
2	:	_	:	_	:	7	_	_	_	_	_	_	_	O
3	using	_	Using	_	VBG	7	_	_	_	_	_	_	_	O
4	unk	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
5	2011	_	2011	_	CD	7	_	_	_	_	_	_	_	O
6	unk	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
7	level	_	level	_	NN	7	_	_	_	_	_	level.n	Gizmo	O
8	data	_	data	_	NNS	7	_	_	_	_	_	_	_	O
9	on	_	on	_	IN	7	_	_	_	_	_	_	_	O
10	buprenorphine	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
11	dispensed	_	UNK	_	VBN	7	_	_	_	_	_	_	_	O
12	and	_	and	_	CC	7	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
14	level	_	level	_	NN	7	_	_	_	_	_	_	_	O
15	data	_	data	_	NNS	7	_	_	_	_	_	_	_	O
16	on	_	on	_	IN	7	_	_	_	_	_	_	_	O
17	the	_	the	_	DT	7	_	_	_	_	_	_	_	O
18	number	_	number	_	NN	7	_	_	_	_	_	_	_	O
19	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
20	unk	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
21	unk	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
22	physicians	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
23	and	_	and	_	CC	7	_	_	_	_	_	_	_	O
24	substance	_	substance	_	NN	7	_	_	_	_	_	_	_	O
25	abuse	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
26	treatment	_	treatment	_	NN	7	_	_	_	_	_	_	_	O
27	facilities	_	facility	_	NNS	7	_	_	_	_	_	_	_	O
28	using	_	use	_	VBG	7	_	_	_	_	_	_	_	O
29	buprenorphine	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
30	,	_	,	_	,	7	_	_	_	_	_	_	_	O
31	we	_	we	_	PRP	7	_	_	_	_	_	_	_	O
32	estimated	_	estimate	_	VBD	7	_	_	_	_	_	_	_	O
33	a	_	a	_	DT	7	_	_	_	_	_	_	_	O
34	multivariate	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
35	ordinary	_	ordinary	_	JJ	7	_	_	_	_	_	_	_	O
36	least	_	least	_	JJS	7	_	_	_	_	_	_	_	O
37	squares	_	square	_	NNS	7	_	_	_	_	_	_	_	O
38	regression	_	UNK	_	VBP	7	_	_	_	_	_	_	_	O
39	model	_	model	_	NN	7	_	_	_	_	_	_	_	O
40	with	_	with	_	IN	7	_	_	_	_	_	_	_	O
41	state	_	state	_	NN	7	_	_	_	_	_	_	_	O
42	fixed	_	UNK	_	VBN	7	_	_	_	_	_	_	_	O
43	effects	_	effect	_	NNS	7	_	_	_	_	_	_	_	O
44	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
45	a	_	a	_	DT	7	_	_	_	_	_	_	_	O
46	state	_	state	_	NN	7	_	_	_	_	_	_	_	O
47	's	_	's	_	POS	7	_	_	_	_	_	_	_	O
48	annual	_	annual	_	JJ	7	_	_	_	_	_	_	_	O
49	total	_	total	_	JJ	7	_	_	_	_	_	_	_	O
50	buprenorphine	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
51	dispensed	_	UNK	_	VBN	7	_	_	_	_	_	_	_	O
52	per	_	per	_	FW	7	_	_	_	_	_	_	_	O
53	capita	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
54	as	_	a	_	IN	7	_	_	_	_	_	_	_	O
55	a	_	a	_	DT	7	_	_	_	_	_	_	_	O
56	function	_	function	_	NN	7	_	_	_	_	_	_	_	O
57	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
58	the	_	the	_	DT	7	_	_	_	_	_	_	_	O
59	state	_	state	_	NN	7	_	_	_	_	_	_	_	O
60	's	_	's	_	POS	7	_	_	_	_	_	_	_	O
61	number	_	number	_	NN	7	_	_	_	_	_	_	_	O
62	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
63	buprenorphine	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
64	providers	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
65	.	_	.	_	.	7	_	_	_	_	_	_	_	O

1	methods	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
2	:	_	:	_	:	7	_	_	_	_	_	_	_	O
3	using	_	Using	_	VBG	7	_	_	_	_	_	_	_	O
4	unk	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
5	2011	_	2011	_	CD	7	_	_	_	_	_	_	_	O
6	unk	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
7	level	_	level	_	NN	7	_	_	_	_	_	_	_	O
8	data	_	data	_	NNS	7	_	_	_	_	_	_	_	O
9	on	_	on	_	IN	7	_	_	_	_	_	_	_	O
10	buprenorphine	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
11	dispensed	_	UNK	_	VBN	7	_	_	_	_	_	_	_	O
12	and	_	and	_	CC	7	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
14	level	_	level	_	NN	7	_	_	_	_	_	level.n	Gizmo	O
15	data	_	data	_	NNS	7	_	_	_	_	_	_	_	O
16	on	_	on	_	IN	7	_	_	_	_	_	_	_	O
17	the	_	the	_	DT	7	_	_	_	_	_	_	_	O
18	number	_	number	_	NN	7	_	_	_	_	_	_	_	O
19	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
20	unk	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
21	unk	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
22	physicians	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
23	and	_	and	_	CC	7	_	_	_	_	_	_	_	O
24	substance	_	substance	_	NN	7	_	_	_	_	_	_	_	O
25	abuse	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
26	treatment	_	treatment	_	NN	7	_	_	_	_	_	_	_	O
27	facilities	_	facility	_	NNS	7	_	_	_	_	_	_	_	O
28	using	_	use	_	VBG	7	_	_	_	_	_	_	_	O
29	buprenorphine	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
30	,	_	,	_	,	7	_	_	_	_	_	_	_	O
31	we	_	we	_	PRP	7	_	_	_	_	_	_	_	O
32	estimated	_	estimate	_	VBD	7	_	_	_	_	_	_	_	O
33	a	_	a	_	DT	7	_	_	_	_	_	_	_	O
34	multivariate	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
35	ordinary	_	ordinary	_	JJ	7	_	_	_	_	_	_	_	O
36	least	_	least	_	JJS	7	_	_	_	_	_	_	_	O
37	squares	_	square	_	NNS	7	_	_	_	_	_	_	_	O
38	regression	_	UNK	_	VBP	7	_	_	_	_	_	_	_	O
39	model	_	model	_	NN	7	_	_	_	_	_	_	_	O
40	with	_	with	_	IN	7	_	_	_	_	_	_	_	O
41	state	_	state	_	NN	7	_	_	_	_	_	_	_	O
42	fixed	_	UNK	_	VBN	7	_	_	_	_	_	_	_	O
43	effects	_	effect	_	NNS	7	_	_	_	_	_	_	_	O
44	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
45	a	_	a	_	DT	7	_	_	_	_	_	_	_	O
46	state	_	state	_	NN	7	_	_	_	_	_	_	_	O
47	's	_	's	_	POS	7	_	_	_	_	_	_	_	O
48	annual	_	annual	_	JJ	7	_	_	_	_	_	_	_	O
49	total	_	total	_	JJ	7	_	_	_	_	_	_	_	O
50	buprenorphine	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
51	dispensed	_	UNK	_	VBN	7	_	_	_	_	_	_	_	O
52	per	_	per	_	FW	7	_	_	_	_	_	_	_	O
53	capita	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
54	as	_	a	_	IN	7	_	_	_	_	_	_	_	O
55	a	_	a	_	DT	7	_	_	_	_	_	_	_	O
56	function	_	function	_	NN	7	_	_	_	_	_	_	_	O
57	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
58	the	_	the	_	DT	7	_	_	_	_	_	_	_	O
59	state	_	state	_	NN	7	_	_	_	_	_	_	_	O
60	's	_	's	_	POS	7	_	_	_	_	_	_	_	O
61	number	_	number	_	NN	7	_	_	_	_	_	_	_	O
62	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
63	buprenorphine	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
64	providers	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
65	.	_	.	_	.	7	_	_	_	_	_	_	_	O

1	methods	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
2	:	_	:	_	:	7	_	_	_	_	_	_	_	O
3	using	_	Using	_	VBG	7	_	_	_	_	_	_	_	O
4	unk	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
5	2011	_	2011	_	CD	7	_	_	_	_	_	_	_	O
6	unk	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
7	level	_	level	_	NN	7	_	_	_	_	_	_	_	O
8	data	_	data	_	NNS	7	_	_	_	_	_	_	_	O
9	on	_	on	_	IN	7	_	_	_	_	_	_	_	O
10	buprenorphine	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
11	dispensed	_	UNK	_	VBN	7	_	_	_	_	_	_	_	O
12	and	_	and	_	CC	7	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
14	level	_	level	_	NN	7	_	_	_	_	_	_	_	O
15	data	_	data	_	NNS	7	_	_	_	_	_	_	_	O
16	on	_	on	_	IN	7	_	_	_	_	_	_	_	O
17	the	_	the	_	DT	7	_	_	_	_	_	_	_	O
18	number	_	number	_	NN	7	_	_	_	_	_	number.n	Be_subset_of	O
19	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
20	unk	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
21	unk	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
22	physicians	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
23	and	_	and	_	CC	7	_	_	_	_	_	_	_	O
24	substance	_	substance	_	NN	7	_	_	_	_	_	_	_	O
25	abuse	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
26	treatment	_	treatment	_	NN	7	_	_	_	_	_	_	_	O
27	facilities	_	facility	_	NNS	7	_	_	_	_	_	_	_	O
28	using	_	use	_	VBG	7	_	_	_	_	_	_	_	O
29	buprenorphine	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
30	,	_	,	_	,	7	_	_	_	_	_	_	_	O
31	we	_	we	_	PRP	7	_	_	_	_	_	_	_	O
32	estimated	_	estimate	_	VBD	7	_	_	_	_	_	_	_	O
33	a	_	a	_	DT	7	_	_	_	_	_	_	_	O
34	multivariate	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
35	ordinary	_	ordinary	_	JJ	7	_	_	_	_	_	_	_	O
36	least	_	least	_	JJS	7	_	_	_	_	_	_	_	O
37	squares	_	square	_	NNS	7	_	_	_	_	_	_	_	O
38	regression	_	UNK	_	VBP	7	_	_	_	_	_	_	_	O
39	model	_	model	_	NN	7	_	_	_	_	_	_	_	O
40	with	_	with	_	IN	7	_	_	_	_	_	_	_	O
41	state	_	state	_	NN	7	_	_	_	_	_	_	_	O
42	fixed	_	UNK	_	VBN	7	_	_	_	_	_	_	_	O
43	effects	_	effect	_	NNS	7	_	_	_	_	_	_	_	O
44	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
45	a	_	a	_	DT	7	_	_	_	_	_	_	_	O
46	state	_	state	_	NN	7	_	_	_	_	_	_	_	O
47	's	_	's	_	POS	7	_	_	_	_	_	_	_	O
48	annual	_	annual	_	JJ	7	_	_	_	_	_	_	_	O
49	total	_	total	_	JJ	7	_	_	_	_	_	_	_	O
50	buprenorphine	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
51	dispensed	_	UNK	_	VBN	7	_	_	_	_	_	_	_	O
52	per	_	per	_	FW	7	_	_	_	_	_	_	_	O
53	capita	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
54	as	_	a	_	IN	7	_	_	_	_	_	_	_	O
55	a	_	a	_	DT	7	_	_	_	_	_	_	_	O
56	function	_	function	_	NN	7	_	_	_	_	_	_	_	O
57	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
58	the	_	the	_	DT	7	_	_	_	_	_	_	_	O
59	state	_	state	_	NN	7	_	_	_	_	_	_	_	O
60	's	_	's	_	POS	7	_	_	_	_	_	_	_	O
61	number	_	number	_	NN	7	_	_	_	_	_	_	_	O
62	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
63	buprenorphine	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
64	providers	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
65	.	_	.	_	.	7	_	_	_	_	_	_	_	O

1	methods	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
2	:	_	:	_	:	7	_	_	_	_	_	_	_	O
3	using	_	Using	_	VBG	7	_	_	_	_	_	_	_	O
4	unk	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
5	2011	_	2011	_	CD	7	_	_	_	_	_	_	_	O
6	unk	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
7	level	_	level	_	NN	7	_	_	_	_	_	_	_	O
8	data	_	data	_	NNS	7	_	_	_	_	_	_	_	O
9	on	_	on	_	IN	7	_	_	_	_	_	_	_	O
10	buprenorphine	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
11	dispensed	_	UNK	_	VBN	7	_	_	_	_	_	_	_	O
12	and	_	and	_	CC	7	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
14	level	_	level	_	NN	7	_	_	_	_	_	_	_	O
15	data	_	data	_	NNS	7	_	_	_	_	_	_	_	O
16	on	_	on	_	IN	7	_	_	_	_	_	_	_	O
17	the	_	the	_	DT	7	_	_	_	_	_	_	_	O
18	number	_	number	_	NN	7	_	_	_	_	_	_	_	O
19	of	_	of	_	IN	7	_	_	_	_	_	of.prep	Age	O
20	unk	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
21	unk	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
22	physicians	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
23	and	_	and	_	CC	7	_	_	_	_	_	_	_	O
24	substance	_	substance	_	NN	7	_	_	_	_	_	_	_	O
25	abuse	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
26	treatment	_	treatment	_	NN	7	_	_	_	_	_	_	_	O
27	facilities	_	facility	_	NNS	7	_	_	_	_	_	_	_	O
28	using	_	use	_	VBG	7	_	_	_	_	_	_	_	O
29	buprenorphine	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
30	,	_	,	_	,	7	_	_	_	_	_	_	_	O
31	we	_	we	_	PRP	7	_	_	_	_	_	_	_	O
32	estimated	_	estimate	_	VBD	7	_	_	_	_	_	_	_	O
33	a	_	a	_	DT	7	_	_	_	_	_	_	_	O
34	multivariate	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
35	ordinary	_	ordinary	_	JJ	7	_	_	_	_	_	_	_	O
36	least	_	least	_	JJS	7	_	_	_	_	_	_	_	O
37	squares	_	square	_	NNS	7	_	_	_	_	_	_	_	O
38	regression	_	UNK	_	VBP	7	_	_	_	_	_	_	_	O
39	model	_	model	_	NN	7	_	_	_	_	_	_	_	O
40	with	_	with	_	IN	7	_	_	_	_	_	_	_	O
41	state	_	state	_	NN	7	_	_	_	_	_	_	_	O
42	fixed	_	UNK	_	VBN	7	_	_	_	_	_	_	_	O
43	effects	_	effect	_	NNS	7	_	_	_	_	_	_	_	O
44	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
45	a	_	a	_	DT	7	_	_	_	_	_	_	_	O
46	state	_	state	_	NN	7	_	_	_	_	_	_	_	O
47	's	_	's	_	POS	7	_	_	_	_	_	_	_	O
48	annual	_	annual	_	JJ	7	_	_	_	_	_	_	_	O
49	total	_	total	_	JJ	7	_	_	_	_	_	_	_	O
50	buprenorphine	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
51	dispensed	_	UNK	_	VBN	7	_	_	_	_	_	_	_	O
52	per	_	per	_	FW	7	_	_	_	_	_	_	_	O
53	capita	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
54	as	_	a	_	IN	7	_	_	_	_	_	_	_	O
55	a	_	a	_	DT	7	_	_	_	_	_	_	_	O
56	function	_	function	_	NN	7	_	_	_	_	_	_	_	O
57	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
58	the	_	the	_	DT	7	_	_	_	_	_	_	_	O
59	state	_	state	_	NN	7	_	_	_	_	_	_	_	O
60	's	_	's	_	POS	7	_	_	_	_	_	_	_	O
61	number	_	number	_	NN	7	_	_	_	_	_	_	_	O
62	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
63	buprenorphine	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
64	providers	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
65	.	_	.	_	.	7	_	_	_	_	_	_	_	O

1	methods	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
2	:	_	:	_	:	7	_	_	_	_	_	_	_	O
3	using	_	Using	_	VBG	7	_	_	_	_	_	_	_	O
4	unk	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
5	2011	_	2011	_	CD	7	_	_	_	_	_	_	_	O
6	unk	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
7	level	_	level	_	NN	7	_	_	_	_	_	_	_	O
8	data	_	data	_	NNS	7	_	_	_	_	_	_	_	O
9	on	_	on	_	IN	7	_	_	_	_	_	_	_	O
10	buprenorphine	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
11	dispensed	_	UNK	_	VBN	7	_	_	_	_	_	_	_	O
12	and	_	and	_	CC	7	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
14	level	_	level	_	NN	7	_	_	_	_	_	_	_	O
15	data	_	data	_	NNS	7	_	_	_	_	_	_	_	O
16	on	_	on	_	IN	7	_	_	_	_	_	_	_	O
17	the	_	the	_	DT	7	_	_	_	_	_	_	_	O
18	number	_	number	_	NN	7	_	_	_	_	_	_	_	O
19	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
20	unk	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
21	unk	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
22	physicians	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
23	and	_	and	_	CC	7	_	_	_	_	_	_	_	O
24	substance	_	substance	_	NN	7	_	_	_	_	_	_	_	O
25	abuse	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
26	treatment	_	treatment	_	NN	7	_	_	_	_	_	_	_	O
27	facilities	_	facility	_	NNS	7	_	_	_	_	_	_	_	O
28	using	_	use	_	VBG	7	_	_	_	_	_	use.v	Ingest_substance	O
29	buprenorphine	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
30	,	_	,	_	,	7	_	_	_	_	_	_	_	O
31	we	_	we	_	PRP	7	_	_	_	_	_	_	_	O
32	estimated	_	estimate	_	VBD	7	_	_	_	_	_	_	_	O
33	a	_	a	_	DT	7	_	_	_	_	_	_	_	O
34	multivariate	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
35	ordinary	_	ordinary	_	JJ	7	_	_	_	_	_	_	_	O
36	least	_	least	_	JJS	7	_	_	_	_	_	_	_	O
37	squares	_	square	_	NNS	7	_	_	_	_	_	_	_	O
38	regression	_	UNK	_	VBP	7	_	_	_	_	_	_	_	O
39	model	_	model	_	NN	7	_	_	_	_	_	_	_	O
40	with	_	with	_	IN	7	_	_	_	_	_	_	_	O
41	state	_	state	_	NN	7	_	_	_	_	_	_	_	O
42	fixed	_	UNK	_	VBN	7	_	_	_	_	_	_	_	O
43	effects	_	effect	_	NNS	7	_	_	_	_	_	_	_	O
44	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
45	a	_	a	_	DT	7	_	_	_	_	_	_	_	O
46	state	_	state	_	NN	7	_	_	_	_	_	_	_	O
47	's	_	's	_	POS	7	_	_	_	_	_	_	_	O
48	annual	_	annual	_	JJ	7	_	_	_	_	_	_	_	O
49	total	_	total	_	JJ	7	_	_	_	_	_	_	_	O
50	buprenorphine	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
51	dispensed	_	UNK	_	VBN	7	_	_	_	_	_	_	_	O
52	per	_	per	_	FW	7	_	_	_	_	_	_	_	O
53	capita	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
54	as	_	a	_	IN	7	_	_	_	_	_	_	_	O
55	a	_	a	_	DT	7	_	_	_	_	_	_	_	O
56	function	_	function	_	NN	7	_	_	_	_	_	_	_	O
57	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
58	the	_	the	_	DT	7	_	_	_	_	_	_	_	O
59	state	_	state	_	NN	7	_	_	_	_	_	_	_	O
60	's	_	's	_	POS	7	_	_	_	_	_	_	_	O
61	number	_	number	_	NN	7	_	_	_	_	_	_	_	O
62	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
63	buprenorphine	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
64	providers	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
65	.	_	.	_	.	7	_	_	_	_	_	_	_	O

1	methods	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
2	:	_	:	_	:	7	_	_	_	_	_	_	_	O
3	using	_	Using	_	VBG	7	_	_	_	_	_	_	_	O
4	unk	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
5	2011	_	2011	_	CD	7	_	_	_	_	_	_	_	O
6	unk	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
7	level	_	level	_	NN	7	_	_	_	_	_	_	_	O
8	data	_	data	_	NNS	7	_	_	_	_	_	_	_	O
9	on	_	on	_	IN	7	_	_	_	_	_	_	_	O
10	buprenorphine	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
11	dispensed	_	UNK	_	VBN	7	_	_	_	_	_	_	_	O
12	and	_	and	_	CC	7	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
14	level	_	level	_	NN	7	_	_	_	_	_	_	_	O
15	data	_	data	_	NNS	7	_	_	_	_	_	_	_	O
16	on	_	on	_	IN	7	_	_	_	_	_	_	_	O
17	the	_	the	_	DT	7	_	_	_	_	_	_	_	O
18	number	_	number	_	NN	7	_	_	_	_	_	_	_	O
19	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
20	unk	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
21	unk	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
22	physicians	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
23	and	_	and	_	CC	7	_	_	_	_	_	_	_	O
24	substance	_	substance	_	NN	7	_	_	_	_	_	_	_	O
25	abuse	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
26	treatment	_	treatment	_	NN	7	_	_	_	_	_	_	_	O
27	facilities	_	facility	_	NNS	7	_	_	_	_	_	_	_	O
28	using	_	use	_	VBG	7	_	_	_	_	_	_	_	O
29	buprenorphine	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
30	,	_	,	_	,	7	_	_	_	_	_	_	_	O
31	we	_	we	_	PRP	7	_	_	_	_	_	_	_	O
32	estimated	_	estimate	_	VBD	7	_	_	_	_	_	estimate.v	Estimated_value	O
33	a	_	a	_	DT	7	_	_	_	_	_	_	_	O
34	multivariate	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
35	ordinary	_	ordinary	_	JJ	7	_	_	_	_	_	_	_	O
36	least	_	least	_	JJS	7	_	_	_	_	_	_	_	O
37	squares	_	square	_	NNS	7	_	_	_	_	_	_	_	O
38	regression	_	UNK	_	VBP	7	_	_	_	_	_	_	_	O
39	model	_	model	_	NN	7	_	_	_	_	_	_	_	O
40	with	_	with	_	IN	7	_	_	_	_	_	_	_	O
41	state	_	state	_	NN	7	_	_	_	_	_	_	_	O
42	fixed	_	UNK	_	VBN	7	_	_	_	_	_	_	_	O
43	effects	_	effect	_	NNS	7	_	_	_	_	_	_	_	O
44	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
45	a	_	a	_	DT	7	_	_	_	_	_	_	_	O
46	state	_	state	_	NN	7	_	_	_	_	_	_	_	O
47	's	_	's	_	POS	7	_	_	_	_	_	_	_	O
48	annual	_	annual	_	JJ	7	_	_	_	_	_	_	_	O
49	total	_	total	_	JJ	7	_	_	_	_	_	_	_	O
50	buprenorphine	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
51	dispensed	_	UNK	_	VBN	7	_	_	_	_	_	_	_	O
52	per	_	per	_	FW	7	_	_	_	_	_	_	_	O
53	capita	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
54	as	_	a	_	IN	7	_	_	_	_	_	_	_	O
55	a	_	a	_	DT	7	_	_	_	_	_	_	_	O
56	function	_	function	_	NN	7	_	_	_	_	_	_	_	O
57	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
58	the	_	the	_	DT	7	_	_	_	_	_	_	_	O
59	state	_	state	_	NN	7	_	_	_	_	_	_	_	O
60	's	_	's	_	POS	7	_	_	_	_	_	_	_	O
61	number	_	number	_	NN	7	_	_	_	_	_	_	_	O
62	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
63	buprenorphine	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
64	providers	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
65	.	_	.	_	.	7	_	_	_	_	_	_	_	O

1	methods	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
2	:	_	:	_	:	7	_	_	_	_	_	_	_	O
3	using	_	Using	_	VBG	7	_	_	_	_	_	_	_	O
4	unk	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
5	2011	_	2011	_	CD	7	_	_	_	_	_	_	_	O
6	unk	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
7	level	_	level	_	NN	7	_	_	_	_	_	_	_	O
8	data	_	data	_	NNS	7	_	_	_	_	_	_	_	O
9	on	_	on	_	IN	7	_	_	_	_	_	_	_	O
10	buprenorphine	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
11	dispensed	_	UNK	_	VBN	7	_	_	_	_	_	_	_	O
12	and	_	and	_	CC	7	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
14	level	_	level	_	NN	7	_	_	_	_	_	_	_	O
15	data	_	data	_	NNS	7	_	_	_	_	_	_	_	O
16	on	_	on	_	IN	7	_	_	_	_	_	_	_	O
17	the	_	the	_	DT	7	_	_	_	_	_	_	_	O
18	number	_	number	_	NN	7	_	_	_	_	_	_	_	O
19	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
20	unk	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
21	unk	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
22	physicians	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
23	and	_	and	_	CC	7	_	_	_	_	_	_	_	O
24	substance	_	substance	_	NN	7	_	_	_	_	_	_	_	O
25	abuse	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
26	treatment	_	treatment	_	NN	7	_	_	_	_	_	_	_	O
27	facilities	_	facility	_	NNS	7	_	_	_	_	_	_	_	O
28	using	_	use	_	VBG	7	_	_	_	_	_	_	_	O
29	buprenorphine	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
30	,	_	,	_	,	7	_	_	_	_	_	_	_	O
31	we	_	we	_	PRP	7	_	_	_	_	_	_	_	O
32	estimated	_	estimate	_	VBD	7	_	_	_	_	_	_	_	O
33	a	_	a	_	DT	7	_	_	_	_	_	_	_	O
34	multivariate	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
35	ordinary	_	ordinary	_	JJ	7	_	_	_	_	_	ordinary.a	Typicality	O
36	least	_	least	_	JJS	7	_	_	_	_	_	_	_	O
37	squares	_	square	_	NNS	7	_	_	_	_	_	_	_	O
38	regression	_	UNK	_	VBP	7	_	_	_	_	_	_	_	O
39	model	_	model	_	NN	7	_	_	_	_	_	_	_	O
40	with	_	with	_	IN	7	_	_	_	_	_	_	_	O
41	state	_	state	_	NN	7	_	_	_	_	_	_	_	O
42	fixed	_	UNK	_	VBN	7	_	_	_	_	_	_	_	O
43	effects	_	effect	_	NNS	7	_	_	_	_	_	_	_	O
44	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
45	a	_	a	_	DT	7	_	_	_	_	_	_	_	O
46	state	_	state	_	NN	7	_	_	_	_	_	_	_	O
47	's	_	's	_	POS	7	_	_	_	_	_	_	_	O
48	annual	_	annual	_	JJ	7	_	_	_	_	_	_	_	O
49	total	_	total	_	JJ	7	_	_	_	_	_	_	_	O
50	buprenorphine	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
51	dispensed	_	UNK	_	VBN	7	_	_	_	_	_	_	_	O
52	per	_	per	_	FW	7	_	_	_	_	_	_	_	O
53	capita	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
54	as	_	a	_	IN	7	_	_	_	_	_	_	_	O
55	a	_	a	_	DT	7	_	_	_	_	_	_	_	O
56	function	_	function	_	NN	7	_	_	_	_	_	_	_	O
57	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
58	the	_	the	_	DT	7	_	_	_	_	_	_	_	O
59	state	_	state	_	NN	7	_	_	_	_	_	_	_	O
60	's	_	's	_	POS	7	_	_	_	_	_	_	_	O
61	number	_	number	_	NN	7	_	_	_	_	_	_	_	O
62	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
63	buprenorphine	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
64	providers	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
65	.	_	.	_	.	7	_	_	_	_	_	_	_	O

1	methods	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
2	:	_	:	_	:	7	_	_	_	_	_	_	_	O
3	using	_	Using	_	VBG	7	_	_	_	_	_	_	_	O
4	unk	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
5	2011	_	2011	_	CD	7	_	_	_	_	_	_	_	O
6	unk	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
7	level	_	level	_	NN	7	_	_	_	_	_	_	_	O
8	data	_	data	_	NNS	7	_	_	_	_	_	_	_	O
9	on	_	on	_	IN	7	_	_	_	_	_	_	_	O
10	buprenorphine	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
11	dispensed	_	UNK	_	VBN	7	_	_	_	_	_	_	_	O
12	and	_	and	_	CC	7	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
14	level	_	level	_	NN	7	_	_	_	_	_	_	_	O
15	data	_	data	_	NNS	7	_	_	_	_	_	_	_	O
16	on	_	on	_	IN	7	_	_	_	_	_	_	_	O
17	the	_	the	_	DT	7	_	_	_	_	_	_	_	O
18	number	_	number	_	NN	7	_	_	_	_	_	_	_	O
19	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
20	unk	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
21	unk	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
22	physicians	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
23	and	_	and	_	CC	7	_	_	_	_	_	_	_	O
24	substance	_	substance	_	NN	7	_	_	_	_	_	_	_	O
25	abuse	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
26	treatment	_	treatment	_	NN	7	_	_	_	_	_	_	_	O
27	facilities	_	facility	_	NNS	7	_	_	_	_	_	_	_	O
28	using	_	use	_	VBG	7	_	_	_	_	_	_	_	O
29	buprenorphine	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
30	,	_	,	_	,	7	_	_	_	_	_	_	_	O
31	we	_	we	_	PRP	7	_	_	_	_	_	_	_	O
32	estimated	_	estimate	_	VBD	7	_	_	_	_	_	_	_	O
33	a	_	a	_	DT	7	_	_	_	_	_	_	_	O
34	multivariate	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
35	ordinary	_	ordinary	_	JJ	7	_	_	_	_	_	_	_	O
36	least	_	least	_	JJS	7	_	_	_	_	_	_	_	O
37	squares	_	square	_	NNS	7	_	_	_	_	_	square.n	Compatibility	O
38	regression	_	UNK	_	VBP	7	_	_	_	_	_	_	_	O
39	model	_	model	_	NN	7	_	_	_	_	_	_	_	O
40	with	_	with	_	IN	7	_	_	_	_	_	_	_	O
41	state	_	state	_	NN	7	_	_	_	_	_	_	_	O
42	fixed	_	UNK	_	VBN	7	_	_	_	_	_	_	_	O
43	effects	_	effect	_	NNS	7	_	_	_	_	_	_	_	O
44	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
45	a	_	a	_	DT	7	_	_	_	_	_	_	_	O
46	state	_	state	_	NN	7	_	_	_	_	_	_	_	O
47	's	_	's	_	POS	7	_	_	_	_	_	_	_	O
48	annual	_	annual	_	JJ	7	_	_	_	_	_	_	_	O
49	total	_	total	_	JJ	7	_	_	_	_	_	_	_	O
50	buprenorphine	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
51	dispensed	_	UNK	_	VBN	7	_	_	_	_	_	_	_	O
52	per	_	per	_	FW	7	_	_	_	_	_	_	_	O
53	capita	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
54	as	_	a	_	IN	7	_	_	_	_	_	_	_	O
55	a	_	a	_	DT	7	_	_	_	_	_	_	_	O
56	function	_	function	_	NN	7	_	_	_	_	_	_	_	O
57	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
58	the	_	the	_	DT	7	_	_	_	_	_	_	_	O
59	state	_	state	_	NN	7	_	_	_	_	_	_	_	O
60	's	_	's	_	POS	7	_	_	_	_	_	_	_	O
61	number	_	number	_	NN	7	_	_	_	_	_	_	_	O
62	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
63	buprenorphine	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
64	providers	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
65	.	_	.	_	.	7	_	_	_	_	_	_	_	O

1	methods	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
2	:	_	:	_	:	7	_	_	_	_	_	_	_	O
3	using	_	Using	_	VBG	7	_	_	_	_	_	_	_	O
4	unk	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
5	2011	_	2011	_	CD	7	_	_	_	_	_	_	_	O
6	unk	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
7	level	_	level	_	NN	7	_	_	_	_	_	_	_	O
8	data	_	data	_	NNS	7	_	_	_	_	_	_	_	O
9	on	_	on	_	IN	7	_	_	_	_	_	_	_	O
10	buprenorphine	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
11	dispensed	_	UNK	_	VBN	7	_	_	_	_	_	_	_	O
12	and	_	and	_	CC	7	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
14	level	_	level	_	NN	7	_	_	_	_	_	_	_	O
15	data	_	data	_	NNS	7	_	_	_	_	_	_	_	O
16	on	_	on	_	IN	7	_	_	_	_	_	_	_	O
17	the	_	the	_	DT	7	_	_	_	_	_	_	_	O
18	number	_	number	_	NN	7	_	_	_	_	_	_	_	O
19	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
20	unk	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
21	unk	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
22	physicians	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
23	and	_	and	_	CC	7	_	_	_	_	_	_	_	O
24	substance	_	substance	_	NN	7	_	_	_	_	_	_	_	O
25	abuse	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
26	treatment	_	treatment	_	NN	7	_	_	_	_	_	_	_	O
27	facilities	_	facility	_	NNS	7	_	_	_	_	_	_	_	O
28	using	_	use	_	VBG	7	_	_	_	_	_	_	_	O
29	buprenorphine	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
30	,	_	,	_	,	7	_	_	_	_	_	_	_	O
31	we	_	we	_	PRP	7	_	_	_	_	_	_	_	O
32	estimated	_	estimate	_	VBD	7	_	_	_	_	_	_	_	O
33	a	_	a	_	DT	7	_	_	_	_	_	_	_	O
34	multivariate	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
35	ordinary	_	ordinary	_	JJ	7	_	_	_	_	_	_	_	O
36	least	_	least	_	JJS	7	_	_	_	_	_	_	_	O
37	squares	_	square	_	NNS	7	_	_	_	_	_	_	_	O
38	regression	_	UNK	_	VBP	7	_	_	_	_	_	_	_	O
39	model	_	model	_	NN	7	_	_	_	_	_	model.n	Exemplar	O
40	with	_	with	_	IN	7	_	_	_	_	_	_	_	O
41	state	_	state	_	NN	7	_	_	_	_	_	_	_	O
42	fixed	_	UNK	_	VBN	7	_	_	_	_	_	_	_	O
43	effects	_	effect	_	NNS	7	_	_	_	_	_	_	_	O
44	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
45	a	_	a	_	DT	7	_	_	_	_	_	_	_	O
46	state	_	state	_	NN	7	_	_	_	_	_	_	_	O
47	's	_	's	_	POS	7	_	_	_	_	_	_	_	O
48	annual	_	annual	_	JJ	7	_	_	_	_	_	_	_	O
49	total	_	total	_	JJ	7	_	_	_	_	_	_	_	O
50	buprenorphine	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
51	dispensed	_	UNK	_	VBN	7	_	_	_	_	_	_	_	O
52	per	_	per	_	FW	7	_	_	_	_	_	_	_	O
53	capita	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
54	as	_	a	_	IN	7	_	_	_	_	_	_	_	O
55	a	_	a	_	DT	7	_	_	_	_	_	_	_	O
56	function	_	function	_	NN	7	_	_	_	_	_	_	_	O
57	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
58	the	_	the	_	DT	7	_	_	_	_	_	_	_	O
59	state	_	state	_	NN	7	_	_	_	_	_	_	_	O
60	's	_	's	_	POS	7	_	_	_	_	_	_	_	O
61	number	_	number	_	NN	7	_	_	_	_	_	_	_	O
62	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
63	buprenorphine	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
64	providers	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
65	.	_	.	_	.	7	_	_	_	_	_	_	_	O

1	methods	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
2	:	_	:	_	:	7	_	_	_	_	_	_	_	O
3	using	_	Using	_	VBG	7	_	_	_	_	_	_	_	O
4	unk	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
5	2011	_	2011	_	CD	7	_	_	_	_	_	_	_	O
6	unk	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
7	level	_	level	_	NN	7	_	_	_	_	_	_	_	O
8	data	_	data	_	NNS	7	_	_	_	_	_	_	_	O
9	on	_	on	_	IN	7	_	_	_	_	_	_	_	O
10	buprenorphine	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
11	dispensed	_	UNK	_	VBN	7	_	_	_	_	_	_	_	O
12	and	_	and	_	CC	7	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
14	level	_	level	_	NN	7	_	_	_	_	_	_	_	O
15	data	_	data	_	NNS	7	_	_	_	_	_	_	_	O
16	on	_	on	_	IN	7	_	_	_	_	_	_	_	O
17	the	_	the	_	DT	7	_	_	_	_	_	_	_	O
18	number	_	number	_	NN	7	_	_	_	_	_	_	_	O
19	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
20	unk	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
21	unk	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
22	physicians	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
23	and	_	and	_	CC	7	_	_	_	_	_	_	_	O
24	substance	_	substance	_	NN	7	_	_	_	_	_	_	_	O
25	abuse	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
26	treatment	_	treatment	_	NN	7	_	_	_	_	_	_	_	O
27	facilities	_	facility	_	NNS	7	_	_	_	_	_	_	_	O
28	using	_	use	_	VBG	7	_	_	_	_	_	_	_	O
29	buprenorphine	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
30	,	_	,	_	,	7	_	_	_	_	_	_	_	O
31	we	_	we	_	PRP	7	_	_	_	_	_	_	_	O
32	estimated	_	estimate	_	VBD	7	_	_	_	_	_	_	_	O
33	a	_	a	_	DT	7	_	_	_	_	_	_	_	O
34	multivariate	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
35	ordinary	_	ordinary	_	JJ	7	_	_	_	_	_	_	_	O
36	least	_	least	_	JJS	7	_	_	_	_	_	_	_	O
37	squares	_	square	_	NNS	7	_	_	_	_	_	_	_	O
38	regression	_	UNK	_	VBP	7	_	_	_	_	_	_	_	O
39	model	_	model	_	NN	7	_	_	_	_	_	_	_	O
40	with	_	with	_	IN	7	_	_	_	_	_	_	_	O
41	state	_	state	_	NN	7	_	_	_	_	_	_	_	O
42	fixed	_	UNK	_	VBN	7	_	_	_	_	_	_	_	O
43	effects	_	effect	_	NNS	7	_	_	_	_	_	effect.n	Being_in_effect	O
44	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
45	a	_	a	_	DT	7	_	_	_	_	_	_	_	O
46	state	_	state	_	NN	7	_	_	_	_	_	_	_	O
47	's	_	's	_	POS	7	_	_	_	_	_	_	_	O
48	annual	_	annual	_	JJ	7	_	_	_	_	_	_	_	O
49	total	_	total	_	JJ	7	_	_	_	_	_	_	_	O
50	buprenorphine	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
51	dispensed	_	UNK	_	VBN	7	_	_	_	_	_	_	_	O
52	per	_	per	_	FW	7	_	_	_	_	_	_	_	O
53	capita	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
54	as	_	a	_	IN	7	_	_	_	_	_	_	_	O
55	a	_	a	_	DT	7	_	_	_	_	_	_	_	O
56	function	_	function	_	NN	7	_	_	_	_	_	_	_	O
57	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
58	the	_	the	_	DT	7	_	_	_	_	_	_	_	O
59	state	_	state	_	NN	7	_	_	_	_	_	_	_	O
60	's	_	's	_	POS	7	_	_	_	_	_	_	_	O
61	number	_	number	_	NN	7	_	_	_	_	_	_	_	O
62	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
63	buprenorphine	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
64	providers	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
65	.	_	.	_	.	7	_	_	_	_	_	_	_	O

1	methods	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
2	:	_	:	_	:	7	_	_	_	_	_	_	_	O
3	using	_	Using	_	VBG	7	_	_	_	_	_	_	_	O
4	unk	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
5	2011	_	2011	_	CD	7	_	_	_	_	_	_	_	O
6	unk	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
7	level	_	level	_	NN	7	_	_	_	_	_	_	_	O
8	data	_	data	_	NNS	7	_	_	_	_	_	_	_	O
9	on	_	on	_	IN	7	_	_	_	_	_	_	_	O
10	buprenorphine	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
11	dispensed	_	UNK	_	VBN	7	_	_	_	_	_	_	_	O
12	and	_	and	_	CC	7	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
14	level	_	level	_	NN	7	_	_	_	_	_	_	_	O
15	data	_	data	_	NNS	7	_	_	_	_	_	_	_	O
16	on	_	on	_	IN	7	_	_	_	_	_	_	_	O
17	the	_	the	_	DT	7	_	_	_	_	_	_	_	O
18	number	_	number	_	NN	7	_	_	_	_	_	_	_	O
19	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
20	unk	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
21	unk	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
22	physicians	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
23	and	_	and	_	CC	7	_	_	_	_	_	_	_	O
24	substance	_	substance	_	NN	7	_	_	_	_	_	_	_	O
25	abuse	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
26	treatment	_	treatment	_	NN	7	_	_	_	_	_	_	_	O
27	facilities	_	facility	_	NNS	7	_	_	_	_	_	_	_	O
28	using	_	use	_	VBG	7	_	_	_	_	_	_	_	O
29	buprenorphine	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
30	,	_	,	_	,	7	_	_	_	_	_	_	_	O
31	we	_	we	_	PRP	7	_	_	_	_	_	_	_	O
32	estimated	_	estimate	_	VBD	7	_	_	_	_	_	_	_	O
33	a	_	a	_	DT	7	_	_	_	_	_	_	_	O
34	multivariate	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
35	ordinary	_	ordinary	_	JJ	7	_	_	_	_	_	_	_	O
36	least	_	least	_	JJS	7	_	_	_	_	_	_	_	O
37	squares	_	square	_	NNS	7	_	_	_	_	_	_	_	O
38	regression	_	UNK	_	VBP	7	_	_	_	_	_	_	_	O
39	model	_	model	_	NN	7	_	_	_	_	_	_	_	O
40	with	_	with	_	IN	7	_	_	_	_	_	_	_	O
41	state	_	state	_	NN	7	_	_	_	_	_	_	_	O
42	fixed	_	UNK	_	VBN	7	_	_	_	_	_	_	_	O
43	effects	_	effect	_	NNS	7	_	_	_	_	_	_	_	O
44	of	_	of	_	IN	7	_	_	_	_	_	of.prep	Age	O
45	a	_	a	_	DT	7	_	_	_	_	_	_	_	O
46	state	_	state	_	NN	7	_	_	_	_	_	_	_	O
47	's	_	's	_	POS	7	_	_	_	_	_	_	_	O
48	annual	_	annual	_	JJ	7	_	_	_	_	_	_	_	O
49	total	_	total	_	JJ	7	_	_	_	_	_	_	_	O
50	buprenorphine	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
51	dispensed	_	UNK	_	VBN	7	_	_	_	_	_	_	_	O
52	per	_	per	_	FW	7	_	_	_	_	_	_	_	O
53	capita	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
54	as	_	a	_	IN	7	_	_	_	_	_	_	_	O
55	a	_	a	_	DT	7	_	_	_	_	_	_	_	O
56	function	_	function	_	NN	7	_	_	_	_	_	_	_	O
57	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
58	the	_	the	_	DT	7	_	_	_	_	_	_	_	O
59	state	_	state	_	NN	7	_	_	_	_	_	_	_	O
60	's	_	's	_	POS	7	_	_	_	_	_	_	_	O
61	number	_	number	_	NN	7	_	_	_	_	_	_	_	O
62	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
63	buprenorphine	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
64	providers	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
65	.	_	.	_	.	7	_	_	_	_	_	_	_	O

1	methods	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
2	:	_	:	_	:	7	_	_	_	_	_	_	_	O
3	using	_	Using	_	VBG	7	_	_	_	_	_	_	_	O
4	unk	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
5	2011	_	2011	_	CD	7	_	_	_	_	_	_	_	O
6	unk	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
7	level	_	level	_	NN	7	_	_	_	_	_	_	_	O
8	data	_	data	_	NNS	7	_	_	_	_	_	_	_	O
9	on	_	on	_	IN	7	_	_	_	_	_	_	_	O
10	buprenorphine	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
11	dispensed	_	UNK	_	VBN	7	_	_	_	_	_	_	_	O
12	and	_	and	_	CC	7	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
14	level	_	level	_	NN	7	_	_	_	_	_	_	_	O
15	data	_	data	_	NNS	7	_	_	_	_	_	_	_	O
16	on	_	on	_	IN	7	_	_	_	_	_	_	_	O
17	the	_	the	_	DT	7	_	_	_	_	_	_	_	O
18	number	_	number	_	NN	7	_	_	_	_	_	_	_	O
19	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
20	unk	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
21	unk	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
22	physicians	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
23	and	_	and	_	CC	7	_	_	_	_	_	_	_	O
24	substance	_	substance	_	NN	7	_	_	_	_	_	_	_	O
25	abuse	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
26	treatment	_	treatment	_	NN	7	_	_	_	_	_	_	_	O
27	facilities	_	facility	_	NNS	7	_	_	_	_	_	_	_	O
28	using	_	use	_	VBG	7	_	_	_	_	_	_	_	O
29	buprenorphine	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
30	,	_	,	_	,	7	_	_	_	_	_	_	_	O
31	we	_	we	_	PRP	7	_	_	_	_	_	_	_	O
32	estimated	_	estimate	_	VBD	7	_	_	_	_	_	_	_	O
33	a	_	a	_	DT	7	_	_	_	_	_	_	_	O
34	multivariate	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
35	ordinary	_	ordinary	_	JJ	7	_	_	_	_	_	_	_	O
36	least	_	least	_	JJS	7	_	_	_	_	_	_	_	O
37	squares	_	square	_	NNS	7	_	_	_	_	_	_	_	O
38	regression	_	UNK	_	VBP	7	_	_	_	_	_	_	_	O
39	model	_	model	_	NN	7	_	_	_	_	_	_	_	O
40	with	_	with	_	IN	7	_	_	_	_	_	_	_	O
41	state	_	state	_	NN	7	_	_	_	_	_	_	_	O
42	fixed	_	UNK	_	VBN	7	_	_	_	_	_	_	_	O
43	effects	_	effect	_	NNS	7	_	_	_	_	_	_	_	O
44	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
45	a	_	a	_	DT	7	_	_	_	_	_	_	_	O
46	state	_	state	_	NN	7	_	_	_	_	_	_	_	O
47	's	_	's	_	POS	7	_	_	_	_	_	_	_	O
48	annual	_	annual	_	JJ	7	_	_	_	_	_	_	_	O
49	total	_	total	_	JJ	7	_	_	_	_	_	total.a	Amounting_to	O
50	buprenorphine	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
51	dispensed	_	UNK	_	VBN	7	_	_	_	_	_	_	_	O
52	per	_	per	_	FW	7	_	_	_	_	_	_	_	O
53	capita	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
54	as	_	a	_	IN	7	_	_	_	_	_	_	_	O
55	a	_	a	_	DT	7	_	_	_	_	_	_	_	O
56	function	_	function	_	NN	7	_	_	_	_	_	_	_	O
57	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
58	the	_	the	_	DT	7	_	_	_	_	_	_	_	O
59	state	_	state	_	NN	7	_	_	_	_	_	_	_	O
60	's	_	's	_	POS	7	_	_	_	_	_	_	_	O
61	number	_	number	_	NN	7	_	_	_	_	_	_	_	O
62	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
63	buprenorphine	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
64	providers	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
65	.	_	.	_	.	7	_	_	_	_	_	_	_	O

1	methods	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
2	:	_	:	_	:	7	_	_	_	_	_	_	_	O
3	using	_	Using	_	VBG	7	_	_	_	_	_	_	_	O
4	unk	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
5	2011	_	2011	_	CD	7	_	_	_	_	_	_	_	O
6	unk	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
7	level	_	level	_	NN	7	_	_	_	_	_	_	_	O
8	data	_	data	_	NNS	7	_	_	_	_	_	_	_	O
9	on	_	on	_	IN	7	_	_	_	_	_	_	_	O
10	buprenorphine	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
11	dispensed	_	UNK	_	VBN	7	_	_	_	_	_	_	_	O
12	and	_	and	_	CC	7	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
14	level	_	level	_	NN	7	_	_	_	_	_	_	_	O
15	data	_	data	_	NNS	7	_	_	_	_	_	_	_	O
16	on	_	on	_	IN	7	_	_	_	_	_	_	_	O
17	the	_	the	_	DT	7	_	_	_	_	_	_	_	O
18	number	_	number	_	NN	7	_	_	_	_	_	_	_	O
19	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
20	unk	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
21	unk	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
22	physicians	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
23	and	_	and	_	CC	7	_	_	_	_	_	_	_	O
24	substance	_	substance	_	NN	7	_	_	_	_	_	_	_	O
25	abuse	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
26	treatment	_	treatment	_	NN	7	_	_	_	_	_	_	_	O
27	facilities	_	facility	_	NNS	7	_	_	_	_	_	_	_	O
28	using	_	use	_	VBG	7	_	_	_	_	_	_	_	O
29	buprenorphine	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
30	,	_	,	_	,	7	_	_	_	_	_	_	_	O
31	we	_	we	_	PRP	7	_	_	_	_	_	_	_	O
32	estimated	_	estimate	_	VBD	7	_	_	_	_	_	_	_	O
33	a	_	a	_	DT	7	_	_	_	_	_	_	_	O
34	multivariate	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
35	ordinary	_	ordinary	_	JJ	7	_	_	_	_	_	_	_	O
36	least	_	least	_	JJS	7	_	_	_	_	_	_	_	O
37	squares	_	square	_	NNS	7	_	_	_	_	_	_	_	O
38	regression	_	UNK	_	VBP	7	_	_	_	_	_	_	_	O
39	model	_	model	_	NN	7	_	_	_	_	_	_	_	O
40	with	_	with	_	IN	7	_	_	_	_	_	_	_	O
41	state	_	state	_	NN	7	_	_	_	_	_	_	_	O
42	fixed	_	UNK	_	VBN	7	_	_	_	_	_	_	_	O
43	effects	_	effect	_	NNS	7	_	_	_	_	_	_	_	O
44	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
45	a	_	a	_	DT	7	_	_	_	_	_	_	_	O
46	state	_	state	_	NN	7	_	_	_	_	_	_	_	O
47	's	_	's	_	POS	7	_	_	_	_	_	_	_	O
48	annual	_	annual	_	JJ	7	_	_	_	_	_	_	_	O
49	total	_	total	_	JJ	7	_	_	_	_	_	_	_	O
50	buprenorphine	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
51	dispensed	_	UNK	_	VBN	7	_	_	_	_	_	_	_	O
52	per	_	per	_	FW	7	_	_	_	_	_	_	_	O
53	capita	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
54	as	_	a	_	IN	7	_	_	_	_	_	_	_	O
55	a	_	a	_	DT	7	_	_	_	_	_	_	_	O
56	function	_	function	_	NN	7	_	_	_	_	_	_	_	O
57	of	_	of	_	IN	7	_	_	_	_	_	of.prep	Age	O
58	the	_	the	_	DT	7	_	_	_	_	_	_	_	O
59	state	_	state	_	NN	7	_	_	_	_	_	_	_	O
60	's	_	's	_	POS	7	_	_	_	_	_	_	_	O
61	number	_	number	_	NN	7	_	_	_	_	_	_	_	O
62	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
63	buprenorphine	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
64	providers	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
65	.	_	.	_	.	7	_	_	_	_	_	_	_	O

1	methods	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
2	:	_	:	_	:	7	_	_	_	_	_	_	_	O
3	using	_	Using	_	VBG	7	_	_	_	_	_	_	_	O
4	unk	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
5	2011	_	2011	_	CD	7	_	_	_	_	_	_	_	O
6	unk	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
7	level	_	level	_	NN	7	_	_	_	_	_	_	_	O
8	data	_	data	_	NNS	7	_	_	_	_	_	_	_	O
9	on	_	on	_	IN	7	_	_	_	_	_	_	_	O
10	buprenorphine	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
11	dispensed	_	UNK	_	VBN	7	_	_	_	_	_	_	_	O
12	and	_	and	_	CC	7	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
14	level	_	level	_	NN	7	_	_	_	_	_	_	_	O
15	data	_	data	_	NNS	7	_	_	_	_	_	_	_	O
16	on	_	on	_	IN	7	_	_	_	_	_	_	_	O
17	the	_	the	_	DT	7	_	_	_	_	_	_	_	O
18	number	_	number	_	NN	7	_	_	_	_	_	_	_	O
19	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
20	unk	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
21	unk	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
22	physicians	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
23	and	_	and	_	CC	7	_	_	_	_	_	_	_	O
24	substance	_	substance	_	NN	7	_	_	_	_	_	_	_	O
25	abuse	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
26	treatment	_	treatment	_	NN	7	_	_	_	_	_	_	_	O
27	facilities	_	facility	_	NNS	7	_	_	_	_	_	_	_	O
28	using	_	use	_	VBG	7	_	_	_	_	_	_	_	O
29	buprenorphine	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
30	,	_	,	_	,	7	_	_	_	_	_	_	_	O
31	we	_	we	_	PRP	7	_	_	_	_	_	_	_	O
32	estimated	_	estimate	_	VBD	7	_	_	_	_	_	_	_	O
33	a	_	a	_	DT	7	_	_	_	_	_	_	_	O
34	multivariate	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
35	ordinary	_	ordinary	_	JJ	7	_	_	_	_	_	_	_	O
36	least	_	least	_	JJS	7	_	_	_	_	_	_	_	O
37	squares	_	square	_	NNS	7	_	_	_	_	_	_	_	O
38	regression	_	UNK	_	VBP	7	_	_	_	_	_	_	_	O
39	model	_	model	_	NN	7	_	_	_	_	_	_	_	O
40	with	_	with	_	IN	7	_	_	_	_	_	_	_	O
41	state	_	state	_	NN	7	_	_	_	_	_	_	_	O
42	fixed	_	UNK	_	VBN	7	_	_	_	_	_	_	_	O
43	effects	_	effect	_	NNS	7	_	_	_	_	_	_	_	O
44	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
45	a	_	a	_	DT	7	_	_	_	_	_	_	_	O
46	state	_	state	_	NN	7	_	_	_	_	_	_	_	O
47	's	_	's	_	POS	7	_	_	_	_	_	_	_	O
48	annual	_	annual	_	JJ	7	_	_	_	_	_	_	_	O
49	total	_	total	_	JJ	7	_	_	_	_	_	_	_	O
50	buprenorphine	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
51	dispensed	_	UNK	_	VBN	7	_	_	_	_	_	_	_	O
52	per	_	per	_	FW	7	_	_	_	_	_	_	_	O
53	capita	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
54	as	_	a	_	IN	7	_	_	_	_	_	_	_	O
55	a	_	a	_	DT	7	_	_	_	_	_	_	_	O
56	function	_	function	_	NN	7	_	_	_	_	_	_	_	O
57	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
58	the	_	the	_	DT	7	_	_	_	_	_	_	_	O
59	state	_	state	_	NN	7	_	_	_	_	_	_	_	O
60	's	_	's	_	POS	7	_	_	_	_	_	_	_	O
61	number	_	number	_	NN	7	_	_	_	_	_	number.n	Be_subset_of	O
62	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
63	buprenorphine	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
64	providers	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
65	.	_	.	_	.	7	_	_	_	_	_	_	_	O

1	methods	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
2	:	_	:	_	:	7	_	_	_	_	_	_	_	O
3	using	_	Using	_	VBG	7	_	_	_	_	_	_	_	O
4	unk	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
5	2011	_	2011	_	CD	7	_	_	_	_	_	_	_	O
6	unk	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
7	level	_	level	_	NN	7	_	_	_	_	_	_	_	O
8	data	_	data	_	NNS	7	_	_	_	_	_	_	_	O
9	on	_	on	_	IN	7	_	_	_	_	_	_	_	O
10	buprenorphine	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
11	dispensed	_	UNK	_	VBN	7	_	_	_	_	_	_	_	O
12	and	_	and	_	CC	7	_	_	_	_	_	_	_	O
13	unk	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
14	level	_	level	_	NN	7	_	_	_	_	_	_	_	O
15	data	_	data	_	NNS	7	_	_	_	_	_	_	_	O
16	on	_	on	_	IN	7	_	_	_	_	_	_	_	O
17	the	_	the	_	DT	7	_	_	_	_	_	_	_	O
18	number	_	number	_	NN	7	_	_	_	_	_	_	_	O
19	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
20	unk	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
21	unk	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
22	physicians	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
23	and	_	and	_	CC	7	_	_	_	_	_	_	_	O
24	substance	_	substance	_	NN	7	_	_	_	_	_	_	_	O
25	abuse	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
26	treatment	_	treatment	_	NN	7	_	_	_	_	_	_	_	O
27	facilities	_	facility	_	NNS	7	_	_	_	_	_	_	_	O
28	using	_	use	_	VBG	7	_	_	_	_	_	_	_	O
29	buprenorphine	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
30	,	_	,	_	,	7	_	_	_	_	_	_	_	O
31	we	_	we	_	PRP	7	_	_	_	_	_	_	_	O
32	estimated	_	estimate	_	VBD	7	_	_	_	_	_	_	_	O
33	a	_	a	_	DT	7	_	_	_	_	_	_	_	O
34	multivariate	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
35	ordinary	_	ordinary	_	JJ	7	_	_	_	_	_	_	_	O
36	least	_	least	_	JJS	7	_	_	_	_	_	_	_	O
37	squares	_	square	_	NNS	7	_	_	_	_	_	_	_	O
38	regression	_	UNK	_	VBP	7	_	_	_	_	_	_	_	O
39	model	_	model	_	NN	7	_	_	_	_	_	_	_	O
40	with	_	with	_	IN	7	_	_	_	_	_	_	_	O
41	state	_	state	_	NN	7	_	_	_	_	_	_	_	O
42	fixed	_	UNK	_	VBN	7	_	_	_	_	_	_	_	O
43	effects	_	effect	_	NNS	7	_	_	_	_	_	_	_	O
44	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
45	a	_	a	_	DT	7	_	_	_	_	_	_	_	O
46	state	_	state	_	NN	7	_	_	_	_	_	_	_	O
47	's	_	's	_	POS	7	_	_	_	_	_	_	_	O
48	annual	_	annual	_	JJ	7	_	_	_	_	_	_	_	O
49	total	_	total	_	JJ	7	_	_	_	_	_	_	_	O
50	buprenorphine	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
51	dispensed	_	UNK	_	VBN	7	_	_	_	_	_	_	_	O
52	per	_	per	_	FW	7	_	_	_	_	_	_	_	O
53	capita	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
54	as	_	a	_	IN	7	_	_	_	_	_	_	_	O
55	a	_	a	_	DT	7	_	_	_	_	_	_	_	O
56	function	_	function	_	NN	7	_	_	_	_	_	_	_	O
57	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
58	the	_	the	_	DT	7	_	_	_	_	_	_	_	O
59	state	_	state	_	NN	7	_	_	_	_	_	_	_	O
60	's	_	's	_	POS	7	_	_	_	_	_	_	_	O
61	number	_	number	_	NN	7	_	_	_	_	_	_	_	O
62	of	_	of	_	IN	7	_	_	_	_	_	of.prep	Age	O
63	buprenorphine	_	UNK	_	JJ	7	_	_	_	_	_	_	_	O
64	providers	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
65	.	_	.	_	.	7	_	_	_	_	_	_	_	O

1	findings	_	UNK	_	NNS	8	_	_	_	_	_	_	_	O
2	:	_	:	_	:	8	_	_	_	_	_	_	_	O
3	the	_	The	_	DT	8	_	_	_	_	_	_	_	O
4	amount	_	amount	_	NN	8	_	_	_	_	_	amount.n	Quantity	O
5	of	_	of	_	IN	8	_	_	_	_	_	_	_	O
6	buprenorphine	_	UNK	_	NN	8	_	_	_	_	_	_	_	O
7	dispensed	_	UNK	_	VBN	8	_	_	_	_	_	_	_	O
8	has	_	have	_	VBZ	8	_	_	_	_	_	_	_	O
9	been	_	be	_	VBN	8	_	_	_	_	_	_	_	O
10	increasing	_	increase	_	VBG	8	_	_	_	_	_	_	_	O
11	at	_	at	_	IN	8	_	_	_	_	_	_	_	O
12	a	_	a	_	DT	8	_	_	_	_	_	_	_	O
13	greater	_	greater	_	JJR	8	_	_	_	_	_	_	_	O
14	rate	_	rate	_	NN	8	_	_	_	_	_	_	_	O
15	than	_	than	_	IN	8	_	_	_	_	_	_	_	O
16	the	_	the	_	DT	8	_	_	_	_	_	_	_	O
17	number	_	number	_	NN	8	_	_	_	_	_	_	_	O
18	of	_	of	_	IN	8	_	_	_	_	_	_	_	O
19	buprenorphine	_	UNK	_	JJ	8	_	_	_	_	_	_	_	O
20	providers	_	UNK	_	NNS	8	_	_	_	_	_	_	_	O
21	.	_	.	_	.	8	_	_	_	_	_	_	_	O

1	findings	_	UNK	_	NNS	8	_	_	_	_	_	_	_	O
2	:	_	:	_	:	8	_	_	_	_	_	_	_	O
3	the	_	The	_	DT	8	_	_	_	_	_	_	_	O
4	amount	_	amount	_	NN	8	_	_	_	_	_	_	_	O
5	of	_	of	_	IN	8	_	_	_	_	_	of.prep	Age	O
6	buprenorphine	_	UNK	_	NN	8	_	_	_	_	_	_	_	O
7	dispensed	_	UNK	_	VBN	8	_	_	_	_	_	_	_	O
8	has	_	have	_	VBZ	8	_	_	_	_	_	_	_	O
9	been	_	be	_	VBN	8	_	_	_	_	_	_	_	O
10	increasing	_	increase	_	VBG	8	_	_	_	_	_	_	_	O
11	at	_	at	_	IN	8	_	_	_	_	_	_	_	O
12	a	_	a	_	DT	8	_	_	_	_	_	_	_	O
13	greater	_	greater	_	JJR	8	_	_	_	_	_	_	_	O
14	rate	_	rate	_	NN	8	_	_	_	_	_	_	_	O
15	than	_	than	_	IN	8	_	_	_	_	_	_	_	O
16	the	_	the	_	DT	8	_	_	_	_	_	_	_	O
17	number	_	number	_	NN	8	_	_	_	_	_	_	_	O
18	of	_	of	_	IN	8	_	_	_	_	_	_	_	O
19	buprenorphine	_	UNK	_	JJ	8	_	_	_	_	_	_	_	O
20	providers	_	UNK	_	NNS	8	_	_	_	_	_	_	_	O
21	.	_	.	_	.	8	_	_	_	_	_	_	_	O

1	findings	_	UNK	_	NNS	8	_	_	_	_	_	_	_	O
2	:	_	:	_	:	8	_	_	_	_	_	_	_	O
3	the	_	The	_	DT	8	_	_	_	_	_	_	_	O
4	amount	_	amount	_	NN	8	_	_	_	_	_	_	_	O
5	of	_	of	_	IN	8	_	_	_	_	_	_	_	O
6	buprenorphine	_	UNK	_	NN	8	_	_	_	_	_	_	_	O
7	dispensed	_	UNK	_	VBN	8	_	_	_	_	_	_	_	O
8	has	_	have	_	VBZ	8	_	_	_	_	_	have.v	Possession	O
9	been	_	be	_	VBN	8	_	_	_	_	_	_	_	O
10	increasing	_	increase	_	VBG	8	_	_	_	_	_	_	_	O
11	at	_	at	_	IN	8	_	_	_	_	_	_	_	O
12	a	_	a	_	DT	8	_	_	_	_	_	_	_	O
13	greater	_	greater	_	JJR	8	_	_	_	_	_	_	_	O
14	rate	_	rate	_	NN	8	_	_	_	_	_	_	_	O
15	than	_	than	_	IN	8	_	_	_	_	_	_	_	O
16	the	_	the	_	DT	8	_	_	_	_	_	_	_	O
17	number	_	number	_	NN	8	_	_	_	_	_	_	_	O
18	of	_	of	_	IN	8	_	_	_	_	_	_	_	O
19	buprenorphine	_	UNK	_	JJ	8	_	_	_	_	_	_	_	O
20	providers	_	UNK	_	NNS	8	_	_	_	_	_	_	_	O
21	.	_	.	_	.	8	_	_	_	_	_	_	_	O

1	findings	_	UNK	_	NNS	8	_	_	_	_	_	_	_	O
2	:	_	:	_	:	8	_	_	_	_	_	_	_	O
3	the	_	The	_	DT	8	_	_	_	_	_	_	_	O
4	amount	_	amount	_	NN	8	_	_	_	_	_	_	_	O
5	of	_	of	_	IN	8	_	_	_	_	_	_	_	O
6	buprenorphine	_	UNK	_	NN	8	_	_	_	_	_	_	_	O
7	dispensed	_	UNK	_	VBN	8	_	_	_	_	_	_	_	O
8	has	_	have	_	VBZ	8	_	_	_	_	_	_	_	O
9	been	_	be	_	VBN	8	_	_	_	_	_	_	_	O
10	increasing	_	increase	_	VBG	8	_	_	_	_	_	increase.v	Change_position_on_a_scale	O
11	at	_	at	_	IN	8	_	_	_	_	_	_	_	O
12	a	_	a	_	DT	8	_	_	_	_	_	_	_	O
13	greater	_	greater	_	JJR	8	_	_	_	_	_	_	_	O
14	rate	_	rate	_	NN	8	_	_	_	_	_	_	_	O
15	than	_	than	_	IN	8	_	_	_	_	_	_	_	O
16	the	_	the	_	DT	8	_	_	_	_	_	_	_	O
17	number	_	number	_	NN	8	_	_	_	_	_	_	_	O
18	of	_	of	_	IN	8	_	_	_	_	_	_	_	O
19	buprenorphine	_	UNK	_	JJ	8	_	_	_	_	_	_	_	O
20	providers	_	UNK	_	NNS	8	_	_	_	_	_	_	_	O
21	.	_	.	_	.	8	_	_	_	_	_	_	_	O

1	findings	_	UNK	_	NNS	8	_	_	_	_	_	_	_	O
2	:	_	:	_	:	8	_	_	_	_	_	_	_	O
3	the	_	The	_	DT	8	_	_	_	_	_	_	_	O
4	amount	_	amount	_	NN	8	_	_	_	_	_	_	_	O
5	of	_	of	_	IN	8	_	_	_	_	_	_	_	O
6	buprenorphine	_	UNK	_	NN	8	_	_	_	_	_	_	_	O
7	dispensed	_	UNK	_	VBN	8	_	_	_	_	_	_	_	O
8	has	_	have	_	VBZ	8	_	_	_	_	_	_	_	O
9	been	_	be	_	VBN	8	_	_	_	_	_	_	_	O
10	increasing	_	increase	_	VBG	8	_	_	_	_	_	_	_	O
11	at	_	at	_	IN	8	_	_	_	_	_	at.prep	Locative_relation	O
12	a	_	a	_	DT	8	_	_	_	_	_	_	_	O
13	greater	_	greater	_	JJR	8	_	_	_	_	_	_	_	O
14	rate	_	rate	_	NN	8	_	_	_	_	_	_	_	O
15	than	_	than	_	IN	8	_	_	_	_	_	_	_	O
16	the	_	the	_	DT	8	_	_	_	_	_	_	_	O
17	number	_	number	_	NN	8	_	_	_	_	_	_	_	O
18	of	_	of	_	IN	8	_	_	_	_	_	_	_	O
19	buprenorphine	_	UNK	_	JJ	8	_	_	_	_	_	_	_	O
20	providers	_	UNK	_	NNS	8	_	_	_	_	_	_	_	O
21	.	_	.	_	.	8	_	_	_	_	_	_	_	O

1	findings	_	UNK	_	NNS	8	_	_	_	_	_	_	_	O
2	:	_	:	_	:	8	_	_	_	_	_	_	_	O
3	the	_	The	_	DT	8	_	_	_	_	_	_	_	O
4	amount	_	amount	_	NN	8	_	_	_	_	_	_	_	O
5	of	_	of	_	IN	8	_	_	_	_	_	_	_	O
6	buprenorphine	_	UNK	_	NN	8	_	_	_	_	_	_	_	O
7	dispensed	_	UNK	_	VBN	8	_	_	_	_	_	_	_	O
8	has	_	have	_	VBZ	8	_	_	_	_	_	_	_	O
9	been	_	be	_	VBN	8	_	_	_	_	_	_	_	O
10	increasing	_	increase	_	VBG	8	_	_	_	_	_	_	_	O
11	at	_	at	_	IN	8	_	_	_	_	_	_	_	O
12	a	_	a	_	DT	8	_	_	_	_	_	_	_	O
13	greater	_	greater	_	JJR	8	_	_	_	_	_	_	_	O
14	rate	_	rate	_	NN	8	_	_	_	_	_	_	_	O
15	than	_	than	_	IN	8	_	_	_	_	_	_	_	O
16	the	_	the	_	DT	8	_	_	_	_	_	_	_	O
17	number	_	number	_	NN	8	_	_	_	_	_	number.n	Be_subset_of	O
18	of	_	of	_	IN	8	_	_	_	_	_	_	_	O
19	buprenorphine	_	UNK	_	JJ	8	_	_	_	_	_	_	_	O
20	providers	_	UNK	_	NNS	8	_	_	_	_	_	_	_	O
21	.	_	.	_	.	8	_	_	_	_	_	_	_	O

1	findings	_	UNK	_	NNS	8	_	_	_	_	_	_	_	O
2	:	_	:	_	:	8	_	_	_	_	_	_	_	O
3	the	_	The	_	DT	8	_	_	_	_	_	_	_	O
4	amount	_	amount	_	NN	8	_	_	_	_	_	_	_	O
5	of	_	of	_	IN	8	_	_	_	_	_	_	_	O
6	buprenorphine	_	UNK	_	NN	8	_	_	_	_	_	_	_	O
7	dispensed	_	UNK	_	VBN	8	_	_	_	_	_	_	_	O
8	has	_	have	_	VBZ	8	_	_	_	_	_	_	_	O
9	been	_	be	_	VBN	8	_	_	_	_	_	_	_	O
10	increasing	_	increase	_	VBG	8	_	_	_	_	_	_	_	O
11	at	_	at	_	IN	8	_	_	_	_	_	_	_	O
12	a	_	a	_	DT	8	_	_	_	_	_	_	_	O
13	greater	_	greater	_	JJR	8	_	_	_	_	_	_	_	O
14	rate	_	rate	_	NN	8	_	_	_	_	_	_	_	O
15	than	_	than	_	IN	8	_	_	_	_	_	_	_	O
16	the	_	the	_	DT	8	_	_	_	_	_	_	_	O
17	number	_	number	_	NN	8	_	_	_	_	_	_	_	O
18	of	_	of	_	IN	8	_	_	_	_	_	of.prep	Age	O
19	buprenorphine	_	UNK	_	JJ	8	_	_	_	_	_	_	_	O
20	providers	_	UNK	_	NNS	8	_	_	_	_	_	_	_	O
21	.	_	.	_	.	8	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	9	_	_	_	_	_	_	_	O
2	number	_	number	_	NN	9	_	_	_	_	_	number.n	Be_subset_of	O
3	of	_	of	_	IN	9	_	_	_	_	_	_	_	O
4	physicians	_	UNK	_	NNS	9	_	_	_	_	_	_	_	O
5	unk	_	UNK	_	VBN	9	_	_	_	_	_	_	_	O
6	to	_	to	_	TO	9	_	_	_	_	_	_	_	O
7	treat	_	treat	_	VB	9	_	_	_	_	_	_	_	O
8	100	_	100	_	CD	9	_	_	_	_	_	_	_	O
9	patients	_	patient	_	NNS	9	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	9	_	_	_	_	_	_	_	O
11	buprenorphine	_	UNK	_	NN	9	_	_	_	_	_	_	_	O
12	in	_	in	_	IN	9	_	_	_	_	_	_	_	O
13	both	_	both	_	DT	9	_	_	_	_	_	_	_	O
14	rural	_	rural	_	JJ	9	_	_	_	_	_	_	_	O
15	and	_	and	_	CC	9	_	_	_	_	_	_	_	O
16	urban	_	UNK	_	JJ	9	_	_	_	_	_	_	_	O
17	settings	_	UNK	_	NNS	9	_	_	_	_	_	_	_	O
18	was	_	be	_	VBD	9	_	_	_	_	_	_	_	O
19	significantly	_	significantly	_	RB	9	_	_	_	_	_	_	_	O
20	associated	_	associate	_	VBN	9	_	_	_	_	_	_	_	O
21	with	_	with	_	IN	9	_	_	_	_	_	_	_	O
22	increased	_	increased	_	JJ	9	_	_	_	_	_	_	_	O
23	amounts	_	amount	_	NNS	9	_	_	_	_	_	_	_	O
24	of	_	of	_	IN	9	_	_	_	_	_	_	_	O
25	buprenorphine	_	UNK	_	NN	9	_	_	_	_	_	_	_	O
26	dispensed	_	UNK	_	VBN	9	_	_	_	_	_	_	_	O
27	per	_	per	_	IN	9	_	_	_	_	_	_	_	O
28	capita	_	UNK	_	NN	9	_	_	_	_	_	_	_	O
29	.	_	.	_	.	9	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	9	_	_	_	_	_	_	_	O
2	number	_	number	_	NN	9	_	_	_	_	_	_	_	O
3	of	_	of	_	IN	9	_	_	_	_	_	of.prep	Age	O
4	physicians	_	UNK	_	NNS	9	_	_	_	_	_	_	_	O
5	unk	_	UNK	_	VBN	9	_	_	_	_	_	_	_	O
6	to	_	to	_	TO	9	_	_	_	_	_	_	_	O
7	treat	_	treat	_	VB	9	_	_	_	_	_	_	_	O
8	100	_	100	_	CD	9	_	_	_	_	_	_	_	O
9	patients	_	patient	_	NNS	9	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	9	_	_	_	_	_	_	_	O
11	buprenorphine	_	UNK	_	NN	9	_	_	_	_	_	_	_	O
12	in	_	in	_	IN	9	_	_	_	_	_	_	_	O
13	both	_	both	_	DT	9	_	_	_	_	_	_	_	O
14	rural	_	rural	_	JJ	9	_	_	_	_	_	_	_	O
15	and	_	and	_	CC	9	_	_	_	_	_	_	_	O
16	urban	_	UNK	_	JJ	9	_	_	_	_	_	_	_	O
17	settings	_	UNK	_	NNS	9	_	_	_	_	_	_	_	O
18	was	_	be	_	VBD	9	_	_	_	_	_	_	_	O
19	significantly	_	significantly	_	RB	9	_	_	_	_	_	_	_	O
20	associated	_	associate	_	VBN	9	_	_	_	_	_	_	_	O
21	with	_	with	_	IN	9	_	_	_	_	_	_	_	O
22	increased	_	increased	_	JJ	9	_	_	_	_	_	_	_	O
23	amounts	_	amount	_	NNS	9	_	_	_	_	_	_	_	O
24	of	_	of	_	IN	9	_	_	_	_	_	_	_	O
25	buprenorphine	_	UNK	_	NN	9	_	_	_	_	_	_	_	O
26	dispensed	_	UNK	_	VBN	9	_	_	_	_	_	_	_	O
27	per	_	per	_	IN	9	_	_	_	_	_	_	_	O
28	capita	_	UNK	_	NN	9	_	_	_	_	_	_	_	O
29	.	_	.	_	.	9	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	9	_	_	_	_	_	_	_	O
2	number	_	number	_	NN	9	_	_	_	_	_	_	_	O
3	of	_	of	_	IN	9	_	_	_	_	_	_	_	O
4	physicians	_	UNK	_	NNS	9	_	_	_	_	_	_	_	O
5	unk	_	UNK	_	VBN	9	_	_	_	_	_	_	_	O
6	to	_	to	_	TO	9	_	_	_	_	_	to.prep	Goal	O
7	treat	_	treat	_	VB	9	_	_	_	_	_	_	_	O
8	100	_	100	_	CD	9	_	_	_	_	_	_	_	O
9	patients	_	patient	_	NNS	9	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	9	_	_	_	_	_	_	_	O
11	buprenorphine	_	UNK	_	NN	9	_	_	_	_	_	_	_	O
12	in	_	in	_	IN	9	_	_	_	_	_	_	_	O
13	both	_	both	_	DT	9	_	_	_	_	_	_	_	O
14	rural	_	rural	_	JJ	9	_	_	_	_	_	_	_	O
15	and	_	and	_	CC	9	_	_	_	_	_	_	_	O
16	urban	_	UNK	_	JJ	9	_	_	_	_	_	_	_	O
17	settings	_	UNK	_	NNS	9	_	_	_	_	_	_	_	O
18	was	_	be	_	VBD	9	_	_	_	_	_	_	_	O
19	significantly	_	significantly	_	RB	9	_	_	_	_	_	_	_	O
20	associated	_	associate	_	VBN	9	_	_	_	_	_	_	_	O
21	with	_	with	_	IN	9	_	_	_	_	_	_	_	O
22	increased	_	increased	_	JJ	9	_	_	_	_	_	_	_	O
23	amounts	_	amount	_	NNS	9	_	_	_	_	_	_	_	O
24	of	_	of	_	IN	9	_	_	_	_	_	_	_	O
25	buprenorphine	_	UNK	_	NN	9	_	_	_	_	_	_	_	O
26	dispensed	_	UNK	_	VBN	9	_	_	_	_	_	_	_	O
27	per	_	per	_	IN	9	_	_	_	_	_	_	_	O
28	capita	_	UNK	_	NN	9	_	_	_	_	_	_	_	O
29	.	_	.	_	.	9	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	9	_	_	_	_	_	_	_	O
2	number	_	number	_	NN	9	_	_	_	_	_	_	_	O
3	of	_	of	_	IN	9	_	_	_	_	_	_	_	O
4	physicians	_	UNK	_	NNS	9	_	_	_	_	_	_	_	O
5	unk	_	UNK	_	VBN	9	_	_	_	_	_	_	_	O
6	to	_	to	_	TO	9	_	_	_	_	_	_	_	O
7	treat	_	treat	_	VB	9	_	_	_	_	_	_	_	O
8	100	_	100	_	CD	9	_	_	_	_	_	_	_	O
9	patients	_	patient	_	NNS	9	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	9	_	_	_	_	_	_	_	O
11	buprenorphine	_	UNK	_	NN	9	_	_	_	_	_	_	_	O
12	in	_	in	_	IN	9	_	_	_	_	_	_	_	O
13	both	_	both	_	DT	9	_	_	_	_	_	_	_	O
14	rural	_	rural	_	JJ	9	_	_	_	_	_	rural.a	Locale_by_use	O
15	and	_	and	_	CC	9	_	_	_	_	_	_	_	O
16	urban	_	UNK	_	JJ	9	_	_	_	_	_	_	_	O
17	settings	_	UNK	_	NNS	9	_	_	_	_	_	_	_	O
18	was	_	be	_	VBD	9	_	_	_	_	_	_	_	O
19	significantly	_	significantly	_	RB	9	_	_	_	_	_	_	_	O
20	associated	_	associate	_	VBN	9	_	_	_	_	_	_	_	O
21	with	_	with	_	IN	9	_	_	_	_	_	_	_	O
22	increased	_	increased	_	JJ	9	_	_	_	_	_	_	_	O
23	amounts	_	amount	_	NNS	9	_	_	_	_	_	_	_	O
24	of	_	of	_	IN	9	_	_	_	_	_	_	_	O
25	buprenorphine	_	UNK	_	NN	9	_	_	_	_	_	_	_	O
26	dispensed	_	UNK	_	VBN	9	_	_	_	_	_	_	_	O
27	per	_	per	_	IN	9	_	_	_	_	_	_	_	O
28	capita	_	UNK	_	NN	9	_	_	_	_	_	_	_	O
29	.	_	.	_	.	9	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	9	_	_	_	_	_	_	_	O
2	number	_	number	_	NN	9	_	_	_	_	_	_	_	O
3	of	_	of	_	IN	9	_	_	_	_	_	_	_	O
4	physicians	_	UNK	_	NNS	9	_	_	_	_	_	_	_	O
5	unk	_	UNK	_	VBN	9	_	_	_	_	_	_	_	O
6	to	_	to	_	TO	9	_	_	_	_	_	_	_	O
7	treat	_	treat	_	VB	9	_	_	_	_	_	_	_	O
8	100	_	100	_	CD	9	_	_	_	_	_	_	_	O
9	patients	_	patient	_	NNS	9	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	9	_	_	_	_	_	_	_	O
11	buprenorphine	_	UNK	_	NN	9	_	_	_	_	_	_	_	O
12	in	_	in	_	IN	9	_	_	_	_	_	_	_	O
13	both	_	both	_	DT	9	_	_	_	_	_	_	_	O
14	rural	_	rural	_	JJ	9	_	_	_	_	_	_	_	O
15	and	_	and	_	CC	9	_	_	_	_	_	_	_	O
16	urban	_	UNK	_	JJ	9	_	_	_	_	_	_	_	O
17	settings	_	UNK	_	NNS	9	_	_	_	_	_	_	_	O
18	was	_	be	_	VBD	9	_	_	_	_	_	_	_	O
19	significantly	_	significantly	_	RB	9	_	_	_	_	_	_	_	O
20	associated	_	associate	_	VBN	9	_	_	_	_	_	associate.v	Collaboration	O
21	with	_	with	_	IN	9	_	_	_	_	_	_	_	O
22	increased	_	increased	_	JJ	9	_	_	_	_	_	_	_	O
23	amounts	_	amount	_	NNS	9	_	_	_	_	_	_	_	O
24	of	_	of	_	IN	9	_	_	_	_	_	_	_	O
25	buprenorphine	_	UNK	_	NN	9	_	_	_	_	_	_	_	O
26	dispensed	_	UNK	_	VBN	9	_	_	_	_	_	_	_	O
27	per	_	per	_	IN	9	_	_	_	_	_	_	_	O
28	capita	_	UNK	_	NN	9	_	_	_	_	_	_	_	O
29	.	_	.	_	.	9	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	9	_	_	_	_	_	_	_	O
2	number	_	number	_	NN	9	_	_	_	_	_	_	_	O
3	of	_	of	_	IN	9	_	_	_	_	_	_	_	O
4	physicians	_	UNK	_	NNS	9	_	_	_	_	_	_	_	O
5	unk	_	UNK	_	VBN	9	_	_	_	_	_	_	_	O
6	to	_	to	_	TO	9	_	_	_	_	_	_	_	O
7	treat	_	treat	_	VB	9	_	_	_	_	_	_	_	O
8	100	_	100	_	CD	9	_	_	_	_	_	_	_	O
9	patients	_	patient	_	NNS	9	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	9	_	_	_	_	_	_	_	O
11	buprenorphine	_	UNK	_	NN	9	_	_	_	_	_	_	_	O
12	in	_	in	_	IN	9	_	_	_	_	_	_	_	O
13	both	_	both	_	DT	9	_	_	_	_	_	_	_	O
14	rural	_	rural	_	JJ	9	_	_	_	_	_	_	_	O
15	and	_	and	_	CC	9	_	_	_	_	_	_	_	O
16	urban	_	UNK	_	JJ	9	_	_	_	_	_	_	_	O
17	settings	_	UNK	_	NNS	9	_	_	_	_	_	_	_	O
18	was	_	be	_	VBD	9	_	_	_	_	_	_	_	O
19	significantly	_	significantly	_	RB	9	_	_	_	_	_	_	_	O
20	associated	_	associate	_	VBN	9	_	_	_	_	_	_	_	O
21	with	_	with	_	IN	9	_	_	_	_	_	with.prep	Accompaniment	O
22	increased	_	increased	_	JJ	9	_	_	_	_	_	_	_	O
23	amounts	_	amount	_	NNS	9	_	_	_	_	_	_	_	O
24	of	_	of	_	IN	9	_	_	_	_	_	_	_	O
25	buprenorphine	_	UNK	_	NN	9	_	_	_	_	_	_	_	O
26	dispensed	_	UNK	_	VBN	9	_	_	_	_	_	_	_	O
27	per	_	per	_	IN	9	_	_	_	_	_	_	_	O
28	capita	_	UNK	_	NN	9	_	_	_	_	_	_	_	O
29	.	_	.	_	.	9	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	9	_	_	_	_	_	_	_	O
2	number	_	number	_	NN	9	_	_	_	_	_	_	_	O
3	of	_	of	_	IN	9	_	_	_	_	_	_	_	O
4	physicians	_	UNK	_	NNS	9	_	_	_	_	_	_	_	O
5	unk	_	UNK	_	VBN	9	_	_	_	_	_	_	_	O
6	to	_	to	_	TO	9	_	_	_	_	_	_	_	O
7	treat	_	treat	_	VB	9	_	_	_	_	_	_	_	O
8	100	_	100	_	CD	9	_	_	_	_	_	_	_	O
9	patients	_	patient	_	NNS	9	_	_	_	_	_	_	_	O
10	with	_	with	_	IN	9	_	_	_	_	_	_	_	O
11	buprenorphine	_	UNK	_	NN	9	_	_	_	_	_	_	_	O
12	in	_	in	_	IN	9	_	_	_	_	_	_	_	O
13	both	_	both	_	DT	9	_	_	_	_	_	_	_	O
14	rural	_	rural	_	JJ	9	_	_	_	_	_	_	_	O
15	and	_	and	_	CC	9	_	_	_	_	_	_	_	O
16	urban	_	UNK	_	JJ	9	_	_	_	_	_	_	_	O
17	settings	_	UNK	_	NNS	9	_	_	_	_	_	_	_	O
18	was	_	be	_	VBD	9	_	_	_	_	_	_	_	O
19	significantly	_	significantly	_	RB	9	_	_	_	_	_	_	_	O
20	associated	_	associate	_	VBN	9	_	_	_	_	_	_	_	O
21	with	_	with	_	IN	9	_	_	_	_	_	_	_	O
22	increased	_	increased	_	JJ	9	_	_	_	_	_	_	_	O
23	amounts	_	amount	_	NNS	9	_	_	_	_	_	_	_	O
24	of	_	of	_	IN	9	_	_	_	_	_	of.prep	Age	O
25	buprenorphine	_	UNK	_	NN	9	_	_	_	_	_	_	_	O
26	dispensed	_	UNK	_	VBN	9	_	_	_	_	_	_	_	O
27	per	_	per	_	IN	9	_	_	_	_	_	_	_	O
28	capita	_	UNK	_	NN	9	_	_	_	_	_	_	_	O
29	.	_	.	_	.	9	_	_	_	_	_	_	_	O

1	there	_	There	_	EX	10	_	_	_	_	_	there.adv	Locative_relation	O
2	was	_	be	_	VBD	10	_	_	_	_	_	_	_	O
3	no	_	no	_	DT	10	_	_	_	_	_	_	_	O
4	significant	_	significant	_	JJ	10	_	_	_	_	_	_	_	O
5	association	_	association	_	NN	10	_	_	_	_	_	_	_	O
6	in	_	in	_	IN	10	_	_	_	_	_	_	_	O
7	the	_	the	_	DT	10	_	_	_	_	_	_	_	O
8	growth	_	growth	_	NN	10	_	_	_	_	_	_	_	O
9	of	_	of	_	IN	10	_	_	_	_	_	_	_	O
10	buprenorphine	_	UNK	_	NN	10	_	_	_	_	_	_	_	O
11	distributed	_	distribute	_	VBN	10	_	_	_	_	_	_	_	O
12	and	_	and	_	CC	10	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	10	_	_	_	_	_	_	_	O
14	number	_	number	_	NN	10	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	10	_	_	_	_	_	_	_	O
16	physicians	_	UNK	_	NNS	10	_	_	_	_	_	_	_	O
17	with	_	with	_	IN	10	_	_	_	_	_	_	_	O
18	unk	_	UNK	_	JJ	10	_	_	_	_	_	_	_	O
19	patient	_	patient	_	NN	10	_	_	_	_	_	_	_	O
20	waivers	_	UNK	_	NNS	10	_	_	_	_	_	_	_	O
21	.	_	.	_	.	10	_	_	_	_	_	_	_	O

1	there	_	There	_	EX	10	_	_	_	_	_	_	_	O
2	was	_	be	_	VBD	10	_	_	_	_	_	_	_	O
3	no	_	no	_	DT	10	_	_	_	_	_	no.art	Quantified_mass	O
4	significant	_	significant	_	JJ	10	_	_	_	_	_	_	_	O
5	association	_	association	_	NN	10	_	_	_	_	_	_	_	O
6	in	_	in	_	IN	10	_	_	_	_	_	_	_	O
7	the	_	the	_	DT	10	_	_	_	_	_	_	_	O
8	growth	_	growth	_	NN	10	_	_	_	_	_	_	_	O
9	of	_	of	_	IN	10	_	_	_	_	_	_	_	O
10	buprenorphine	_	UNK	_	NN	10	_	_	_	_	_	_	_	O
11	distributed	_	distribute	_	VBN	10	_	_	_	_	_	_	_	O
12	and	_	and	_	CC	10	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	10	_	_	_	_	_	_	_	O
14	number	_	number	_	NN	10	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	10	_	_	_	_	_	_	_	O
16	physicians	_	UNK	_	NNS	10	_	_	_	_	_	_	_	O
17	with	_	with	_	IN	10	_	_	_	_	_	_	_	O
18	unk	_	UNK	_	JJ	10	_	_	_	_	_	_	_	O
19	patient	_	patient	_	NN	10	_	_	_	_	_	_	_	O
20	waivers	_	UNK	_	NNS	10	_	_	_	_	_	_	_	O
21	.	_	.	_	.	10	_	_	_	_	_	_	_	O

1	there	_	There	_	EX	10	_	_	_	_	_	_	_	O
2	was	_	be	_	VBD	10	_	_	_	_	_	_	_	O
3	no	_	no	_	DT	10	_	_	_	_	_	_	_	O
4	significant	_	significant	_	JJ	10	_	_	_	_	_	_	_	O
5	association	_	association	_	NN	10	_	_	_	_	_	association.n	Organization	O
6	in	_	in	_	IN	10	_	_	_	_	_	_	_	O
7	the	_	the	_	DT	10	_	_	_	_	_	_	_	O
8	growth	_	growth	_	NN	10	_	_	_	_	_	_	_	O
9	of	_	of	_	IN	10	_	_	_	_	_	_	_	O
10	buprenorphine	_	UNK	_	NN	10	_	_	_	_	_	_	_	O
11	distributed	_	distribute	_	VBN	10	_	_	_	_	_	_	_	O
12	and	_	and	_	CC	10	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	10	_	_	_	_	_	_	_	O
14	number	_	number	_	NN	10	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	10	_	_	_	_	_	_	_	O
16	physicians	_	UNK	_	NNS	10	_	_	_	_	_	_	_	O
17	with	_	with	_	IN	10	_	_	_	_	_	_	_	O
18	unk	_	UNK	_	JJ	10	_	_	_	_	_	_	_	O
19	patient	_	patient	_	NN	10	_	_	_	_	_	_	_	O
20	waivers	_	UNK	_	NNS	10	_	_	_	_	_	_	_	O
21	.	_	.	_	.	10	_	_	_	_	_	_	_	O

1	there	_	There	_	EX	10	_	_	_	_	_	_	_	O
2	was	_	be	_	VBD	10	_	_	_	_	_	_	_	O
3	no	_	no	_	DT	10	_	_	_	_	_	_	_	O
4	significant	_	significant	_	JJ	10	_	_	_	_	_	_	_	O
5	association	_	association	_	NN	10	_	_	_	_	_	_	_	O
6	in	_	in	_	IN	10	_	_	_	_	_	_	_	O
7	the	_	the	_	DT	10	_	_	_	_	_	_	_	O
8	growth	_	growth	_	NN	10	_	_	_	_	_	growth.n	Cause_expansion	O
9	of	_	of	_	IN	10	_	_	_	_	_	_	_	O
10	buprenorphine	_	UNK	_	NN	10	_	_	_	_	_	_	_	O
11	distributed	_	distribute	_	VBN	10	_	_	_	_	_	_	_	O
12	and	_	and	_	CC	10	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	10	_	_	_	_	_	_	_	O
14	number	_	number	_	NN	10	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	10	_	_	_	_	_	_	_	O
16	physicians	_	UNK	_	NNS	10	_	_	_	_	_	_	_	O
17	with	_	with	_	IN	10	_	_	_	_	_	_	_	O
18	unk	_	UNK	_	JJ	10	_	_	_	_	_	_	_	O
19	patient	_	patient	_	NN	10	_	_	_	_	_	_	_	O
20	waivers	_	UNK	_	NNS	10	_	_	_	_	_	_	_	O
21	.	_	.	_	.	10	_	_	_	_	_	_	_	O

1	there	_	There	_	EX	10	_	_	_	_	_	_	_	O
2	was	_	be	_	VBD	10	_	_	_	_	_	_	_	O
3	no	_	no	_	DT	10	_	_	_	_	_	_	_	O
4	significant	_	significant	_	JJ	10	_	_	_	_	_	_	_	O
5	association	_	association	_	NN	10	_	_	_	_	_	_	_	O
6	in	_	in	_	IN	10	_	_	_	_	_	_	_	O
7	the	_	the	_	DT	10	_	_	_	_	_	_	_	O
8	growth	_	growth	_	NN	10	_	_	_	_	_	_	_	O
9	of	_	of	_	IN	10	_	_	_	_	_	of.prep	Age	O
10	buprenorphine	_	UNK	_	NN	10	_	_	_	_	_	_	_	O
11	distributed	_	distribute	_	VBN	10	_	_	_	_	_	_	_	O
12	and	_	and	_	CC	10	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	10	_	_	_	_	_	_	_	O
14	number	_	number	_	NN	10	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	10	_	_	_	_	_	_	_	O
16	physicians	_	UNK	_	NNS	10	_	_	_	_	_	_	_	O
17	with	_	with	_	IN	10	_	_	_	_	_	_	_	O
18	unk	_	UNK	_	JJ	10	_	_	_	_	_	_	_	O
19	patient	_	patient	_	NN	10	_	_	_	_	_	_	_	O
20	waivers	_	UNK	_	NNS	10	_	_	_	_	_	_	_	O
21	.	_	.	_	.	10	_	_	_	_	_	_	_	O

1	there	_	There	_	EX	10	_	_	_	_	_	_	_	O
2	was	_	be	_	VBD	10	_	_	_	_	_	_	_	O
3	no	_	no	_	DT	10	_	_	_	_	_	_	_	O
4	significant	_	significant	_	JJ	10	_	_	_	_	_	_	_	O
5	association	_	association	_	NN	10	_	_	_	_	_	_	_	O
6	in	_	in	_	IN	10	_	_	_	_	_	_	_	O
7	the	_	the	_	DT	10	_	_	_	_	_	_	_	O
8	growth	_	growth	_	NN	10	_	_	_	_	_	_	_	O
9	of	_	of	_	IN	10	_	_	_	_	_	_	_	O
10	buprenorphine	_	UNK	_	NN	10	_	_	_	_	_	_	_	O
11	distributed	_	distribute	_	VBN	10	_	_	_	_	_	distribute.v	Dispersal	O
12	and	_	and	_	CC	10	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	10	_	_	_	_	_	_	_	O
14	number	_	number	_	NN	10	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	10	_	_	_	_	_	_	_	O
16	physicians	_	UNK	_	NNS	10	_	_	_	_	_	_	_	O
17	with	_	with	_	IN	10	_	_	_	_	_	_	_	O
18	unk	_	UNK	_	JJ	10	_	_	_	_	_	_	_	O
19	patient	_	patient	_	NN	10	_	_	_	_	_	_	_	O
20	waivers	_	UNK	_	NNS	10	_	_	_	_	_	_	_	O
21	.	_	.	_	.	10	_	_	_	_	_	_	_	O

1	there	_	There	_	EX	10	_	_	_	_	_	_	_	O
2	was	_	be	_	VBD	10	_	_	_	_	_	_	_	O
3	no	_	no	_	DT	10	_	_	_	_	_	_	_	O
4	significant	_	significant	_	JJ	10	_	_	_	_	_	_	_	O
5	association	_	association	_	NN	10	_	_	_	_	_	_	_	O
6	in	_	in	_	IN	10	_	_	_	_	_	_	_	O
7	the	_	the	_	DT	10	_	_	_	_	_	_	_	O
8	growth	_	growth	_	NN	10	_	_	_	_	_	_	_	O
9	of	_	of	_	IN	10	_	_	_	_	_	_	_	O
10	buprenorphine	_	UNK	_	NN	10	_	_	_	_	_	_	_	O
11	distributed	_	distribute	_	VBN	10	_	_	_	_	_	_	_	O
12	and	_	and	_	CC	10	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	10	_	_	_	_	_	_	_	O
14	number	_	number	_	NN	10	_	_	_	_	_	number.n	Be_subset_of	O
15	of	_	of	_	IN	10	_	_	_	_	_	_	_	O
16	physicians	_	UNK	_	NNS	10	_	_	_	_	_	_	_	O
17	with	_	with	_	IN	10	_	_	_	_	_	_	_	O
18	unk	_	UNK	_	JJ	10	_	_	_	_	_	_	_	O
19	patient	_	patient	_	NN	10	_	_	_	_	_	_	_	O
20	waivers	_	UNK	_	NNS	10	_	_	_	_	_	_	_	O
21	.	_	.	_	.	10	_	_	_	_	_	_	_	O

1	there	_	There	_	EX	10	_	_	_	_	_	_	_	O
2	was	_	be	_	VBD	10	_	_	_	_	_	_	_	O
3	no	_	no	_	DT	10	_	_	_	_	_	_	_	O
4	significant	_	significant	_	JJ	10	_	_	_	_	_	_	_	O
5	association	_	association	_	NN	10	_	_	_	_	_	_	_	O
6	in	_	in	_	IN	10	_	_	_	_	_	_	_	O
7	the	_	the	_	DT	10	_	_	_	_	_	_	_	O
8	growth	_	growth	_	NN	10	_	_	_	_	_	_	_	O
9	of	_	of	_	IN	10	_	_	_	_	_	_	_	O
10	buprenorphine	_	UNK	_	NN	10	_	_	_	_	_	_	_	O
11	distributed	_	distribute	_	VBN	10	_	_	_	_	_	_	_	O
12	and	_	and	_	CC	10	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	10	_	_	_	_	_	_	_	O
14	number	_	number	_	NN	10	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	10	_	_	_	_	_	of.prep	Age	O
16	physicians	_	UNK	_	NNS	10	_	_	_	_	_	_	_	O
17	with	_	with	_	IN	10	_	_	_	_	_	_	_	O
18	unk	_	UNK	_	JJ	10	_	_	_	_	_	_	_	O
19	patient	_	patient	_	NN	10	_	_	_	_	_	_	_	O
20	waivers	_	UNK	_	NNS	10	_	_	_	_	_	_	_	O
21	.	_	.	_	.	10	_	_	_	_	_	_	_	O

1	there	_	There	_	EX	10	_	_	_	_	_	_	_	O
2	was	_	be	_	VBD	10	_	_	_	_	_	_	_	O
3	no	_	no	_	DT	10	_	_	_	_	_	_	_	O
4	significant	_	significant	_	JJ	10	_	_	_	_	_	_	_	O
5	association	_	association	_	NN	10	_	_	_	_	_	_	_	O
6	in	_	in	_	IN	10	_	_	_	_	_	_	_	O
7	the	_	the	_	DT	10	_	_	_	_	_	_	_	O
8	growth	_	growth	_	NN	10	_	_	_	_	_	_	_	O
9	of	_	of	_	IN	10	_	_	_	_	_	_	_	O
10	buprenorphine	_	UNK	_	NN	10	_	_	_	_	_	_	_	O
11	distributed	_	distribute	_	VBN	10	_	_	_	_	_	_	_	O
12	and	_	and	_	CC	10	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	10	_	_	_	_	_	_	_	O
14	number	_	number	_	NN	10	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	10	_	_	_	_	_	_	_	O
16	physicians	_	UNK	_	NNS	10	_	_	_	_	_	_	_	O
17	with	_	with	_	IN	10	_	_	_	_	_	with.prep	Accompaniment	O
18	unk	_	UNK	_	JJ	10	_	_	_	_	_	_	_	O
19	patient	_	patient	_	NN	10	_	_	_	_	_	_	_	O
20	waivers	_	UNK	_	NNS	10	_	_	_	_	_	_	_	O
21	.	_	.	_	.	10	_	_	_	_	_	_	_	O

1	there	_	There	_	EX	10	_	_	_	_	_	_	_	O
2	was	_	be	_	VBD	10	_	_	_	_	_	_	_	O
3	no	_	no	_	DT	10	_	_	_	_	_	_	_	O
4	significant	_	significant	_	JJ	10	_	_	_	_	_	_	_	O
5	association	_	association	_	NN	10	_	_	_	_	_	_	_	O
6	in	_	in	_	IN	10	_	_	_	_	_	_	_	O
7	the	_	the	_	DT	10	_	_	_	_	_	_	_	O
8	growth	_	growth	_	NN	10	_	_	_	_	_	_	_	O
9	of	_	of	_	IN	10	_	_	_	_	_	_	_	O
10	buprenorphine	_	UNK	_	NN	10	_	_	_	_	_	_	_	O
11	distributed	_	distribute	_	VBN	10	_	_	_	_	_	_	_	O
12	and	_	and	_	CC	10	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	10	_	_	_	_	_	_	_	O
14	number	_	number	_	NN	10	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	10	_	_	_	_	_	_	_	O
16	physicians	_	UNK	_	NNS	10	_	_	_	_	_	_	_	O
17	with	_	with	_	IN	10	_	_	_	_	_	_	_	O
18	unk	_	UNK	_	JJ	10	_	_	_	_	_	_	_	O
19	patient	_	patient	_	NN	10	_	_	_	_	_	patient.n	Rashness	O
20	waivers	_	UNK	_	NNS	10	_	_	_	_	_	_	_	O
21	.	_	.	_	.	10	_	_	_	_	_	_	_	O

1	conclusions	_	UNK	_	NNS	11	_	_	_	_	_	_	_	O
2	:	_	:	_	:	11	_	_	_	_	_	_	_	O
3	the	_	The	_	DT	11	_	_	_	_	_	_	_	O
4	greater	_	greater	_	JJR	11	_	_	_	_	_	_	_	O
5	amounts	_	amount	_	NNS	11	_	_	_	_	_	_	_	O
6	of	_	of	_	IN	11	_	_	_	_	_	of.prep	Age	O
7	buprenorphine	_	UNK	_	NN	11	_	_	_	_	_	_	_	O
8	dispensed	_	UNK	_	VBN	11	_	_	_	_	_	_	_	O
9	are	_	be	_	VBP	11	_	_	_	_	_	_	_	O
10	consistent	_	UNK	_	JJ	11	_	_	_	_	_	_	_	O
11	with	_	with	_	IN	11	_	_	_	_	_	_	_	O
12	the	_	the	_	DT	11	_	_	_	_	_	_	_	O
13	potentially	_	potentially	_	RB	11	_	_	_	_	_	_	_	O
14	greater	_	greater	_	JJR	11	_	_	_	_	_	_	_	O
15	use	_	use	_	NN	11	_	_	_	_	_	_	_	O
16	of	_	of	_	IN	11	_	_	_	_	_	_	_	O
17	opioid	_	UNK	_	JJ	11	_	_	_	_	_	_	_	O
18	agonists	_	UNK	_	NNS	11	_	_	_	_	_	_	_	O
19	for	_	for	_	IN	11	_	_	_	_	_	_	_	O
20	opioid	_	UNK	_	JJ	11	_	_	_	_	_	_	_	O
21	use	_	use	_	NN	11	_	_	_	_	_	_	_	O
22	disorder	_	UNK	_	NN	11	_	_	_	_	_	_	_	O
23	treatment	_	treatment	_	NN	11	_	_	_	_	_	_	_	O
24	,	_	,	_	,	11	_	_	_	_	_	_	_	O
25	though	_	though	_	IN	11	_	_	_	_	_	_	_	O
26	they	_	they	_	PRP	11	_	_	_	_	_	_	_	O
27	also	_	also	_	RB	11	_	_	_	_	_	_	_	O
28	make	_	make	_	VBP	11	_	_	_	_	_	_	_	O
29	their	_	their	_	PRP$	11	_	_	_	_	_	_	_	O
30	misuse	_	UNK	_	NN	11	_	_	_	_	_	_	_	O
31	more	_	more	_	RBR	11	_	_	_	_	_	_	_	O
32	likely	_	likely	_	JJ	11	_	_	_	_	_	_	_	O
33	.	_	.	_	.	11	_	_	_	_	_	_	_	O

1	conclusions	_	UNK	_	NNS	11	_	_	_	_	_	_	_	O
2	:	_	:	_	:	11	_	_	_	_	_	_	_	O
3	the	_	The	_	DT	11	_	_	_	_	_	_	_	O
4	greater	_	greater	_	JJR	11	_	_	_	_	_	_	_	O
5	amounts	_	amount	_	NNS	11	_	_	_	_	_	_	_	O
6	of	_	of	_	IN	11	_	_	_	_	_	_	_	O
7	buprenorphine	_	UNK	_	NN	11	_	_	_	_	_	_	_	O
8	dispensed	_	UNK	_	VBN	11	_	_	_	_	_	_	_	O
9	are	_	be	_	VBP	11	_	_	_	_	_	_	_	O
10	consistent	_	UNK	_	JJ	11	_	_	_	_	_	_	_	O
11	with	_	with	_	IN	11	_	_	_	_	_	_	_	O
12	the	_	the	_	DT	11	_	_	_	_	_	_	_	O
13	potentially	_	potentially	_	RB	11	_	_	_	_	_	_	_	O
14	greater	_	greater	_	JJR	11	_	_	_	_	_	_	_	O
15	use	_	use	_	NN	11	_	_	_	_	_	use.n	Ingest_substance	O
16	of	_	of	_	IN	11	_	_	_	_	_	_	_	O
17	opioid	_	UNK	_	JJ	11	_	_	_	_	_	_	_	O
18	agonists	_	UNK	_	NNS	11	_	_	_	_	_	_	_	O
19	for	_	for	_	IN	11	_	_	_	_	_	_	_	O
20	opioid	_	UNK	_	JJ	11	_	_	_	_	_	_	_	O
21	use	_	use	_	NN	11	_	_	_	_	_	_	_	O
22	disorder	_	UNK	_	NN	11	_	_	_	_	_	_	_	O
23	treatment	_	treatment	_	NN	11	_	_	_	_	_	_	_	O
24	,	_	,	_	,	11	_	_	_	_	_	_	_	O
25	though	_	though	_	IN	11	_	_	_	_	_	_	_	O
26	they	_	they	_	PRP	11	_	_	_	_	_	_	_	O
27	also	_	also	_	RB	11	_	_	_	_	_	_	_	O
28	make	_	make	_	VBP	11	_	_	_	_	_	_	_	O
29	their	_	their	_	PRP$	11	_	_	_	_	_	_	_	O
30	misuse	_	UNK	_	NN	11	_	_	_	_	_	_	_	O
31	more	_	more	_	RBR	11	_	_	_	_	_	_	_	O
32	likely	_	likely	_	JJ	11	_	_	_	_	_	_	_	O
33	.	_	.	_	.	11	_	_	_	_	_	_	_	O

1	conclusions	_	UNK	_	NNS	11	_	_	_	_	_	_	_	O
2	:	_	:	_	:	11	_	_	_	_	_	_	_	O
3	the	_	The	_	DT	11	_	_	_	_	_	_	_	O
4	greater	_	greater	_	JJR	11	_	_	_	_	_	_	_	O
5	amounts	_	amount	_	NNS	11	_	_	_	_	_	_	_	O
6	of	_	of	_	IN	11	_	_	_	_	_	_	_	O
7	buprenorphine	_	UNK	_	NN	11	_	_	_	_	_	_	_	O
8	dispensed	_	UNK	_	VBN	11	_	_	_	_	_	_	_	O
9	are	_	be	_	VBP	11	_	_	_	_	_	_	_	O
10	consistent	_	UNK	_	JJ	11	_	_	_	_	_	_	_	O
11	with	_	with	_	IN	11	_	_	_	_	_	_	_	O
12	the	_	the	_	DT	11	_	_	_	_	_	_	_	O
13	potentially	_	potentially	_	RB	11	_	_	_	_	_	_	_	O
14	greater	_	greater	_	JJR	11	_	_	_	_	_	_	_	O
15	use	_	use	_	NN	11	_	_	_	_	_	_	_	O
16	of	_	of	_	IN	11	_	_	_	_	_	of.prep	Age	O
17	opioid	_	UNK	_	JJ	11	_	_	_	_	_	_	_	O
18	agonists	_	UNK	_	NNS	11	_	_	_	_	_	_	_	O
19	for	_	for	_	IN	11	_	_	_	_	_	_	_	O
20	opioid	_	UNK	_	JJ	11	_	_	_	_	_	_	_	O
21	use	_	use	_	NN	11	_	_	_	_	_	_	_	O
22	disorder	_	UNK	_	NN	11	_	_	_	_	_	_	_	O
23	treatment	_	treatment	_	NN	11	_	_	_	_	_	_	_	O
24	,	_	,	_	,	11	_	_	_	_	_	_	_	O
25	though	_	though	_	IN	11	_	_	_	_	_	_	_	O
26	they	_	they	_	PRP	11	_	_	_	_	_	_	_	O
27	also	_	also	_	RB	11	_	_	_	_	_	_	_	O
28	make	_	make	_	VBP	11	_	_	_	_	_	_	_	O
29	their	_	their	_	PRP$	11	_	_	_	_	_	_	_	O
30	misuse	_	UNK	_	NN	11	_	_	_	_	_	_	_	O
31	more	_	more	_	RBR	11	_	_	_	_	_	_	_	O
32	likely	_	likely	_	JJ	11	_	_	_	_	_	_	_	O
33	.	_	.	_	.	11	_	_	_	_	_	_	_	O

1	conclusions	_	UNK	_	NNS	11	_	_	_	_	_	_	_	O
2	:	_	:	_	:	11	_	_	_	_	_	_	_	O
3	the	_	The	_	DT	11	_	_	_	_	_	_	_	O
4	greater	_	greater	_	JJR	11	_	_	_	_	_	_	_	O
5	amounts	_	amount	_	NNS	11	_	_	_	_	_	_	_	O
6	of	_	of	_	IN	11	_	_	_	_	_	_	_	O
7	buprenorphine	_	UNK	_	NN	11	_	_	_	_	_	_	_	O
8	dispensed	_	UNK	_	VBN	11	_	_	_	_	_	_	_	O
9	are	_	be	_	VBP	11	_	_	_	_	_	_	_	O
10	consistent	_	UNK	_	JJ	11	_	_	_	_	_	_	_	O
11	with	_	with	_	IN	11	_	_	_	_	_	_	_	O
12	the	_	the	_	DT	11	_	_	_	_	_	_	_	O
13	potentially	_	potentially	_	RB	11	_	_	_	_	_	_	_	O
14	greater	_	greater	_	JJR	11	_	_	_	_	_	_	_	O
15	use	_	use	_	NN	11	_	_	_	_	_	_	_	O
16	of	_	of	_	IN	11	_	_	_	_	_	_	_	O
17	opioid	_	UNK	_	JJ	11	_	_	_	_	_	_	_	O
18	agonists	_	UNK	_	NNS	11	_	_	_	_	_	_	_	O
19	for	_	for	_	IN	11	_	_	_	_	_	_	_	O
20	opioid	_	UNK	_	JJ	11	_	_	_	_	_	_	_	O
21	use	_	use	_	NN	11	_	_	_	_	_	use.n	Ingest_substance	O
22	disorder	_	UNK	_	NN	11	_	_	_	_	_	_	_	O
23	treatment	_	treatment	_	NN	11	_	_	_	_	_	_	_	O
24	,	_	,	_	,	11	_	_	_	_	_	_	_	O
25	though	_	though	_	IN	11	_	_	_	_	_	_	_	O
26	they	_	they	_	PRP	11	_	_	_	_	_	_	_	O
27	also	_	also	_	RB	11	_	_	_	_	_	_	_	O
28	make	_	make	_	VBP	11	_	_	_	_	_	_	_	O
29	their	_	their	_	PRP$	11	_	_	_	_	_	_	_	O
30	misuse	_	UNK	_	NN	11	_	_	_	_	_	_	_	O
31	more	_	more	_	RBR	11	_	_	_	_	_	_	_	O
32	likely	_	likely	_	JJ	11	_	_	_	_	_	_	_	O
33	.	_	.	_	.	11	_	_	_	_	_	_	_	O

1	conclusions	_	UNK	_	NNS	11	_	_	_	_	_	_	_	O
2	:	_	:	_	:	11	_	_	_	_	_	_	_	O
3	the	_	The	_	DT	11	_	_	_	_	_	_	_	O
4	greater	_	greater	_	JJR	11	_	_	_	_	_	_	_	O
5	amounts	_	amount	_	NNS	11	_	_	_	_	_	_	_	O
6	of	_	of	_	IN	11	_	_	_	_	_	_	_	O
7	buprenorphine	_	UNK	_	NN	11	_	_	_	_	_	_	_	O
8	dispensed	_	UNK	_	VBN	11	_	_	_	_	_	_	_	O
9	are	_	be	_	VBP	11	_	_	_	_	_	_	_	O
10	consistent	_	UNK	_	JJ	11	_	_	_	_	_	_	_	O
11	with	_	with	_	IN	11	_	_	_	_	_	_	_	O
12	the	_	the	_	DT	11	_	_	_	_	_	_	_	O
13	potentially	_	potentially	_	RB	11	_	_	_	_	_	_	_	O
14	greater	_	greater	_	JJR	11	_	_	_	_	_	_	_	O
15	use	_	use	_	NN	11	_	_	_	_	_	_	_	O
16	of	_	of	_	IN	11	_	_	_	_	_	_	_	O
17	opioid	_	UNK	_	JJ	11	_	_	_	_	_	_	_	O
18	agonists	_	UNK	_	NNS	11	_	_	_	_	_	_	_	O
19	for	_	for	_	IN	11	_	_	_	_	_	_	_	O
20	opioid	_	UNK	_	JJ	11	_	_	_	_	_	_	_	O
21	use	_	use	_	NN	11	_	_	_	_	_	_	_	O
22	disorder	_	UNK	_	NN	11	_	_	_	_	_	_	_	O
23	treatment	_	treatment	_	NN	11	_	_	_	_	_	_	_	O
24	,	_	,	_	,	11	_	_	_	_	_	_	_	O
25	though	_	though	_	IN	11	_	_	_	_	_	_	_	O
26	they	_	they	_	PRP	11	_	_	_	_	_	_	_	O
27	also	_	also	_	RB	11	_	_	_	_	_	_	_	O
28	make	_	make	_	VBP	11	_	_	_	_	_	_	_	O
29	their	_	their	_	PRP$	11	_	_	_	_	_	_	_	O
30	misuse	_	UNK	_	NN	11	_	_	_	_	_	_	_	O
31	more	_	more	_	RBR	11	_	_	_	_	_	more.a	Increment	O
32	likely	_	likely	_	JJ	11	_	_	_	_	_	_	_	O
33	.	_	.	_	.	11	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	12	_	_	_	_	_	_	_	O
2	changes	_	change	_	NNS	12	_	_	_	_	_	change.n	Exchange	O
3	after	_	after	_	IN	12	_	_	_	_	_	_	_	O
4	the	_	the	_	DT	12	_	_	_	_	_	_	_	O
5	2006	_	2006	_	CD	12	_	_	_	_	_	_	_	O
6	legislation	_	UNK	_	NN	12	_	_	_	_	_	_	_	O
7	suggest	_	suggest	_	VBP	12	_	_	_	_	_	_	_	O
8	that	_	that	_	IN	12	_	_	_	_	_	_	_	O
9	policies	_	policy	_	NNS	12	_	_	_	_	_	_	_	O
10	focused	_	focus	_	VBD	12	_	_	_	_	_	_	_	O
11	on	_	on	_	IN	12	_	_	_	_	_	_	_	O
12	increasing	_	increase	_	VBG	12	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	12	_	_	_	_	_	_	_	O
14	number	_	number	_	NN	12	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	12	_	_	_	_	_	_	_	O
16	patients	_	patient	_	NNS	12	_	_	_	_	_	_	_	O
17	that	_	that	_	IN	12	_	_	_	_	_	_	_	O
18	a	_	a	_	DT	12	_	_	_	_	_	_	_	O
19	single	_	single	_	JJ	12	_	_	_	_	_	_	_	O
20	unk	_	UNK	_	JJ	12	_	_	_	_	_	_	_	O
21	physician	_	UNK	_	NN	12	_	_	_	_	_	_	_	O
22	could	_	could	_	MD	12	_	_	_	_	_	_	_	O
23	safely	_	safely	_	RB	12	_	_	_	_	_	_	_	O
24	and	_	and	_	CC	12	_	_	_	_	_	_	_	O
25	effectively	_	effectively	_	RB	12	_	_	_	_	_	_	_	O
26	treat	_	treat	_	NN	12	_	_	_	_	_	_	_	O
27	could	_	could	_	MD	12	_	_	_	_	_	_	_	O
28	unk	_	UNK	_	VB	12	_	_	_	_	_	_	_	O
29	effective	_	effective	_	JJ	12	_	_	_	_	_	_	_	O
30	in	_	in	_	IN	12	_	_	_	_	_	_	_	O
31	increasing	_	increase	_	VBG	12	_	_	_	_	_	_	_	O
32	buprenorphine	_	UNK	_	NN	12	_	_	_	_	_	_	_	O
33	use	_	use	_	NN	12	_	_	_	_	_	_	_	O
34	than	_	than	_	IN	12	_	_	_	_	_	_	_	O
35	would	_	would	_	MD	12	_	_	_	_	_	_	_	O
36	alternatives	_	alternative	_	NNS	12	_	_	_	_	_	_	_	O
37	such	_	such	_	JJ	12	_	_	_	_	_	_	_	O
38	as	_	a	_	IN	12	_	_	_	_	_	_	_	O
39	opening	_	open	_	VBG	12	_	_	_	_	_	_	_	O
40	new	_	new	_	JJ	12	_	_	_	_	_	_	_	O
41	substance	_	substance	_	NN	12	_	_	_	_	_	_	_	O
42	abuse	_	UNK	_	NN	12	_	_	_	_	_	_	_	O
43	treatment	_	treatment	_	NN	12	_	_	_	_	_	_	_	O
44	facilities	_	facility	_	NNS	12	_	_	_	_	_	_	_	O
45	or	_	or	_	CC	12	_	_	_	_	_	_	_	O
46	raising	_	raise	_	VBG	12	_	_	_	_	_	_	_	O
47	the	_	the	_	DT	12	_	_	_	_	_	_	_	O
48	overall	_	overall	_	JJ	12	_	_	_	_	_	_	_	O
49	number	_	number	_	NN	12	_	_	_	_	_	_	_	O
50	of	_	of	_	IN	12	_	_	_	_	_	_	_	O
51	unk	_	UNK	_	JJ	12	_	_	_	_	_	_	_	O
52	physicians	_	UNK	_	NNS	12	_	_	_	_	_	_	_	O
53	.	_	.	_	.	12	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	12	_	_	_	_	_	_	_	O
2	changes	_	change	_	NNS	12	_	_	_	_	_	_	_	O
3	after	_	after	_	IN	12	_	_	_	_	_	_	_	O
4	the	_	the	_	DT	12	_	_	_	_	_	_	_	O
5	2006	_	2006	_	CD	12	_	_	_	_	_	_	_	O
6	legislation	_	UNK	_	NN	12	_	_	_	_	_	_	_	O
7	suggest	_	suggest	_	VBP	12	_	_	_	_	_	_	_	O
8	that	_	that	_	IN	12	_	_	_	_	_	that.adv	Degree	O
9	policies	_	policy	_	NNS	12	_	_	_	_	_	_	_	O
10	focused	_	focus	_	VBD	12	_	_	_	_	_	_	_	O
11	on	_	on	_	IN	12	_	_	_	_	_	_	_	O
12	increasing	_	increase	_	VBG	12	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	12	_	_	_	_	_	_	_	O
14	number	_	number	_	NN	12	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	12	_	_	_	_	_	_	_	O
16	patients	_	patient	_	NNS	12	_	_	_	_	_	_	_	O
17	that	_	that	_	IN	12	_	_	_	_	_	_	_	O
18	a	_	a	_	DT	12	_	_	_	_	_	_	_	O
19	single	_	single	_	JJ	12	_	_	_	_	_	_	_	O
20	unk	_	UNK	_	JJ	12	_	_	_	_	_	_	_	O
21	physician	_	UNK	_	NN	12	_	_	_	_	_	_	_	O
22	could	_	could	_	MD	12	_	_	_	_	_	_	_	O
23	safely	_	safely	_	RB	12	_	_	_	_	_	_	_	O
24	and	_	and	_	CC	12	_	_	_	_	_	_	_	O
25	effectively	_	effectively	_	RB	12	_	_	_	_	_	_	_	O
26	treat	_	treat	_	NN	12	_	_	_	_	_	_	_	O
27	could	_	could	_	MD	12	_	_	_	_	_	_	_	O
28	unk	_	UNK	_	VB	12	_	_	_	_	_	_	_	O
29	effective	_	effective	_	JJ	12	_	_	_	_	_	_	_	O
30	in	_	in	_	IN	12	_	_	_	_	_	_	_	O
31	increasing	_	increase	_	VBG	12	_	_	_	_	_	_	_	O
32	buprenorphine	_	UNK	_	NN	12	_	_	_	_	_	_	_	O
33	use	_	use	_	NN	12	_	_	_	_	_	_	_	O
34	than	_	than	_	IN	12	_	_	_	_	_	_	_	O
35	would	_	would	_	MD	12	_	_	_	_	_	_	_	O
36	alternatives	_	alternative	_	NNS	12	_	_	_	_	_	_	_	O
37	such	_	such	_	JJ	12	_	_	_	_	_	_	_	O
38	as	_	a	_	IN	12	_	_	_	_	_	_	_	O
39	opening	_	open	_	VBG	12	_	_	_	_	_	_	_	O
40	new	_	new	_	JJ	12	_	_	_	_	_	_	_	O
41	substance	_	substance	_	NN	12	_	_	_	_	_	_	_	O
42	abuse	_	UNK	_	NN	12	_	_	_	_	_	_	_	O
43	treatment	_	treatment	_	NN	12	_	_	_	_	_	_	_	O
44	facilities	_	facility	_	NNS	12	_	_	_	_	_	_	_	O
45	or	_	or	_	CC	12	_	_	_	_	_	_	_	O
46	raising	_	raise	_	VBG	12	_	_	_	_	_	_	_	O
47	the	_	the	_	DT	12	_	_	_	_	_	_	_	O
48	overall	_	overall	_	JJ	12	_	_	_	_	_	_	_	O
49	number	_	number	_	NN	12	_	_	_	_	_	_	_	O
50	of	_	of	_	IN	12	_	_	_	_	_	_	_	O
51	unk	_	UNK	_	JJ	12	_	_	_	_	_	_	_	O
52	physicians	_	UNK	_	NNS	12	_	_	_	_	_	_	_	O
53	.	_	.	_	.	12	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	12	_	_	_	_	_	_	_	O
2	changes	_	change	_	NNS	12	_	_	_	_	_	_	_	O
3	after	_	after	_	IN	12	_	_	_	_	_	_	_	O
4	the	_	the	_	DT	12	_	_	_	_	_	_	_	O
5	2006	_	2006	_	CD	12	_	_	_	_	_	_	_	O
6	legislation	_	UNK	_	NN	12	_	_	_	_	_	_	_	O
7	suggest	_	suggest	_	VBP	12	_	_	_	_	_	_	_	O
8	that	_	that	_	IN	12	_	_	_	_	_	_	_	O
9	policies	_	policy	_	NNS	12	_	_	_	_	_	policy.n	Law	O
10	focused	_	focus	_	VBD	12	_	_	_	_	_	_	_	O
11	on	_	on	_	IN	12	_	_	_	_	_	_	_	O
12	increasing	_	increase	_	VBG	12	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	12	_	_	_	_	_	_	_	O
14	number	_	number	_	NN	12	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	12	_	_	_	_	_	_	_	O
16	patients	_	patient	_	NNS	12	_	_	_	_	_	_	_	O
17	that	_	that	_	IN	12	_	_	_	_	_	_	_	O
18	a	_	a	_	DT	12	_	_	_	_	_	_	_	O
19	single	_	single	_	JJ	12	_	_	_	_	_	_	_	O
20	unk	_	UNK	_	JJ	12	_	_	_	_	_	_	_	O
21	physician	_	UNK	_	NN	12	_	_	_	_	_	_	_	O
22	could	_	could	_	MD	12	_	_	_	_	_	_	_	O
23	safely	_	safely	_	RB	12	_	_	_	_	_	_	_	O
24	and	_	and	_	CC	12	_	_	_	_	_	_	_	O
25	effectively	_	effectively	_	RB	12	_	_	_	_	_	_	_	O
26	treat	_	treat	_	NN	12	_	_	_	_	_	_	_	O
27	could	_	could	_	MD	12	_	_	_	_	_	_	_	O
28	unk	_	UNK	_	VB	12	_	_	_	_	_	_	_	O
29	effective	_	effective	_	JJ	12	_	_	_	_	_	_	_	O
30	in	_	in	_	IN	12	_	_	_	_	_	_	_	O
31	increasing	_	increase	_	VBG	12	_	_	_	_	_	_	_	O
32	buprenorphine	_	UNK	_	NN	12	_	_	_	_	_	_	_	O
33	use	_	use	_	NN	12	_	_	_	_	_	_	_	O
34	than	_	than	_	IN	12	_	_	_	_	_	_	_	O
35	would	_	would	_	MD	12	_	_	_	_	_	_	_	O
36	alternatives	_	alternative	_	NNS	12	_	_	_	_	_	_	_	O
37	such	_	such	_	JJ	12	_	_	_	_	_	_	_	O
38	as	_	a	_	IN	12	_	_	_	_	_	_	_	O
39	opening	_	open	_	VBG	12	_	_	_	_	_	_	_	O
40	new	_	new	_	JJ	12	_	_	_	_	_	_	_	O
41	substance	_	substance	_	NN	12	_	_	_	_	_	_	_	O
42	abuse	_	UNK	_	NN	12	_	_	_	_	_	_	_	O
43	treatment	_	treatment	_	NN	12	_	_	_	_	_	_	_	O
44	facilities	_	facility	_	NNS	12	_	_	_	_	_	_	_	O
45	or	_	or	_	CC	12	_	_	_	_	_	_	_	O
46	raising	_	raise	_	VBG	12	_	_	_	_	_	_	_	O
47	the	_	the	_	DT	12	_	_	_	_	_	_	_	O
48	overall	_	overall	_	JJ	12	_	_	_	_	_	_	_	O
49	number	_	number	_	NN	12	_	_	_	_	_	_	_	O
50	of	_	of	_	IN	12	_	_	_	_	_	_	_	O
51	unk	_	UNK	_	JJ	12	_	_	_	_	_	_	_	O
52	physicians	_	UNK	_	NNS	12	_	_	_	_	_	_	_	O
53	.	_	.	_	.	12	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	12	_	_	_	_	_	_	_	O
2	changes	_	change	_	NNS	12	_	_	_	_	_	_	_	O
3	after	_	after	_	IN	12	_	_	_	_	_	_	_	O
4	the	_	the	_	DT	12	_	_	_	_	_	_	_	O
5	2006	_	2006	_	CD	12	_	_	_	_	_	_	_	O
6	legislation	_	UNK	_	NN	12	_	_	_	_	_	_	_	O
7	suggest	_	suggest	_	VBP	12	_	_	_	_	_	_	_	O
8	that	_	that	_	IN	12	_	_	_	_	_	_	_	O
9	policies	_	policy	_	NNS	12	_	_	_	_	_	_	_	O
10	focused	_	focus	_	VBD	12	_	_	_	_	_	_	_	O
11	on	_	on	_	IN	12	_	_	_	_	_	on.prep	Being_in_operation	O
12	increasing	_	increase	_	VBG	12	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	12	_	_	_	_	_	_	_	O
14	number	_	number	_	NN	12	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	12	_	_	_	_	_	_	_	O
16	patients	_	patient	_	NNS	12	_	_	_	_	_	_	_	O
17	that	_	that	_	IN	12	_	_	_	_	_	_	_	O
18	a	_	a	_	DT	12	_	_	_	_	_	_	_	O
19	single	_	single	_	JJ	12	_	_	_	_	_	_	_	O
20	unk	_	UNK	_	JJ	12	_	_	_	_	_	_	_	O
21	physician	_	UNK	_	NN	12	_	_	_	_	_	_	_	O
22	could	_	could	_	MD	12	_	_	_	_	_	_	_	O
23	safely	_	safely	_	RB	12	_	_	_	_	_	_	_	O
24	and	_	and	_	CC	12	_	_	_	_	_	_	_	O
25	effectively	_	effectively	_	RB	12	_	_	_	_	_	_	_	O
26	treat	_	treat	_	NN	12	_	_	_	_	_	_	_	O
27	could	_	could	_	MD	12	_	_	_	_	_	_	_	O
28	unk	_	UNK	_	VB	12	_	_	_	_	_	_	_	O
29	effective	_	effective	_	JJ	12	_	_	_	_	_	_	_	O
30	in	_	in	_	IN	12	_	_	_	_	_	_	_	O
31	increasing	_	increase	_	VBG	12	_	_	_	_	_	_	_	O
32	buprenorphine	_	UNK	_	NN	12	_	_	_	_	_	_	_	O
33	use	_	use	_	NN	12	_	_	_	_	_	_	_	O
34	than	_	than	_	IN	12	_	_	_	_	_	_	_	O
35	would	_	would	_	MD	12	_	_	_	_	_	_	_	O
36	alternatives	_	alternative	_	NNS	12	_	_	_	_	_	_	_	O
37	such	_	such	_	JJ	12	_	_	_	_	_	_	_	O
38	as	_	a	_	IN	12	_	_	_	_	_	_	_	O
39	opening	_	open	_	VBG	12	_	_	_	_	_	_	_	O
40	new	_	new	_	JJ	12	_	_	_	_	_	_	_	O
41	substance	_	substance	_	NN	12	_	_	_	_	_	_	_	O
42	abuse	_	UNK	_	NN	12	_	_	_	_	_	_	_	O
43	treatment	_	treatment	_	NN	12	_	_	_	_	_	_	_	O
44	facilities	_	facility	_	NNS	12	_	_	_	_	_	_	_	O
45	or	_	or	_	CC	12	_	_	_	_	_	_	_	O
46	raising	_	raise	_	VBG	12	_	_	_	_	_	_	_	O
47	the	_	the	_	DT	12	_	_	_	_	_	_	_	O
48	overall	_	overall	_	JJ	12	_	_	_	_	_	_	_	O
49	number	_	number	_	NN	12	_	_	_	_	_	_	_	O
50	of	_	of	_	IN	12	_	_	_	_	_	_	_	O
51	unk	_	UNK	_	JJ	12	_	_	_	_	_	_	_	O
52	physicians	_	UNK	_	NNS	12	_	_	_	_	_	_	_	O
53	.	_	.	_	.	12	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	12	_	_	_	_	_	_	_	O
2	changes	_	change	_	NNS	12	_	_	_	_	_	_	_	O
3	after	_	after	_	IN	12	_	_	_	_	_	_	_	O
4	the	_	the	_	DT	12	_	_	_	_	_	_	_	O
5	2006	_	2006	_	CD	12	_	_	_	_	_	_	_	O
6	legislation	_	UNK	_	NN	12	_	_	_	_	_	_	_	O
7	suggest	_	suggest	_	VBP	12	_	_	_	_	_	_	_	O
8	that	_	that	_	IN	12	_	_	_	_	_	_	_	O
9	policies	_	policy	_	NNS	12	_	_	_	_	_	_	_	O
10	focused	_	focus	_	VBD	12	_	_	_	_	_	_	_	O
11	on	_	on	_	IN	12	_	_	_	_	_	_	_	O
12	increasing	_	increase	_	VBG	12	_	_	_	_	_	increase.v	Change_position_on_a_scale	O
13	the	_	the	_	DT	12	_	_	_	_	_	_	_	O
14	number	_	number	_	NN	12	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	12	_	_	_	_	_	_	_	O
16	patients	_	patient	_	NNS	12	_	_	_	_	_	_	_	O
17	that	_	that	_	IN	12	_	_	_	_	_	_	_	O
18	a	_	a	_	DT	12	_	_	_	_	_	_	_	O
19	single	_	single	_	JJ	12	_	_	_	_	_	_	_	O
20	unk	_	UNK	_	JJ	12	_	_	_	_	_	_	_	O
21	physician	_	UNK	_	NN	12	_	_	_	_	_	_	_	O
22	could	_	could	_	MD	12	_	_	_	_	_	_	_	O
23	safely	_	safely	_	RB	12	_	_	_	_	_	_	_	O
24	and	_	and	_	CC	12	_	_	_	_	_	_	_	O
25	effectively	_	effectively	_	RB	12	_	_	_	_	_	_	_	O
26	treat	_	treat	_	NN	12	_	_	_	_	_	_	_	O
27	could	_	could	_	MD	12	_	_	_	_	_	_	_	O
28	unk	_	UNK	_	VB	12	_	_	_	_	_	_	_	O
29	effective	_	effective	_	JJ	12	_	_	_	_	_	_	_	O
30	in	_	in	_	IN	12	_	_	_	_	_	_	_	O
31	increasing	_	increase	_	VBG	12	_	_	_	_	_	_	_	O
32	buprenorphine	_	UNK	_	NN	12	_	_	_	_	_	_	_	O
33	use	_	use	_	NN	12	_	_	_	_	_	_	_	O
34	than	_	than	_	IN	12	_	_	_	_	_	_	_	O
35	would	_	would	_	MD	12	_	_	_	_	_	_	_	O
36	alternatives	_	alternative	_	NNS	12	_	_	_	_	_	_	_	O
37	such	_	such	_	JJ	12	_	_	_	_	_	_	_	O
38	as	_	a	_	IN	12	_	_	_	_	_	_	_	O
39	opening	_	open	_	VBG	12	_	_	_	_	_	_	_	O
40	new	_	new	_	JJ	12	_	_	_	_	_	_	_	O
41	substance	_	substance	_	NN	12	_	_	_	_	_	_	_	O
42	abuse	_	UNK	_	NN	12	_	_	_	_	_	_	_	O
43	treatment	_	treatment	_	NN	12	_	_	_	_	_	_	_	O
44	facilities	_	facility	_	NNS	12	_	_	_	_	_	_	_	O
45	or	_	or	_	CC	12	_	_	_	_	_	_	_	O
46	raising	_	raise	_	VBG	12	_	_	_	_	_	_	_	O
47	the	_	the	_	DT	12	_	_	_	_	_	_	_	O
48	overall	_	overall	_	JJ	12	_	_	_	_	_	_	_	O
49	number	_	number	_	NN	12	_	_	_	_	_	_	_	O
50	of	_	of	_	IN	12	_	_	_	_	_	_	_	O
51	unk	_	UNK	_	JJ	12	_	_	_	_	_	_	_	O
52	physicians	_	UNK	_	NNS	12	_	_	_	_	_	_	_	O
53	.	_	.	_	.	12	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	12	_	_	_	_	_	_	_	O
2	changes	_	change	_	NNS	12	_	_	_	_	_	_	_	O
3	after	_	after	_	IN	12	_	_	_	_	_	_	_	O
4	the	_	the	_	DT	12	_	_	_	_	_	_	_	O
5	2006	_	2006	_	CD	12	_	_	_	_	_	_	_	O
6	legislation	_	UNK	_	NN	12	_	_	_	_	_	_	_	O
7	suggest	_	suggest	_	VBP	12	_	_	_	_	_	_	_	O
8	that	_	that	_	IN	12	_	_	_	_	_	_	_	O
9	policies	_	policy	_	NNS	12	_	_	_	_	_	_	_	O
10	focused	_	focus	_	VBD	12	_	_	_	_	_	_	_	O
11	on	_	on	_	IN	12	_	_	_	_	_	_	_	O
12	increasing	_	increase	_	VBG	12	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	12	_	_	_	_	_	_	_	O
14	number	_	number	_	NN	12	_	_	_	_	_	number.n	Be_subset_of	O
15	of	_	of	_	IN	12	_	_	_	_	_	_	_	O
16	patients	_	patient	_	NNS	12	_	_	_	_	_	_	_	O
17	that	_	that	_	IN	12	_	_	_	_	_	_	_	O
18	a	_	a	_	DT	12	_	_	_	_	_	_	_	O
19	single	_	single	_	JJ	12	_	_	_	_	_	_	_	O
20	unk	_	UNK	_	JJ	12	_	_	_	_	_	_	_	O
21	physician	_	UNK	_	NN	12	_	_	_	_	_	_	_	O
22	could	_	could	_	MD	12	_	_	_	_	_	_	_	O
23	safely	_	safely	_	RB	12	_	_	_	_	_	_	_	O
24	and	_	and	_	CC	12	_	_	_	_	_	_	_	O
25	effectively	_	effectively	_	RB	12	_	_	_	_	_	_	_	O
26	treat	_	treat	_	NN	12	_	_	_	_	_	_	_	O
27	could	_	could	_	MD	12	_	_	_	_	_	_	_	O
28	unk	_	UNK	_	VB	12	_	_	_	_	_	_	_	O
29	effective	_	effective	_	JJ	12	_	_	_	_	_	_	_	O
30	in	_	in	_	IN	12	_	_	_	_	_	_	_	O
31	increasing	_	increase	_	VBG	12	_	_	_	_	_	_	_	O
32	buprenorphine	_	UNK	_	NN	12	_	_	_	_	_	_	_	O
33	use	_	use	_	NN	12	_	_	_	_	_	_	_	O
34	than	_	than	_	IN	12	_	_	_	_	_	_	_	O
35	would	_	would	_	MD	12	_	_	_	_	_	_	_	O
36	alternatives	_	alternative	_	NNS	12	_	_	_	_	_	_	_	O
37	such	_	such	_	JJ	12	_	_	_	_	_	_	_	O
38	as	_	a	_	IN	12	_	_	_	_	_	_	_	O
39	opening	_	open	_	VBG	12	_	_	_	_	_	_	_	O
40	new	_	new	_	JJ	12	_	_	_	_	_	_	_	O
41	substance	_	substance	_	NN	12	_	_	_	_	_	_	_	O
42	abuse	_	UNK	_	NN	12	_	_	_	_	_	_	_	O
43	treatment	_	treatment	_	NN	12	_	_	_	_	_	_	_	O
44	facilities	_	facility	_	NNS	12	_	_	_	_	_	_	_	O
45	or	_	or	_	CC	12	_	_	_	_	_	_	_	O
46	raising	_	raise	_	VBG	12	_	_	_	_	_	_	_	O
47	the	_	the	_	DT	12	_	_	_	_	_	_	_	O
48	overall	_	overall	_	JJ	12	_	_	_	_	_	_	_	O
49	number	_	number	_	NN	12	_	_	_	_	_	_	_	O
50	of	_	of	_	IN	12	_	_	_	_	_	_	_	O
51	unk	_	UNK	_	JJ	12	_	_	_	_	_	_	_	O
52	physicians	_	UNK	_	NNS	12	_	_	_	_	_	_	_	O
53	.	_	.	_	.	12	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	12	_	_	_	_	_	_	_	O
2	changes	_	change	_	NNS	12	_	_	_	_	_	_	_	O
3	after	_	after	_	IN	12	_	_	_	_	_	_	_	O
4	the	_	the	_	DT	12	_	_	_	_	_	_	_	O
5	2006	_	2006	_	CD	12	_	_	_	_	_	_	_	O
6	legislation	_	UNK	_	NN	12	_	_	_	_	_	_	_	O
7	suggest	_	suggest	_	VBP	12	_	_	_	_	_	_	_	O
8	that	_	that	_	IN	12	_	_	_	_	_	_	_	O
9	policies	_	policy	_	NNS	12	_	_	_	_	_	_	_	O
10	focused	_	focus	_	VBD	12	_	_	_	_	_	_	_	O
11	on	_	on	_	IN	12	_	_	_	_	_	_	_	O
12	increasing	_	increase	_	VBG	12	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	12	_	_	_	_	_	_	_	O
14	number	_	number	_	NN	12	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	12	_	_	_	_	_	of.prep	Age	O
16	patients	_	patient	_	NNS	12	_	_	_	_	_	_	_	O
17	that	_	that	_	IN	12	_	_	_	_	_	_	_	O
18	a	_	a	_	DT	12	_	_	_	_	_	_	_	O
19	single	_	single	_	JJ	12	_	_	_	_	_	_	_	O
20	unk	_	UNK	_	JJ	12	_	_	_	_	_	_	_	O
21	physician	_	UNK	_	NN	12	_	_	_	_	_	_	_	O
22	could	_	could	_	MD	12	_	_	_	_	_	_	_	O
23	safely	_	safely	_	RB	12	_	_	_	_	_	_	_	O
24	and	_	and	_	CC	12	_	_	_	_	_	_	_	O
25	effectively	_	effectively	_	RB	12	_	_	_	_	_	_	_	O
26	treat	_	treat	_	NN	12	_	_	_	_	_	_	_	O
27	could	_	could	_	MD	12	_	_	_	_	_	_	_	O
28	unk	_	UNK	_	VB	12	_	_	_	_	_	_	_	O
29	effective	_	effective	_	JJ	12	_	_	_	_	_	_	_	O
30	in	_	in	_	IN	12	_	_	_	_	_	_	_	O
31	increasing	_	increase	_	VBG	12	_	_	_	_	_	_	_	O
32	buprenorphine	_	UNK	_	NN	12	_	_	_	_	_	_	_	O
33	use	_	use	_	NN	12	_	_	_	_	_	_	_	O
34	than	_	than	_	IN	12	_	_	_	_	_	_	_	O
35	would	_	would	_	MD	12	_	_	_	_	_	_	_	O
36	alternatives	_	alternative	_	NNS	12	_	_	_	_	_	_	_	O
37	such	_	such	_	JJ	12	_	_	_	_	_	_	_	O
38	as	_	a	_	IN	12	_	_	_	_	_	_	_	O
39	opening	_	open	_	VBG	12	_	_	_	_	_	_	_	O
40	new	_	new	_	JJ	12	_	_	_	_	_	_	_	O
41	substance	_	substance	_	NN	12	_	_	_	_	_	_	_	O
42	abuse	_	UNK	_	NN	12	_	_	_	_	_	_	_	O
43	treatment	_	treatment	_	NN	12	_	_	_	_	_	_	_	O
44	facilities	_	facility	_	NNS	12	_	_	_	_	_	_	_	O
45	or	_	or	_	CC	12	_	_	_	_	_	_	_	O
46	raising	_	raise	_	VBG	12	_	_	_	_	_	_	_	O
47	the	_	the	_	DT	12	_	_	_	_	_	_	_	O
48	overall	_	overall	_	JJ	12	_	_	_	_	_	_	_	O
49	number	_	number	_	NN	12	_	_	_	_	_	_	_	O
50	of	_	of	_	IN	12	_	_	_	_	_	_	_	O
51	unk	_	UNK	_	JJ	12	_	_	_	_	_	_	_	O
52	physicians	_	UNK	_	NNS	12	_	_	_	_	_	_	_	O
53	.	_	.	_	.	12	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	12	_	_	_	_	_	_	_	O
2	changes	_	change	_	NNS	12	_	_	_	_	_	_	_	O
3	after	_	after	_	IN	12	_	_	_	_	_	_	_	O
4	the	_	the	_	DT	12	_	_	_	_	_	_	_	O
5	2006	_	2006	_	CD	12	_	_	_	_	_	_	_	O
6	legislation	_	UNK	_	NN	12	_	_	_	_	_	_	_	O
7	suggest	_	suggest	_	VBP	12	_	_	_	_	_	_	_	O
8	that	_	that	_	IN	12	_	_	_	_	_	_	_	O
9	policies	_	policy	_	NNS	12	_	_	_	_	_	_	_	O
10	focused	_	focus	_	VBD	12	_	_	_	_	_	_	_	O
11	on	_	on	_	IN	12	_	_	_	_	_	_	_	O
12	increasing	_	increase	_	VBG	12	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	12	_	_	_	_	_	_	_	O
14	number	_	number	_	NN	12	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	12	_	_	_	_	_	_	_	O
16	patients	_	patient	_	NNS	12	_	_	_	_	_	_	_	O
17	that	_	that	_	IN	12	_	_	_	_	_	that.adv	Degree	O
18	a	_	a	_	DT	12	_	_	_	_	_	_	_	O
19	single	_	single	_	JJ	12	_	_	_	_	_	_	_	O
20	unk	_	UNK	_	JJ	12	_	_	_	_	_	_	_	O
21	physician	_	UNK	_	NN	12	_	_	_	_	_	_	_	O
22	could	_	could	_	MD	12	_	_	_	_	_	_	_	O
23	safely	_	safely	_	RB	12	_	_	_	_	_	_	_	O
24	and	_	and	_	CC	12	_	_	_	_	_	_	_	O
25	effectively	_	effectively	_	RB	12	_	_	_	_	_	_	_	O
26	treat	_	treat	_	NN	12	_	_	_	_	_	_	_	O
27	could	_	could	_	MD	12	_	_	_	_	_	_	_	O
28	unk	_	UNK	_	VB	12	_	_	_	_	_	_	_	O
29	effective	_	effective	_	JJ	12	_	_	_	_	_	_	_	O
30	in	_	in	_	IN	12	_	_	_	_	_	_	_	O
31	increasing	_	increase	_	VBG	12	_	_	_	_	_	_	_	O
32	buprenorphine	_	UNK	_	NN	12	_	_	_	_	_	_	_	O
33	use	_	use	_	NN	12	_	_	_	_	_	_	_	O
34	than	_	than	_	IN	12	_	_	_	_	_	_	_	O
35	would	_	would	_	MD	12	_	_	_	_	_	_	_	O
36	alternatives	_	alternative	_	NNS	12	_	_	_	_	_	_	_	O
37	such	_	such	_	JJ	12	_	_	_	_	_	_	_	O
38	as	_	a	_	IN	12	_	_	_	_	_	_	_	O
39	opening	_	open	_	VBG	12	_	_	_	_	_	_	_	O
40	new	_	new	_	JJ	12	_	_	_	_	_	_	_	O
41	substance	_	substance	_	NN	12	_	_	_	_	_	_	_	O
42	abuse	_	UNK	_	NN	12	_	_	_	_	_	_	_	O
43	treatment	_	treatment	_	NN	12	_	_	_	_	_	_	_	O
44	facilities	_	facility	_	NNS	12	_	_	_	_	_	_	_	O
45	or	_	or	_	CC	12	_	_	_	_	_	_	_	O
46	raising	_	raise	_	VBG	12	_	_	_	_	_	_	_	O
47	the	_	the	_	DT	12	_	_	_	_	_	_	_	O
48	overall	_	overall	_	JJ	12	_	_	_	_	_	_	_	O
49	number	_	number	_	NN	12	_	_	_	_	_	_	_	O
50	of	_	of	_	IN	12	_	_	_	_	_	_	_	O
51	unk	_	UNK	_	JJ	12	_	_	_	_	_	_	_	O
52	physicians	_	UNK	_	NNS	12	_	_	_	_	_	_	_	O
53	.	_	.	_	.	12	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	12	_	_	_	_	_	_	_	O
2	changes	_	change	_	NNS	12	_	_	_	_	_	_	_	O
3	after	_	after	_	IN	12	_	_	_	_	_	_	_	O
4	the	_	the	_	DT	12	_	_	_	_	_	_	_	O
5	2006	_	2006	_	CD	12	_	_	_	_	_	_	_	O
6	legislation	_	UNK	_	NN	12	_	_	_	_	_	_	_	O
7	suggest	_	suggest	_	VBP	12	_	_	_	_	_	_	_	O
8	that	_	that	_	IN	12	_	_	_	_	_	_	_	O
9	policies	_	policy	_	NNS	12	_	_	_	_	_	_	_	O
10	focused	_	focus	_	VBD	12	_	_	_	_	_	_	_	O
11	on	_	on	_	IN	12	_	_	_	_	_	_	_	O
12	increasing	_	increase	_	VBG	12	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	12	_	_	_	_	_	_	_	O
14	number	_	number	_	NN	12	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	12	_	_	_	_	_	_	_	O
16	patients	_	patient	_	NNS	12	_	_	_	_	_	_	_	O
17	that	_	that	_	IN	12	_	_	_	_	_	_	_	O
18	a	_	a	_	DT	12	_	_	_	_	_	_	_	O
19	single	_	single	_	JJ	12	_	_	_	_	_	_	_	O
20	unk	_	UNK	_	JJ	12	_	_	_	_	_	_	_	O
21	physician	_	UNK	_	NN	12	_	_	_	_	_	_	_	O
22	could	_	could	_	MD	12	_	_	_	_	_	_	_	O
23	safely	_	safely	_	RB	12	_	_	_	_	_	safely.adv	Risky_situation	O
24	and	_	and	_	CC	12	_	_	_	_	_	_	_	O
25	effectively	_	effectively	_	RB	12	_	_	_	_	_	_	_	O
26	treat	_	treat	_	NN	12	_	_	_	_	_	_	_	O
27	could	_	could	_	MD	12	_	_	_	_	_	_	_	O
28	unk	_	UNK	_	VB	12	_	_	_	_	_	_	_	O
29	effective	_	effective	_	JJ	12	_	_	_	_	_	_	_	O
30	in	_	in	_	IN	12	_	_	_	_	_	_	_	O
31	increasing	_	increase	_	VBG	12	_	_	_	_	_	_	_	O
32	buprenorphine	_	UNK	_	NN	12	_	_	_	_	_	_	_	O
33	use	_	use	_	NN	12	_	_	_	_	_	_	_	O
34	than	_	than	_	IN	12	_	_	_	_	_	_	_	O
35	would	_	would	_	MD	12	_	_	_	_	_	_	_	O
36	alternatives	_	alternative	_	NNS	12	_	_	_	_	_	_	_	O
37	such	_	such	_	JJ	12	_	_	_	_	_	_	_	O
38	as	_	a	_	IN	12	_	_	_	_	_	_	_	O
39	opening	_	open	_	VBG	12	_	_	_	_	_	_	_	O
40	new	_	new	_	JJ	12	_	_	_	_	_	_	_	O
41	substance	_	substance	_	NN	12	_	_	_	_	_	_	_	O
42	abuse	_	UNK	_	NN	12	_	_	_	_	_	_	_	O
43	treatment	_	treatment	_	NN	12	_	_	_	_	_	_	_	O
44	facilities	_	facility	_	NNS	12	_	_	_	_	_	_	_	O
45	or	_	or	_	CC	12	_	_	_	_	_	_	_	O
46	raising	_	raise	_	VBG	12	_	_	_	_	_	_	_	O
47	the	_	the	_	DT	12	_	_	_	_	_	_	_	O
48	overall	_	overall	_	JJ	12	_	_	_	_	_	_	_	O
49	number	_	number	_	NN	12	_	_	_	_	_	_	_	O
50	of	_	of	_	IN	12	_	_	_	_	_	_	_	O
51	unk	_	UNK	_	JJ	12	_	_	_	_	_	_	_	O
52	physicians	_	UNK	_	NNS	12	_	_	_	_	_	_	_	O
53	.	_	.	_	.	12	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	12	_	_	_	_	_	_	_	O
2	changes	_	change	_	NNS	12	_	_	_	_	_	_	_	O
3	after	_	after	_	IN	12	_	_	_	_	_	_	_	O
4	the	_	the	_	DT	12	_	_	_	_	_	_	_	O
5	2006	_	2006	_	CD	12	_	_	_	_	_	_	_	O
6	legislation	_	UNK	_	NN	12	_	_	_	_	_	_	_	O
7	suggest	_	suggest	_	VBP	12	_	_	_	_	_	_	_	O
8	that	_	that	_	IN	12	_	_	_	_	_	_	_	O
9	policies	_	policy	_	NNS	12	_	_	_	_	_	_	_	O
10	focused	_	focus	_	VBD	12	_	_	_	_	_	_	_	O
11	on	_	on	_	IN	12	_	_	_	_	_	_	_	O
12	increasing	_	increase	_	VBG	12	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	12	_	_	_	_	_	_	_	O
14	number	_	number	_	NN	12	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	12	_	_	_	_	_	_	_	O
16	patients	_	patient	_	NNS	12	_	_	_	_	_	_	_	O
17	that	_	that	_	IN	12	_	_	_	_	_	_	_	O
18	a	_	a	_	DT	12	_	_	_	_	_	_	_	O
19	single	_	single	_	JJ	12	_	_	_	_	_	_	_	O
20	unk	_	UNK	_	JJ	12	_	_	_	_	_	_	_	O
21	physician	_	UNK	_	NN	12	_	_	_	_	_	_	_	O
22	could	_	could	_	MD	12	_	_	_	_	_	_	_	O
23	safely	_	safely	_	RB	12	_	_	_	_	_	_	_	O
24	and	_	and	_	CC	12	_	_	_	_	_	_	_	O
25	effectively	_	effectively	_	RB	12	_	_	_	_	_	_	_	O
26	treat	_	treat	_	NN	12	_	_	_	_	_	_	_	O
27	could	_	could	_	MD	12	_	_	_	_	_	_	_	O
28	unk	_	UNK	_	VB	12	_	_	_	_	_	_	_	O
29	effective	_	effective	_	JJ	12	_	_	_	_	_	_	_	O
30	in	_	in	_	IN	12	_	_	_	_	_	_	_	O
31	increasing	_	increase	_	VBG	12	_	_	_	_	_	increase.v	Change_position_on_a_scale	O
32	buprenorphine	_	UNK	_	NN	12	_	_	_	_	_	_	_	O
33	use	_	use	_	NN	12	_	_	_	_	_	_	_	O
34	than	_	than	_	IN	12	_	_	_	_	_	_	_	O
35	would	_	would	_	MD	12	_	_	_	_	_	_	_	O
36	alternatives	_	alternative	_	NNS	12	_	_	_	_	_	_	_	O
37	such	_	such	_	JJ	12	_	_	_	_	_	_	_	O
38	as	_	a	_	IN	12	_	_	_	_	_	_	_	O
39	opening	_	open	_	VBG	12	_	_	_	_	_	_	_	O
40	new	_	new	_	JJ	12	_	_	_	_	_	_	_	O
41	substance	_	substance	_	NN	12	_	_	_	_	_	_	_	O
42	abuse	_	UNK	_	NN	12	_	_	_	_	_	_	_	O
43	treatment	_	treatment	_	NN	12	_	_	_	_	_	_	_	O
44	facilities	_	facility	_	NNS	12	_	_	_	_	_	_	_	O
45	or	_	or	_	CC	12	_	_	_	_	_	_	_	O
46	raising	_	raise	_	VBG	12	_	_	_	_	_	_	_	O
47	the	_	the	_	DT	12	_	_	_	_	_	_	_	O
48	overall	_	overall	_	JJ	12	_	_	_	_	_	_	_	O
49	number	_	number	_	NN	12	_	_	_	_	_	_	_	O
50	of	_	of	_	IN	12	_	_	_	_	_	_	_	O
51	unk	_	UNK	_	JJ	12	_	_	_	_	_	_	_	O
52	physicians	_	UNK	_	NNS	12	_	_	_	_	_	_	_	O
53	.	_	.	_	.	12	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	12	_	_	_	_	_	_	_	O
2	changes	_	change	_	NNS	12	_	_	_	_	_	_	_	O
3	after	_	after	_	IN	12	_	_	_	_	_	_	_	O
4	the	_	the	_	DT	12	_	_	_	_	_	_	_	O
5	2006	_	2006	_	CD	12	_	_	_	_	_	_	_	O
6	legislation	_	UNK	_	NN	12	_	_	_	_	_	_	_	O
7	suggest	_	suggest	_	VBP	12	_	_	_	_	_	_	_	O
8	that	_	that	_	IN	12	_	_	_	_	_	_	_	O
9	policies	_	policy	_	NNS	12	_	_	_	_	_	_	_	O
10	focused	_	focus	_	VBD	12	_	_	_	_	_	_	_	O
11	on	_	on	_	IN	12	_	_	_	_	_	_	_	O
12	increasing	_	increase	_	VBG	12	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	12	_	_	_	_	_	_	_	O
14	number	_	number	_	NN	12	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	12	_	_	_	_	_	_	_	O
16	patients	_	patient	_	NNS	12	_	_	_	_	_	_	_	O
17	that	_	that	_	IN	12	_	_	_	_	_	_	_	O
18	a	_	a	_	DT	12	_	_	_	_	_	_	_	O
19	single	_	single	_	JJ	12	_	_	_	_	_	_	_	O
20	unk	_	UNK	_	JJ	12	_	_	_	_	_	_	_	O
21	physician	_	UNK	_	NN	12	_	_	_	_	_	_	_	O
22	could	_	could	_	MD	12	_	_	_	_	_	_	_	O
23	safely	_	safely	_	RB	12	_	_	_	_	_	_	_	O
24	and	_	and	_	CC	12	_	_	_	_	_	_	_	O
25	effectively	_	effectively	_	RB	12	_	_	_	_	_	_	_	O
26	treat	_	treat	_	NN	12	_	_	_	_	_	_	_	O
27	could	_	could	_	MD	12	_	_	_	_	_	_	_	O
28	unk	_	UNK	_	VB	12	_	_	_	_	_	_	_	O
29	effective	_	effective	_	JJ	12	_	_	_	_	_	_	_	O
30	in	_	in	_	IN	12	_	_	_	_	_	_	_	O
31	increasing	_	increase	_	VBG	12	_	_	_	_	_	_	_	O
32	buprenorphine	_	UNK	_	NN	12	_	_	_	_	_	_	_	O
33	use	_	use	_	NN	12	_	_	_	_	_	use.n	Ingest_substance	O
34	than	_	than	_	IN	12	_	_	_	_	_	_	_	O
35	would	_	would	_	MD	12	_	_	_	_	_	_	_	O
36	alternatives	_	alternative	_	NNS	12	_	_	_	_	_	_	_	O
37	such	_	such	_	JJ	12	_	_	_	_	_	_	_	O
38	as	_	a	_	IN	12	_	_	_	_	_	_	_	O
39	opening	_	open	_	VBG	12	_	_	_	_	_	_	_	O
40	new	_	new	_	JJ	12	_	_	_	_	_	_	_	O
41	substance	_	substance	_	NN	12	_	_	_	_	_	_	_	O
42	abuse	_	UNK	_	NN	12	_	_	_	_	_	_	_	O
43	treatment	_	treatment	_	NN	12	_	_	_	_	_	_	_	O
44	facilities	_	facility	_	NNS	12	_	_	_	_	_	_	_	O
45	or	_	or	_	CC	12	_	_	_	_	_	_	_	O
46	raising	_	raise	_	VBG	12	_	_	_	_	_	_	_	O
47	the	_	the	_	DT	12	_	_	_	_	_	_	_	O
48	overall	_	overall	_	JJ	12	_	_	_	_	_	_	_	O
49	number	_	number	_	NN	12	_	_	_	_	_	_	_	O
50	of	_	of	_	IN	12	_	_	_	_	_	_	_	O
51	unk	_	UNK	_	JJ	12	_	_	_	_	_	_	_	O
52	physicians	_	UNK	_	NNS	12	_	_	_	_	_	_	_	O
53	.	_	.	_	.	12	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	12	_	_	_	_	_	_	_	O
2	changes	_	change	_	NNS	12	_	_	_	_	_	_	_	O
3	after	_	after	_	IN	12	_	_	_	_	_	_	_	O
4	the	_	the	_	DT	12	_	_	_	_	_	_	_	O
5	2006	_	2006	_	CD	12	_	_	_	_	_	_	_	O
6	legislation	_	UNK	_	NN	12	_	_	_	_	_	_	_	O
7	suggest	_	suggest	_	VBP	12	_	_	_	_	_	_	_	O
8	that	_	that	_	IN	12	_	_	_	_	_	_	_	O
9	policies	_	policy	_	NNS	12	_	_	_	_	_	_	_	O
10	focused	_	focus	_	VBD	12	_	_	_	_	_	_	_	O
11	on	_	on	_	IN	12	_	_	_	_	_	_	_	O
12	increasing	_	increase	_	VBG	12	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	12	_	_	_	_	_	_	_	O
14	number	_	number	_	NN	12	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	12	_	_	_	_	_	_	_	O
16	patients	_	patient	_	NNS	12	_	_	_	_	_	_	_	O
17	that	_	that	_	IN	12	_	_	_	_	_	_	_	O
18	a	_	a	_	DT	12	_	_	_	_	_	_	_	O
19	single	_	single	_	JJ	12	_	_	_	_	_	_	_	O
20	unk	_	UNK	_	JJ	12	_	_	_	_	_	_	_	O
21	physician	_	UNK	_	NN	12	_	_	_	_	_	_	_	O
22	could	_	could	_	MD	12	_	_	_	_	_	_	_	O
23	safely	_	safely	_	RB	12	_	_	_	_	_	_	_	O
24	and	_	and	_	CC	12	_	_	_	_	_	_	_	O
25	effectively	_	effectively	_	RB	12	_	_	_	_	_	_	_	O
26	treat	_	treat	_	NN	12	_	_	_	_	_	_	_	O
27	could	_	could	_	MD	12	_	_	_	_	_	_	_	O
28	unk	_	UNK	_	VB	12	_	_	_	_	_	_	_	O
29	effective	_	effective	_	JJ	12	_	_	_	_	_	_	_	O
30	in	_	in	_	IN	12	_	_	_	_	_	_	_	O
31	increasing	_	increase	_	VBG	12	_	_	_	_	_	_	_	O
32	buprenorphine	_	UNK	_	NN	12	_	_	_	_	_	_	_	O
33	use	_	use	_	NN	12	_	_	_	_	_	_	_	O
34	than	_	than	_	IN	12	_	_	_	_	_	_	_	O
35	would	_	would	_	MD	12	_	_	_	_	_	_	_	O
36	alternatives	_	alternative	_	NNS	12	_	_	_	_	_	alternative.n	Alternatives	O
37	such	_	such	_	JJ	12	_	_	_	_	_	_	_	O
38	as	_	a	_	IN	12	_	_	_	_	_	_	_	O
39	opening	_	open	_	VBG	12	_	_	_	_	_	_	_	O
40	new	_	new	_	JJ	12	_	_	_	_	_	_	_	O
41	substance	_	substance	_	NN	12	_	_	_	_	_	_	_	O
42	abuse	_	UNK	_	NN	12	_	_	_	_	_	_	_	O
43	treatment	_	treatment	_	NN	12	_	_	_	_	_	_	_	O
44	facilities	_	facility	_	NNS	12	_	_	_	_	_	_	_	O
45	or	_	or	_	CC	12	_	_	_	_	_	_	_	O
46	raising	_	raise	_	VBG	12	_	_	_	_	_	_	_	O
47	the	_	the	_	DT	12	_	_	_	_	_	_	_	O
48	overall	_	overall	_	JJ	12	_	_	_	_	_	_	_	O
49	number	_	number	_	NN	12	_	_	_	_	_	_	_	O
50	of	_	of	_	IN	12	_	_	_	_	_	_	_	O
51	unk	_	UNK	_	JJ	12	_	_	_	_	_	_	_	O
52	physicians	_	UNK	_	NNS	12	_	_	_	_	_	_	_	O
53	.	_	.	_	.	12	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	12	_	_	_	_	_	_	_	O
2	changes	_	change	_	NNS	12	_	_	_	_	_	_	_	O
3	after	_	after	_	IN	12	_	_	_	_	_	_	_	O
4	the	_	the	_	DT	12	_	_	_	_	_	_	_	O
5	2006	_	2006	_	CD	12	_	_	_	_	_	_	_	O
6	legislation	_	UNK	_	NN	12	_	_	_	_	_	_	_	O
7	suggest	_	suggest	_	VBP	12	_	_	_	_	_	_	_	O
8	that	_	that	_	IN	12	_	_	_	_	_	_	_	O
9	policies	_	policy	_	NNS	12	_	_	_	_	_	_	_	O
10	focused	_	focus	_	VBD	12	_	_	_	_	_	_	_	O
11	on	_	on	_	IN	12	_	_	_	_	_	_	_	O
12	increasing	_	increase	_	VBG	12	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	12	_	_	_	_	_	_	_	O
14	number	_	number	_	NN	12	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	12	_	_	_	_	_	_	_	O
16	patients	_	patient	_	NNS	12	_	_	_	_	_	_	_	O
17	that	_	that	_	IN	12	_	_	_	_	_	_	_	O
18	a	_	a	_	DT	12	_	_	_	_	_	_	_	O
19	single	_	single	_	JJ	12	_	_	_	_	_	_	_	O
20	unk	_	UNK	_	JJ	12	_	_	_	_	_	_	_	O
21	physician	_	UNK	_	NN	12	_	_	_	_	_	_	_	O
22	could	_	could	_	MD	12	_	_	_	_	_	_	_	O
23	safely	_	safely	_	RB	12	_	_	_	_	_	_	_	O
24	and	_	and	_	CC	12	_	_	_	_	_	_	_	O
25	effectively	_	effectively	_	RB	12	_	_	_	_	_	_	_	O
26	treat	_	treat	_	NN	12	_	_	_	_	_	_	_	O
27	could	_	could	_	MD	12	_	_	_	_	_	_	_	O
28	unk	_	UNK	_	VB	12	_	_	_	_	_	_	_	O
29	effective	_	effective	_	JJ	12	_	_	_	_	_	_	_	O
30	in	_	in	_	IN	12	_	_	_	_	_	_	_	O
31	increasing	_	increase	_	VBG	12	_	_	_	_	_	_	_	O
32	buprenorphine	_	UNK	_	NN	12	_	_	_	_	_	_	_	O
33	use	_	use	_	NN	12	_	_	_	_	_	_	_	O
34	than	_	than	_	IN	12	_	_	_	_	_	_	_	O
35	would	_	would	_	MD	12	_	_	_	_	_	_	_	O
36	alternatives	_	alternative	_	NNS	12	_	_	_	_	_	_	_	O
37	such	_	such	_	JJ	12	_	_	_	_	_	_	_	O
38	as	_	a	_	IN	12	_	_	_	_	_	_	_	O
39	opening	_	open	_	VBG	12	_	_	_	_	_	open.v	Candidness	O
40	new	_	new	_	JJ	12	_	_	_	_	_	_	_	O
41	substance	_	substance	_	NN	12	_	_	_	_	_	_	_	O
42	abuse	_	UNK	_	NN	12	_	_	_	_	_	_	_	O
43	treatment	_	treatment	_	NN	12	_	_	_	_	_	_	_	O
44	facilities	_	facility	_	NNS	12	_	_	_	_	_	_	_	O
45	or	_	or	_	CC	12	_	_	_	_	_	_	_	O
46	raising	_	raise	_	VBG	12	_	_	_	_	_	_	_	O
47	the	_	the	_	DT	12	_	_	_	_	_	_	_	O
48	overall	_	overall	_	JJ	12	_	_	_	_	_	_	_	O
49	number	_	number	_	NN	12	_	_	_	_	_	_	_	O
50	of	_	of	_	IN	12	_	_	_	_	_	_	_	O
51	unk	_	UNK	_	JJ	12	_	_	_	_	_	_	_	O
52	physicians	_	UNK	_	NNS	12	_	_	_	_	_	_	_	O
53	.	_	.	_	.	12	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	12	_	_	_	_	_	_	_	O
2	changes	_	change	_	NNS	12	_	_	_	_	_	_	_	O
3	after	_	after	_	IN	12	_	_	_	_	_	_	_	O
4	the	_	the	_	DT	12	_	_	_	_	_	_	_	O
5	2006	_	2006	_	CD	12	_	_	_	_	_	_	_	O
6	legislation	_	UNK	_	NN	12	_	_	_	_	_	_	_	O
7	suggest	_	suggest	_	VBP	12	_	_	_	_	_	_	_	O
8	that	_	that	_	IN	12	_	_	_	_	_	_	_	O
9	policies	_	policy	_	NNS	12	_	_	_	_	_	_	_	O
10	focused	_	focus	_	VBD	12	_	_	_	_	_	_	_	O
11	on	_	on	_	IN	12	_	_	_	_	_	_	_	O
12	increasing	_	increase	_	VBG	12	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	12	_	_	_	_	_	_	_	O
14	number	_	number	_	NN	12	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	12	_	_	_	_	_	_	_	O
16	patients	_	patient	_	NNS	12	_	_	_	_	_	_	_	O
17	that	_	that	_	IN	12	_	_	_	_	_	_	_	O
18	a	_	a	_	DT	12	_	_	_	_	_	_	_	O
19	single	_	single	_	JJ	12	_	_	_	_	_	_	_	O
20	unk	_	UNK	_	JJ	12	_	_	_	_	_	_	_	O
21	physician	_	UNK	_	NN	12	_	_	_	_	_	_	_	O
22	could	_	could	_	MD	12	_	_	_	_	_	_	_	O
23	safely	_	safely	_	RB	12	_	_	_	_	_	_	_	O
24	and	_	and	_	CC	12	_	_	_	_	_	_	_	O
25	effectively	_	effectively	_	RB	12	_	_	_	_	_	_	_	O
26	treat	_	treat	_	NN	12	_	_	_	_	_	_	_	O
27	could	_	could	_	MD	12	_	_	_	_	_	_	_	O
28	unk	_	UNK	_	VB	12	_	_	_	_	_	_	_	O
29	effective	_	effective	_	JJ	12	_	_	_	_	_	_	_	O
30	in	_	in	_	IN	12	_	_	_	_	_	_	_	O
31	increasing	_	increase	_	VBG	12	_	_	_	_	_	_	_	O
32	buprenorphine	_	UNK	_	NN	12	_	_	_	_	_	_	_	O
33	use	_	use	_	NN	12	_	_	_	_	_	_	_	O
34	than	_	than	_	IN	12	_	_	_	_	_	_	_	O
35	would	_	would	_	MD	12	_	_	_	_	_	_	_	O
36	alternatives	_	alternative	_	NNS	12	_	_	_	_	_	_	_	O
37	such	_	such	_	JJ	12	_	_	_	_	_	_	_	O
38	as	_	a	_	IN	12	_	_	_	_	_	_	_	O
39	opening	_	open	_	VBG	12	_	_	_	_	_	_	_	O
40	new	_	new	_	JJ	12	_	_	_	_	_	_	_	O
41	substance	_	substance	_	NN	12	_	_	_	_	_	_	_	O
42	abuse	_	UNK	_	NN	12	_	_	_	_	_	_	_	O
43	treatment	_	treatment	_	NN	12	_	_	_	_	_	_	_	O
44	facilities	_	facility	_	NNS	12	_	_	_	_	_	_	_	O
45	or	_	or	_	CC	12	_	_	_	_	_	_	_	O
46	raising	_	raise	_	VBG	12	_	_	_	_	_	_	_	O
47	the	_	the	_	DT	12	_	_	_	_	_	_	_	O
48	overall	_	overall	_	JJ	12	_	_	_	_	_	overall.n	Clothing	O
49	number	_	number	_	NN	12	_	_	_	_	_	_	_	O
50	of	_	of	_	IN	12	_	_	_	_	_	_	_	O
51	unk	_	UNK	_	JJ	12	_	_	_	_	_	_	_	O
52	physicians	_	UNK	_	NNS	12	_	_	_	_	_	_	_	O
53	.	_	.	_	.	12	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	12	_	_	_	_	_	_	_	O
2	changes	_	change	_	NNS	12	_	_	_	_	_	_	_	O
3	after	_	after	_	IN	12	_	_	_	_	_	_	_	O
4	the	_	the	_	DT	12	_	_	_	_	_	_	_	O
5	2006	_	2006	_	CD	12	_	_	_	_	_	_	_	O
6	legislation	_	UNK	_	NN	12	_	_	_	_	_	_	_	O
7	suggest	_	suggest	_	VBP	12	_	_	_	_	_	_	_	O
8	that	_	that	_	IN	12	_	_	_	_	_	_	_	O
9	policies	_	policy	_	NNS	12	_	_	_	_	_	_	_	O
10	focused	_	focus	_	VBD	12	_	_	_	_	_	_	_	O
11	on	_	on	_	IN	12	_	_	_	_	_	_	_	O
12	increasing	_	increase	_	VBG	12	_	_	_	_	_	_	_	O
13	the	_	the	_	DT	12	_	_	_	_	_	_	_	O
14	number	_	number	_	NN	12	_	_	_	_	_	_	_	O
15	of	_	of	_	IN	12	_	_	_	_	_	_	_	O
16	patients	_	patient	_	NNS	12	_	_	_	_	_	_	_	O
17	that	_	that	_	IN	12	_	_	_	_	_	_	_	O
18	a	_	a	_	DT	12	_	_	_	_	_	_	_	O
19	single	_	single	_	JJ	12	_	_	_	_	_	_	_	O
20	unk	_	UNK	_	JJ	12	_	_	_	_	_	_	_	O
21	physician	_	UNK	_	NN	12	_	_	_	_	_	_	_	O
22	could	_	could	_	MD	12	_	_	_	_	_	_	_	O
23	safely	_	safely	_	RB	12	_	_	_	_	_	_	_	O
24	and	_	and	_	CC	12	_	_	_	_	_	_	_	O
25	effectively	_	effectively	_	RB	12	_	_	_	_	_	_	_	O
26	treat	_	treat	_	NN	12	_	_	_	_	_	_	_	O
27	could	_	could	_	MD	12	_	_	_	_	_	_	_	O
28	unk	_	UNK	_	VB	12	_	_	_	_	_	_	_	O
29	effective	_	effective	_	JJ	12	_	_	_	_	_	_	_	O
30	in	_	in	_	IN	12	_	_	_	_	_	_	_	O
31	increasing	_	increase	_	VBG	12	_	_	_	_	_	_	_	O
32	buprenorphine	_	UNK	_	NN	12	_	_	_	_	_	_	_	O
33	use	_	use	_	NN	12	_	_	_	_	_	_	_	O
34	than	_	than	_	IN	12	_	_	_	_	_	_	_	O
35	would	_	would	_	MD	12	_	_	_	_	_	_	_	O
36	alternatives	_	alternative	_	NNS	12	_	_	_	_	_	_	_	O
37	such	_	such	_	JJ	12	_	_	_	_	_	_	_	O
38	as	_	a	_	IN	12	_	_	_	_	_	_	_	O
39	opening	_	open	_	VBG	12	_	_	_	_	_	_	_	O
40	new	_	new	_	JJ	12	_	_	_	_	_	_	_	O
41	substance	_	substance	_	NN	12	_	_	_	_	_	_	_	O
42	abuse	_	UNK	_	NN	12	_	_	_	_	_	_	_	O
43	treatment	_	treatment	_	NN	12	_	_	_	_	_	_	_	O
44	facilities	_	facility	_	NNS	12	_	_	_	_	_	_	_	O
45	or	_	or	_	CC	12	_	_	_	_	_	_	_	O
46	raising	_	raise	_	VBG	12	_	_	_	_	_	_	_	O
47	the	_	the	_	DT	12	_	_	_	_	_	_	_	O
48	overall	_	overall	_	JJ	12	_	_	_	_	_	_	_	O
49	number	_	number	_	NN	12	_	_	_	_	_	number.n	Be_subset_of	O
50	of	_	of	_	IN	12	_	_	_	_	_	_	_	O
51	unk	_	UNK	_	JJ	12	_	_	_	_	_	_	_	O
52	physicians	_	UNK	_	NNS	12	_	_	_	_	_	_	_	O
53	.	_	.	_	.	12	_	_	_	_	_	_	_	O

